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2Abstract
In order to examine the metabolism of bacteria in the genus Enterobacteriaceae tools
for gene complement comparison and stoichiometric model building have been developed
to take advantage of both the number of complete bacterial genome sequences currently
available and the relationship between genes and metabolism.
A functional genomic approach to improving knowledge of the metabolism of Es-
cherichia coli CFT073 (a uropathogen) has been undertaken taking into account not only
its genome sequence, but its close relationship to E. coli MG1655. A fresh comparison of
E. coli CFT073 has been done with E. coli MG1655 to identify all those genes in CFT073
that are not present in MG1655 and may have metabolic characteristics. These genes have
further been bioinformatically assessed to determine whether they might encode enzymes
for the metabolism of chemicals commonly found in human urine, and one set of such
genes has been experimentally conﬁrmed to encode an L-sorbose utilisation pathway.
Little experimental work has been done as yet to elucidate how bacteria adaptively
respond to the introduction of heterologous metabolic genes. To investigate how bacteria
respond to such DNA, genes encoding the L-sorbose utilisation and uptake operon from
CFT073 have been cloned and transformed into DH5 and a selective pressure (minimal
medium with L-sorbose as sole carbon source) has been applied over 100 generations of
growth of this strain in serial passage to investigate the change in its behaviour.
The availability of large numbers of completely sequenced genomes, along with the de-
velopmentofastoichiometricmetabolicmodelwithveryhighcoverageofE.colimetabolism
(iAF1260 [1]) have made possible the analysis of the core metabolism of large numbers of
bacteria to investigate gene essentiality in these bacteria. A novel way of assessing gene
complement has been developed using BLAST and DiagHunter to improve reliability of
gene synteny comparisons with contextual information about the genes and to extend work
by others to cover all E. coli and Shigella genome sequences with available sequences on
GanBank (as of 1st June 2009) in order to bioinformatically investigate essential genes in
these bacteria and the heterogeneity of their metabolic networks. Further to this a metabolic
model has been constructed for DH5 with an added L-sorbose pathway and for CFT073
and these models have been used to investigate behavioural changes during adaptation of
bacteria to novel heterologous genes.
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9Chapter 1
Introduction
1.1 Bacterial metabolism and its genomic basis
All bacteria must eat to survive. They must take in an array of relevant
moleculesthenthroughthecontrolledbreakdownanduseofthesemolecules
they must maintain their structural integrity, respond to changes in the envi-
ronment, grow and ultimately reproduce. At the same time, they must keep
out a whole tranche of deleterious molecules, and delicately control the up-
take and rate of metabolism of those molecules that are to be used because
too much of almost any molecule is dangerous. Further when competing
with other bacteria, even sister cells, efﬁciency is the key to outcompeting
and ultimately dominating in the evolutionary arms race. This competition
in metabolic terms consists of optimising the enzymes at the bacterium’s
disposal to increase activity but also, and perhaps more importantly when
many enzymes are well optimised already, of tuning the regulatory response
of the bacterium such that in any particular environment or conditions only
relevant enzymes are produced, in the right amounts and in the correct pro-
portions, so that metabolic capacity is not wasted in making too much of
10one product or not enough of another.
Ultimately through a delicate balance of levels of all enzymes in the bac-
terium efﬁcient use can be made of the molecules both outside and inside
the cell. Transport across the cell boundary and the intricate web of in-
terdependent reactions that carry on inside the cell combine to produce a
well ordered and ultimately successful living organism. The gene centred
model of bacterial metabolic function began in the Nineteenth Century with
Mendel’s experiments on heredity providing the ﬁrst evidence of links be-
tween ancestry and what is now called phenotype [2]. Louis Pasteur’s work
on fermentation of sugar to ethanol by yeast cells was seminal in the asso-
ciation of unicellular organisms and chemical processes. A further step was
required, however, to link enzymatic metabolism with inheritance, and this
was taken by Beadle and Tatum [3] when their observations that a single
mutation in a gene of Neurospora crassa’s seemed to produce dependence
of that organism on vitamin B6. So it was established that in the majority of
casesa single geneaccountsfor asingleenzymaticfunction soineffect each
gene (or set of genes in the case of multi-protein enzymes) corresponds to
the ability of an organism to drive a particular chemical reaction or transport
process within the cells of the organism. Thus the problem of understanding
how bacteria adapt to their environment, carry out their day-to-day mainte-
nance and reproduce has become one in a great part of genetics and, in the
post-Genomic era, of genomics. Through the one-to-one association be-
tween genes and enzymatic proteins the intimate link between genomes and
metabolic function is established.
There is more information about metabolism in the genome than just the
11gene-enzyme correspondence. Genes are grouped in co-expressed groups,
operons, which often indicate an association of function. Operons are con-
trolled by various mechanisms related to the speciﬁc DNA sequence directly
upstream of the ﬁrst gene in the operon, which regulate the rate of produc-
tion of each enzyme and indeed whether an enzyme is expressed at all. For
instance possibly the best studied and certainly the most famous regulatory
mechanisms are those of the lac operon, studied by Monod [4], which re-
press the production of the lactose transport and metabolism genes in the
presence of glucose or in the absence of lactose, and up-regulate the expres-
sion of these genes when glucose is lacking and lactose is present. Indeed
regulatory mechanisms extend beyond control of single operons to global
regulation of gene expression and they co-ordinate regulation of large sets
of genes by speciﬁc transcription factors (TFs) which are themselves pro-
teins encoded by genes and under the control of further TFs and of other
stimuli, for instance presence or absence of speciﬁc molecules, as with the
lac operon.
This tangled web of interactions between proteins and chemicals which
extends to thousands of speciﬁed components and permeates all of life con-
trolseveryaspectofcells’lives; responsetotheenvironment, growthandre-
production all require high precision timing and control of thousands of bio-
logical actions which are achieved through these complex networks of inter-
acting regulators and enzymatic proteins. To fully understand the metabolic
network of a bacterium and ultimately to adapt it to practical ends, for in-
stance the production of useful chemicals (e.g. [5]), in pharmaceuticals
(e.g. [6]), or the clean-up of toxic waste, the components of this network
12must be identiﬁed, characterised and eventually understood in the context of
the whole cell. One great step towards this goal is the sequencing of whole
bacterial genomes, which gives the composition of all proteins involved in
the life of a bacterium and, when it can be deciphered, the details of many
of the mechanisms of control of expression of these proteins.
1.2 Genomic Sequencing and Comparisons
1.2.1 Genome Sequencing Techniques
The bacterial genome, if correctly interpreted, is a complete list of tools
for a bacterium. It is therefore a vital step in the understanding of bacteria
to sequence their genomes. The double helical structure [7], linear nature
and small alphabet coding system of DNA [8] make it convenient to repre-
sent in a linear way using four characters: C, A, T and G; efﬁcient genome
sequencing also relies on these characteristics. The ﬁrst feasible systems
for sequencing large amounts of DNA were developed by Sanger et al in
Cambridge, UK, in the mid-1970s ([9, 10]), at the same time as Maxam
and Gilbert developed their own method in at Harvard, Cambridge, Mas-
sachusetts [11].
Sanger’s dideoxy method was widely adopted over Maxam and Gilbert’s
chemical sequencing method and was used, once full-scale automation of
this genome sequencing technique had been developed (for instance by
Leroy Hood’s laboratory in Caltech [12]), for the sequencing of increas-
ing amounts of DNA. In the mid 1990s The Institute for Genomic Research
(TIGR) was set up at NIH by Venter with a large number of automated
13sequencing machines from ABI producing one of the ﬁrst large-scale se-
quencing centres [13]. It was here that the ﬁrst complete bacterial genome
sequence, that of Haemophylus inﬂuenza [14], was completed. Further de-
velopment of automation based on the dideoxy technique involved the re-
placement of a slab gel for running samples with more efﬁcient capillary
electrophoresis, pioneered by ABI in the form of the ABI Prism 300 au-
tomated sequencer in 1996. At this point in the development of DNA se-
quencing the idea of sequencing the human genome became feasible and
this was pursued both publicly and privately culminating in two draft hu-
man genomes published in 2001 [15, 16].
Capillary array electrophoresis (CAE), where many capillaries in paral-
lel are used for sequencing, is currently the standard technique for DNA se-
quencing. However, in the past few years several commercial systems have
been developed that do not rely on the dideoxy method for sequencing, but
instead use novel techniques which sacriﬁce length of individual reads of
DNA for very high numbers of DNA fragments read. The machines of 454
Life Sciences [17] use pyrosequencing [18] to produce sequences of length
approximately 250 bp, those of Solexa use a single molecule sequencing
(SMS) technique to produce reads. CAE currently routinely produces read
lengths of approximately 1000 bp [19] in comparison to these.
New sequencing techniques are being developed at a great pace (re-
viewed by Chan [20]) and the ones mentioned above are still in their in-
fancy, so still being improved very rapidly. Developments of several dif-
ferent approaches to SMS are currently being researched and as this type
of technique, using a single DNA molecule, solves several of the problems
14associated with traditional sequencing techniques, such as PCR bias, and
has the potential to give long reads at high precision quickly (for a review
of SMS technology and research see Gupta [21]).
1.2.2 BLAST
The Basic Local Alignment Search Tool (BLAST) [22, 23] was developed
in response to the increasing amount of sequence data produced by sequenc-
ing projects. Gene sequence data were proliferating through the 1990s and
although databases of sequences were set up the full potential of genome,
gene and genetic product sequences was not yet realisable. What was re-
quired was a system for assessing relationships between sequences, specif-
ically a way to determine common ancestry. Since all life is related, sim-
ilarities in genes and genomes range across the whole spectrum from sin-
gle celled bacteria to trees to humans, from hyperthermophilic organisms
clustered around deep sea thermal vents to polar bears. Quantiﬁcation of
relationships between genes and determination of function through com-
parisons with already functionally characterised genes required a tool for
comparisons and BLAST was that tool.
BLAST uses variations on a single algorithm for comparing different
types of sequences: such as protein sequences against other protein se-
quences or DNA sequences against DNA sequences. Since genome se-
quence comparisons are of interest the DNA versus DNA algorithm will
be described. For similarity measures there is a simple matrix of scores
for base pair identities and differences between the query and reference se-
quences. Since identities score positively and differences score negatively,
15there will be two lengths of DNA (not necessarily the full length of either
of the sequences being tested), one in each tested sequence, that give the
highest score when compared with each other. This is called the maximal
segment pair (MSP) and the score derived from this MSP is then used as an
indicator of the extent of similarity between the two sequences. This simi-
larity is quantitative and can be used to ﬁnd closely related sequences, and
lower scoring pairs of sequences that may be bear random similarities even
though they are unrelated or be distantly related.
There are various techniques used by the BLAST algorithm which com-
promise between accuracy and time taken for a comparison to be done, but
generally these have a very low impact on the reliability of the results pro-
duced [22]. The limitations in terms of gaps in alignments, where perhaps a
pair of sequences had more than a single region of high similarity, separated
by an unrelated or poorly conserved region of DNA, was eliminated by the
introduction of gapped BLAST in 1997 [23] and this allowed the applica-
tion of BLAST to ever more sequences in various circumstances. There
are very many articles which rely on BLAST results since its creation and
for genome sequence comparisons (discussed below) all rely on BLAST for
their comparative power. Not only can BLAST be used directly between
two sequences of interest, but it can be used to survey the entirety of any
sequence database to ﬁnd homologs and consequently infer gene function.
The databases used most frequently are accessed through the National Cen-
ter for Biotechnology Information (NCBI) Entrez system [24] which incor-
porates the GenBank [25] database of nucleotide sequences for more than
300,000 organisms, including 944 complete published genome sequences
16according to the Genomes Online Database (GOLD) [26] as well as many
complete genome sequences without an associated publication.
BLASTisthereforeusefulintwosituationsinanalysingcompletegenome
sequences: ﬁrstly to identify putative (and perhaps even speciﬁc) functions
for genes and secondly to survey differences between complete genome se-
quences. There are however limitations to BLAST, of course it cannot pre-
dict the function of a gene where there are no homologous genes in the in-
terrogated database or where none of the homologs have an experimentally
conﬁrmed function. Also, even when genes have almost identical sequences
this does not guarantee that the genes perform the same function. It is pos-
sible that a single point mutation might completely inactivate the product
of a mutated gene and has been shown to occur in some cases (for instance
in [27]). This does not invalidate the BLAST approach to identifying gene
function through sequence comparison, since in the vast majority of cases
point mutation does not signiﬁcantly affect gene function. If a gene is inac-
tivated in a viable organism and does not affect the organism’s viability the
gene no longer has any evolutionary pressure on it and will quickly accumu-
late other mutations (on an adaptive timescale), moving the gene sequences
away from homology. Thus although care is needed when inferring conser-
vation of function, BLAST is an excellent tool in most cases.
According to its NCBI protein table a recently sequenced E. coli genome
(that of E. coli O127 H6 [28]) contains 843 labelled hypothetical proteins
out of a total of 4554 protein coding genes in the genome. This means
that the proteins are predicted to be expressible but there were no other se-
quences at the point of sequence analysis that could have been homologs
17and have the same function, that were functionally annotated in GenBank.
This is a fairly typical number in whole genome sequences that roughly 20
% of the genes have unknown function. A notable exception to this state
of affairs is E. coli K-12 strain MG1655 and very closely related strains:
MG1655 has 26 proteins labelled as hypothetical, in large part due to its
position as model commensal E. coli in laboratories around the world and
the huge number of published articles on its properties. This does not mean
that every other gene in MG1655 has a known function and others are la-
belled with such descriptions as ’inner membrane protein’ and other general
labels, but it indicates the current knowledge of E. coli as a whole.
WhenBLASTfailstoﬁndhomologsforgenesincurrentsequencedatabases
there are several other programs to aid the search if not for a speciﬁc func-
tion then at least for a class description or other general indication of the
coded protein’s function. These are often also based on sequence similari-
ties, but of translated nucleotide amino acid sequences, the inferred protein
sequences of the uncharacterised genes. One example of this approach is
the NCBI’s Conserved Domains [29] which compares the inferred protein
sequence of a gene with conserved protein domains in an NCBI domain
database. These conserved domains are based on a pre-run multiple se-
quence alignment of the relevant part of various proteins that contain the
same domain, coming from several different organisms, to give a more ro-
bust comparison where a consensus sequence derived from these previous
comparisons shows which parts of the sequence are conserved most in these
different contexts and therefore which parts of the sequence are most im-
portant for conserving function.
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tions to proteins of otherwise unknown function. Another technique for the
elucidation of protein function is de novo protein chain folding models and
3-dimensional structure comparisons, often aided by genome sequences as
in subgenome analysis of functionally and evolutionarily linked genes in a
particular genome (a technique reviewed by Man et al [30]) although struc-
ture and function are related in a complex way and the difﬁculties of infer-
ring function from structure are very similar to those of inferring function
from homology, as discussed by Punta and Ofran [31]. In practice attempts
to get better functional annotations of novel proteins combine several meth-
ods ofanalysis into synthesisefrom thesea morespeciﬁc functional annota-
tion. Where proteins are unlike any other thus far functionally characterised
combinations of methods are also used to ﬁnd clues about potential function
[32, 33].
1.2.3 Genome Comparisons
The ﬁrst complete DNA genome to be sequenced was that of bacteriophage
 X 176 which contains 5386 bases [34]. The ﬁrst organism to have its
genome completely sequenced was Haemophilus inﬂuenzae [14], which is
1.8 Mb (megabases) in length. The ﬁrst E. coli to be sequenced was strain
K12 MG1655 [35], 4.6 Mb in length, and since then 45 more strains of bac-
teria in genus Escherichia have been fully sequenced according to the NCBI
TaxonomyBrowserhttp://www.ncbi.nlm.nih.gov/Taxonomy/.
Table 1.1 (p. 42) shows most of these strains and their accession number or
source if they have not yet been assigned an accession number. Where the
19genome sequences have associated publications these have been indicated.
It is also shown in Table 1.1 whether the genome sequence is in the form
of a complete single contig, or still in multiple contigs from the shotgun se-
quencing, and not yet fully pieced together. This has consequences for the
analysis of whole genomes so the feasibility of using these whole genome
shotgun (WGS) sequences will be discussed here. The nature of the change
of bacterial genomes is plastic, that is, they are quite capable of large-scale
rearrangements (for instance the inversion of the segment of DNA between
loci rrnD and rrnE in E. coli W3110 [58] relative to MG1655), so even large
segments of sequenced DNA cannot necessarily be lined up and joined us-
ing another closely related strain as a template. However, this does not com-
pletely preclude these multi-contig shotgun sequences from use: that large
scale rearrangements can be accommodated by bacteria is shown by W3110
and MG1655, with only very little phenotypic change, so in some appli-
cations it is irrelevant to bacterial function how large tracts of the genome
sequence ﬁt together, only which genes and operons are intact and func-
tional.
The WGS sequences listed in Table 1.1 have varying numbers of contigs,
but typically they have around 100. The coverage of these contigs seems
good: lengths of shotgun sequences appear to be of a similar length to com-
plete sequences, suggesting that there is not much left unsequenced. If it is
assumed that almost all of the genome covered by the shotgun sequences,
that all of it is made up of DNA related to one operon or another and that
operons are randomly sized then approximately 100 will be incorrectly se-
quenced, since they will lie across the ends of the contigs. Indeed, due to
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in the same operon) the actual number of incompletely sequenced operons
may well be less than 100. This compares to 2670 operons overall in Es-
cherichia coli K12 MG1655 according to RegulonDB [59], so under 5 % of
operons are incompletely sequenced. So for the purposes of whole genome
comparisons these WGS sequences can at least be considered for addition
to any whole genome comparison, albeit with the proviso that sequences at
the edges of the contigs should be treated carefully.
Comparisons of bacterial genomes have occurred more-or-less since the
second bacterial genome was sequenced, that of Mycoplasma genitalium
[60] in 1995. Many investigations now take subsets of genomes for com-
parison, but do it across all sequenced organisms, giving a short but wide set
of data to analyse (for instance [61]). BLAST [23] is the workhorse of such
comparisons, providing conﬁdence levels that genes or operons are con-
served between bacteria. This comparison of genome sequences is of vital
importance when investigating how and why genome complements differ
between bacteria, even very closely related ones, and eventually for eluci-
dating some insight into how genomes change in time. The actual process
of comparison can be as simple as single BLAST searches against whole
genomes of interest to ﬁnd homologs using an identity cutoff [62] or very
intricate, using many computer programs to assess alignment and phylo-
genetic distance [61], though many systems, however complex, often still
require visual inspection before ﬁnal results are obtained. Human pattern
recognition has yet to be rendered entirely redundant, but computers vastly
increase the amount of data that can be processed and ultimately enable
21analyses of this sort.
Comparisonsarenotlimitedtoinferringconservedfunctionsinthenewer
bacterial genome, but also in studying evolution and evolutionary dynam-
ics. They have been used in trying to ﬁnd a minimal set of genes required
for a self-sufﬁcient organism [63], which is closely related to the search for
essential genes, in inferring not only recent (100 million years) evolution-
ary dynamics [64] but also in gaining insights into the characteristics of the
evolution of early life [65, 61] and even in supporting the claim that there
was life supported by an RNA genome before DNA became the ubiquitous
material for genomes as it is with all modern terrestrial life [66]. Evolution
on the timescale of the existence of animals, particularly mammals, is of
particular interest since it sheds light on how commensal and pathogenic
bacteria that inhabit humanity have developed in interaction with their hosts
who would in many respects have been quite similar to modern humans, and
with other contemporaneous bacteria, and in this genome comparisons are
invaluable. They shed light on those aspects of chromosome organisation
and complement that are essential and those which are unimportant in coex-
istence with a host and with competing organisms, which particularly aids
attempts to understand and combat bacterial pathogenic infection [67, 62].
Comparisons are often carried out over multiple genome sequences to
build up patterns of similarities and differences. For instance the library of
genome sequences of genus Escherichia has been used to investigate the
acquisition of toxin genes across sequenced enterotoxigenic E. coli (ETEC)
[68]. Various methods for making the most of bacterial genome sequence
libraries have been developed, such as robust inference of transcriptional
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dynamics of large-scale clustering of bacterial operons by sequence com-
parisons [70]. Whole genome sequence comparisons have also enabled the
investigation of those aspects of organisms’ lifecycles that are intrinsically
related to the whole genome or large parts of it, such as the metabolic net-
work, which typically in E. coli involves of the order of 1000 genes, and
although mostly only a small subset of those will be expressed at a single
time tight control of every single gene is essential for competitive advantage
and even survival in certain conditions.
The challenge for Biologists when given all these new data for analysis is
to extract as much information as is possible from these genome sequences
with as little benchwork as possible (to save time, energy and money) and
to allow experimental time to be used effectively and in a targeted manner.
While undertaking this task there is a payoff to be had using these sequences
between general results, rich in explanatory power but of limited immediate
practical use (such as the investigation of bacterial operon clustering [70])
and speciﬁc results, of limited applicability but very useful in that small area
of research (such as developing the knowledge of ETEC with the hopes of
pointing the way to the development of more effective vaccines [68]). Re-
search into bacterial metabolism, including genome-scale metabolic models
(for instance iAF1260 [1]) and genome-scale transcriptional regulatory net-
works [69], tries to bridge the scale divides between general insight into
how bacterial networks are built and speciﬁc questions about how bacte-
ria respond to changes in environment, how they respond to natural genetic
perturbations and increasingly how they respond to genetic engineering.
231.2.4 Successive inferred annotation
In essence the normal method of annotation is to ﬁnd mutual best BLAST
hits in the GenBank non-redundant database for each gene found in the new
genome. The problem is that once this new gene has been annotated and
submitted to GenBank as part of the newly sequenced genome it becomes a
valid target for other BLAST runs for newer sequenced genes. So for exam-
ple if gene A (the function of which has been experimentally veriﬁed) is a
mutual best BLAST hit for gene B and gene B is a mutual best BLAST hit
for gene C then gene C can be inferred to have the same function (or at least
the same annotation) as gene A despite it not necessarily being close enough
in sequence homology to gene A to merit this inference. One of the potential
mechanisms of evolution is gene duplication and consequent genetic drift of
one of the genes to produce novel function. Paralogs produced in this fash-
ion will be particularly susceptible to the successive BLAST annotational
inference error due to their identical genetic origin.
1.3 Bacterial metabolic models
The metabolic network of a bacterium can be modelled as a system of dif-
ferential equations, each equation representing a reaction that is present in
a particular system (though not necessarily with any ﬂux through it), how-
ever a realistic model governing reaction rates is often intransigent to solu-
tion when there are a large number of simultaneous differential equations to
solve, so often just the network of reactions and metabolites is used [1], or a
small subset of metabolites and reactions (eg. limited to central metabolism)
24is used, but even then a simpliﬁed regulatory model is usually used [71, 72].
In the evolution of modern metabolic networks many factors will have
impacted on how they developed, including their network nature. One
model of this evolution is that it has occurred as a stepwise construction
of the metabolism one reaction at a time - this model has led Handorf et al
to conduct simulated network creation in this manner and to the conclusion
that the expansion of metabolic networks is robust to small perturbations
(eliminations of a few reactions), but some reactions when lost hamper the
growth of these metabolic networks considerably [73]. A common attribute
of all biological metabolic networks is their scale-free nature, that there is a
power lawdistribution of connectivityfor the metabolites [74], and although
the reason for this is by no means settled it seems that it is a consequence of
the way in which metabolic networks have been constructed and that even
given very few assumptions about the mechanisms of evolution of these net-
works the log-normal dynamics of the growth of metabolic networks pro-
duce scale-free networks and metabolic networks that are not scale-free at
any particular time tend towards this characteristic as they develop [75, 76].
The huge amount of data on metabolic pathways and genome sequences
availablehaveproducedevermorecomplexandintegrativetoolsformetabolic
network reconstruction, such as the SEED tool curated by the Fellowship
for the Interpretation of Genomes (FIG) [77], which breaks up the whole
metabolic network into smaller component networks which are analysed
against a database of components to get robust veriﬁcation of these compo-
nents independently, then reconnects the whole network of the given organ-
ism. Also, information about gene functions can often be extracted from
25metabolic gene annotations since these annotations include the name of the
reaction catalysed by the enzyme coded for by the gene (for instance this
is the basis of MetaCyc’s PathoLogic algorithm for inferring metabolic net-
works [78]), but annotations do not always wholly deﬁne the gene function.
It would be more convenient thereofore to infer a quantitative metabolic
function from a manually created and curated model of a closely related or-
ganism, which could then be integrated with all other metabolic functions of
all other coded proteins in a particular organism to infer a stoichiometrically
complete metabolic model.
1.3.1 Whole genome metabolic models in metabolic engineering
Whole genome metabolic models are being increasingly used in metabolic
engineering for assessing the impact of gene complement changes in bacte-
ria and directing improvement by identifying gene deletions that could im-
prove production of, say, recombinant protein by redirection of metabolic
ﬂux. For instance Oddone et al [79] have recently used such a model to
qualitatively predict improved ﬂux distribution in L. lactis engineered to
overproduce a target protein. The construction of this model was done by
initial inference from gene annotation data and manual assessment of each
gene functional assignment [80].
Approaches like this have also been used to improve succinate produc-
tion in E. coli, by modiﬁcation of genes identiﬁed by ﬂux analysis of a
whole genome metabolic model [81]. These uses of metabolic models in
engineering are becoming increasingly common, as they provide ways of
26directing genetic modiﬁcation for improvement of production of recombi-
nant proteins and small molecules.
1.3.2 Reconstructing metabolic networks
One resource for metabolic reactions that takes advantage of genome se-
quencing and annotation is MetaCyc’s Pathway Tools software [82] which
reconstructs metabolic networks and currently (as of June 2009) holds pre-
dicted gene complements of a large number of organisms, including 8 E.
coli and 6 Shigella strains, including MG1655 and uropathogenic E. coli
CFT073. The Pathologic algorithm for producing metabolic networks for
MetaCyc relies on gene annotations from sequenced bacteria, requiring an
initial annotation step before comparison. Further, steps towards fully au-
tomated reconstruction of metabolic networks have been taken using Geno-
matica’s proprietary SimphenyTMsoftware, for instance to produce an in-
ferred metabolic network for Lactococcus lactis IL1403 [83] using previ-
ously constructed networks from 3 other metabolic networks, including that
of MG1655.
Ithasbeennotedbyothersthattheannotationofnewlysequencedgenomes
are often poor, despite the large number of bioinformatic tools available for
the task [84]. Therefore in the production of new metabolic models it would
be useful not to rely on such annotations. Further, there is often a lack of
physicochemical characteristics of reactions (such as their reversibility in
physiological conditions and the physical locations of the reactions in the
cell) which must be found by analysis of individual reactions [85]. There
27have been metabolic model reconstructions that have collected such data
for several reference organisms, which rely on biochemical characterisa-
tion (from literature) for their characteristics, thus represent repositories of
knowledge speciﬁcally relevant to the metabolism of those reference organ-
isms.
On such model is of E. coli MG1655, iAF1260 [1], which accounts for
1260 open reading frames (ORFs) of the 4244 genes in that organism. It
is a constraint-based stoichiometric model which means that it comprises
stoichiometrically balanced reactions with absolute ﬂux constraints on each
reaction, butisotherwiseonlyconstrainedbyreactiondirectionsdetermined
by thermodynamic considerations. It does not take into account any regu-
latory information about the bacterium, even though much is known about
speciﬁcregulatorymechanisms(forinstanceasavailablefromRegulonDB),
since adding regulation to this size of model would make it computationally
difﬁcult to solve. Instead solutions produced by the linear optimisation of
the model with an objective of maximising the so-called ‘Biomass’ reaction
represent boundaries between physically possible and physically impossi-
ble ﬂux distributions. The ‘Biomass’ reaction is balanced such that in the
solution of ﬂux values for each reaction, ﬂux through the Biomass reaction
is equal to the growth rate of the organism in those conditions. It is not as-
sumed that bacteria in their natural habitat will achieve this rate of growth,
indeed the idea that maximising growth rate or molar yield is a goal of bac-
teria has been shown not to be universal [86], though it has been shown that
MG1655 approaches this rate when grown in conditions designed to select
for high growth rates in a constant environment [87].
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model iAF1260 includes gene-protein-reaction relationships [1]. These re-
lationships are very important in the inference of new metabolic models
since they link genomic comparisons, in the form of BLAST hits between
genes or some other bioinformatic method for gene inferences, with con-
served metabolic reactions between MG1655 and the query bacterium. The
stoichiometric nature of the model means that the inference of a new model
is equivalent to deletions of the columns corresponding to unconserved re-
actions in a matrix of reactions available in the original model. It is imme-
diately apparent that there might be limitations to the use of a single model
for inferring other bacterial models - any reactions not present in the model
strain must be added by some other method to a new model of a different
bacterium.
There are currently many genome sequences of bacteria of genus Es-
cherichia listed in Table 1.1, as well as those of Shigella bacteria, which are
verycloselyrelatedtogenusEscherichia. Withthislargenumberofgenome
sequences it should be possible to reconstruct and compare many metabolic
models, running them according to the conditions set out for iAF1260, that
is, using the same model parameters and initial conditions to compare the
models. The principles applied to comparing these closely related bacteria
could also be used with more distantly related bacteria, and the limits of
the applicability of one bacterial model to genomically disparate organisms
could be tested.
291.4 Gene essentiality in E. coli
Gene essentiality knowledge is potentially a useful tool in assessing valid-
ity of gene function inferences and will be considered in Chapter 6. Sev-
eral experimental attempts have been made to identify the essential genes
in E. coli, that is, the genes which when disrupted in otherwise wild-type
E. coli render the bacterium incapable of growth in rich media. The Keio
collection [88] was constructed as a complete set of viable in-frame single
gene-knockout mutants of E. coli K-12 BW25113. The process by which
this was achieved produced in principle knockouts for every gene in that
bacterium, but those which were not viable did not grow for their deletions
to be conﬁrmed. Therefore all of the genes for which a knockout could not
be found are candidate essential genes.
The strain BW25113 is closely related to MG1655, having been de-
rived from the same wild-type parent strain and its genotype with respect to
the wild-type K-12 EMG2 is: rrnB3 lacZ4787 hsdR514 (araBAD)567
(rhaBAD)568rph-1. ThegenotypeofMG1655isrph-1, sothedifferences
only account for a few well-deﬁned genes; in both strains the F plasmid and
phage  are absent. MG1655 gene equivalents in BW25113 for which no
viable deletion mutants could be produced, 296 in total, are listed Supple-
mentary Table 3. Four other genes inferred in this study have since had their
entries discontinued in GenBank. Essentiality of genes inferred by Baba et
al [88] was determined in LB medium. They also did a comparison of the
number of essential genes in three other E. coli strains and found that 282
of these genes were also present (according to contemporary annotations)
30in these other three strains.
Gerdes et al [89] have made a survey of essential genes using a genetic
ﬁngerprintingtechnique(usingtransposonmutagenesis), revealing620genes
found to be essential in the conditions set out in the survey - these genes are
also indicated in Supplementary Table 3. The ’Proﬁling of E. coli Chromo-
some’ database [90] contains a list of essential genes according to literature
surveys and is included in Supplementary Table 3. Finding gene essential-
ity is a reductive enterprise - if a gene can be shown to be non-essential
in a particular environment then it can be removed from the list of essen-
tial genes. The two mutagenesis studies mentioned above both use LB rich
media, which was designed for growth of E. coli [91], and is therefore ex-
cellent for elucidating truly essential genes from media-speciﬁc essential
genes. The set of essential genes used to investigate the genome compar-
isons presented in this thesis is the intersection of the sets of genes that are
essential according to the three lists described above, 191 in total shown in
Supplementary Table 3.
1.5 Uropathogenic E. coli and Metabolism
UropathogenicE.coli(UPEC)arethecausalagentsof80%ofallcommunity-
acquired urinary tract infections (UTIs) [92]; other bacteria such as Kleb-
siella spp. and Pseudomonas spp. as well as many others can also infect
the urinary tract. UPEC typically cause disease in one of several parts of
the urinary tract: urine (bacteriuria), the kidneys (pyelonephritis), the blad-
der (cystitis), the ureter (ureteritis) and the prostate (prostatitis), for instance
31UPEC CFT073 was isolated from a patient with acute pyelonephritis [93]
(though it was isolated from the blood) and F11 from a patient with cystitis
[45] - these are the most common forms of UTIs, thus bacteria causing these
have been the most extensively investigated. Although these two strains are
very closely related, inklings of the sensitivity ofthese bacteria to gene com-
plement can be seen in the fact that the courses of pyelonephritis and cysti-
tis caused by CFT073 and F11 (and several others of each type) have been
shown to be quite different [94]. It should be noted, however, that there are
commonalities between the infections: they are generally rising infections
from the lower urinary tract and thus must survive in very similar conditions
as they colonise their host’s urinary tract.
One of the fascinating and most important discoveries resulting from
widespread whole genome sequencing of pathogenic bacteria is the discov-
ery that many of these virulence factors are physically close on the bacterial
genome and that they generally fall into Pathogenicity-Associated Islands
(PAIs) which are ﬂanked by directly repeated sequences which are impli-
cated in the evolution of the pathogenic bacteria via horizontal gene transfer.
PAIs were ﬁrst recognised by Blum et al [95] in E. coli 536, another UPEC,
but it was on full genome sequencing of these strains that the paradigm of
multiple unstable sites of PAI integration and the ability of bacteria to ex-
change these PAIs in single (and very common) excision/insertion events
became clear, with transfer RNA genes being the target sites for excision
(and insertion). These events are presumed to be mediated by integrases or
IS elements which are usually present in the PAIs themselves, though often
they are cryptic, indicating that many PAIs were once unstable, but have
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[96]).
E. coli CFT073 was selected, presumably because it was one of the most
virulent UPEC isolated at that time, as the ﬁrst UPEC to have its com-
plete genome sequenced [42]. It already had several of its PAIs sequenced
([97, 98]) which contained many of its virulence factors - those genes con-
tributing signiﬁcantly to virulence - such as those coding for P ﬁmbriae
which are implicated in bacterial adhesion in the urinary tract and those
coding for iron chelation proteins. Iron chelation is a common preoccupa-
tion of bacteria invading human hosts as generally the host’s iron is closely
bound to large complexes (such as haemoglobin) and there is little free for
the use of bacterial cells [99] - this iron paucity is especially pronounced
in the urinary tract. CFT073 also contains genes encoding a haemolysin
(hly [98]) and a secreted autotransporter cytotoxin (Sat [100]) which both
may help not only in iron acquisition but also acquisition of other scarce
molecules through the disruption and lysis of host cells.
Several UPEC have had their complete genomes sequenced (CFT073,
UTI89, 536, F11, see Table 1.1), along with twenty other or so E. coli, giv-
ing an excellent resource for discovering and investigating these PAIs. The
nature of the PAIs and how bacteria come to acquire them is of course of
much interest to those wishing to combat UTIs: much research has focused
on these parts of the UPEC genomes. For instance, Welch et al [42] dis-
cussed PAIs found further to those found previously in CFT073 and com-
pared the genome with (commensal) MG1655 and (EHEC) E. coli strain
O157 H7 EDL933 and showed that only a small fraction of the genes that
33were absent from the commensal strain were contained in both pathogenic
strains ( 3 % of the total CFT073 genes compared to 24 % of the CFT073
genes not contained in MG1655), though these genes included iron uptake
systems, adhesins and other potentially virulence related genes.
Further to this it was found by Brzuszkiewicz et al [62] on comparing
the complete sequences of CFT073 and E. coli 536, another UPEC, that al-
though there was a signiﬁcant overlap of 180 genes implicated as virulence
factors(includingabout20implicatedinmetabolism: someencodingcobal-
amine biosynthesis and others of putative metabolic function) there are also
more than 200 genes speciﬁc to 536 that are in regions that may contribute
to virulence. This lack of consensus in the complement of virulence related
genes carried by individual strains of UPEC can be seen over a large range
of bacterial isolates from people with UTIs and the comparison of 125 com-
mensal E. coli and UPEC by PCR-based detection used by Brzuszkiewicz
et al [62] illustrates this heterogeneity in virulence factor gene complement.
However, it should be borne in mind that although speciﬁc genes may not be
conserved at the same position on the genomes of two bacteria, homologous
and functionally equivalent genes may be present at different positions, or
even non-homologous functional equivalents.
Genome sequence comparisons such as those mentioned above are use-
ful since exact sequences for all genes in each strain are known. How-
ever, it is possible to experimentally determine approximate gene comple-
ment overlaps using several different approaches, including that used by
Brzuszkiewicz et al [62]. Comparative genomic hybridisation (CGH) is also
acommontechniqueusedforsuchanalyses. Thistechniquetakesadvantage
34of the hybridisation of query DNA from a sample (say, from a bacterium of
interest) to a pre-prepared array of DNA from a reference species and con-
sequent positional detection of ﬂuorescence. CGH has been used by Lloyd
et al [101] to investigate the presence of known virulence determinants in
CFT073 in seven UPEC and several faecal isolates.
This type of investigation is incredibly valuable in helping to examine the
contributions of various known virulence determinants by their presence or
absenceinisolatesfrompeoplewithvariousspeciﬁcurinarytractinfections,
though it has the limitation that it will not by itself ﬁnd further virulence
determinants that are not present in the sequenced bacterium used as the
hybridisation subject (in the case above, CFT073). An advantage of genome
sequence comparisons and correspondences is that if an unexpected gene or
set of genes is newly characterised (say, as a virulence determinant) then
testing all sequenced bacteria for the gene or genes is a matter of conducting
a BLAST search.
The traits commonly attributed with enabling E. coli to colonise the uri-
narytractareproductionofvariousspeciﬁcﬁmbriae(sometimescalledpili),
the presence of a chemically modulated and smooth polysaccharide coat,
ironsequestrationmechanisms, serumresistance, productionofhaemolysins
[102]. However, infections of the urinary tract by certain E. coli have been
found which do not produce symptoms in the host, a state of so-called
asymptomatic bacteriuria (ABU). One such bacterium is E. coli 83972, a
strain that was isolated from a Swedish girl [103] who had been stably
infected for 3 years with no symptoms associated with a urinary tract in-
fection. This bacterium has non-functional ﬁmbriae genes, and does not
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alternative colonisation strategy for bacteria in the urinary tract to virulence
related aggression. An unexplained property of this bacterium is that it out-
competes UPEC (including CFT073, 536 and E. coli NU14 [105]) in human
urine and when in competition with NU14 (the strain which it outcompeted
by the least amount in human urine) in a murine UTI model [106]. E. coli
83972 grows faster than these UPEC and the data from Roos et al [106]
indicate that it somehow arrests the progress of such bacteria in the urinary
tract (as has also been observed in human urinary tracts where 83972 has
been used as a prophylactic [107]), perhaps by inhabiting the niche other-
wise vulnerable to UPEC, or by some other mechanism yet to be elucidated.
It is unknown why UPEC do not have the capability to grow as quickly
as 83972. Its ancestors were almost certainly pathogenic and the non-
functional ﬁmbrial genes present in its genome attest to that, but at some
point the host-pathogen interaction may have promoted a mutually bene-
ﬁcial system where the bacteria somehow remained, but with the loss of
function of several antigenic genes. If 83972 does not have several impor-
tant virulence factors then it must have an alternative colonisation strategy,
which may purely be by way of growth rate. The competitive advantage
that 83972 has could be due to modiﬁed regulation of metabolic genes to
enable faster growth; it has been shown that bacteria can improve growth
rates in constant environments [108]. It could be that given 83972’s con-
tinuous colonisation of a single host for 3 years (and possibly in previous
human hosts), it has optimised its growth in the urinary tract environment,
but chronic symptomatic urinary tract infections are common so might pro-
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uncharacterised metabolic genes increasing 83972’s ability to grow in urine,
though given the frequency of horizontal gene transfer the lack of a “su-
perstrain” containing both functional virulence genes and these metabolic
genes seems indicate that this is not the case. A third potential reason is
that just removal of virulence genes improves 83972’s ﬁtness, but then the
existence of any uropathogenic E. coli is a puzzle.
The ability of UPEC to colonise the urinary tract has been studied in-
depth in terms of virulence factors such as pili and haemolysins [109], how-
ever the ability to utilise the metabolites available in this environment has
not been fully investigated to date. While studies of growth rates in urine
have been conducted (for instance by Gordon and Riley [110]), it has never
been established exactly what is used as the primary carbon source (or if
there is a single one) for growth of UPEC, and which genes enable the util-
isation of this carbon source. The growth of UPEC in this environment,
however, indicate that it is certainly possible for bacteria to use purely urine
for their metabolic needs rather than, for instance, the mucus produced by
the epithelial cells of the urinary tract to which the bacteria adhere. There
has been discussion of metabolic genes contributing to uropathogenicity,
considering two UPEC: CFT073 and 536 [62]. D-serine has been posited
as a potential carbon and nitrogen source, due to the presence of D-serine
catabolic genes in E. coli CFT073 and E. coli 536 (both UPEC), the require-
ment for these genes or their involvement in the course of a UTI has yet to
be investigated.
By separating the genome sequences of those bacteria that successfully
37colonisetheurinarytractandthosethatdonotitmightbepossibletodiscern
a set of genes more common in the ﬁrst set than the second, therefore which
mightbeacontributingfactortosuccessfulcolonisation. Indeedsomegenes
have been looked for in this very way, for instance by Brzuszkiewicz et al
[62], who compared 5 complete genome sequences in search of conserved
and non-conserved genes between UPEC and non-UPEC which might con-
tribute speciﬁcally to virulence. There is huge potential for widening this
type of approach to a large number of completely sequenced bacteria, and
since the pace of genomic sequencing is increasing exponentially [111]
comparisons of this sort will be increasingly useful. The application to dis-
covering whether metabolic genes are implicated in pathogen survival, as
shown in the work presented here, is viable and informative.
Parts of the metabolism of UPEC have been studied for their importance
in the course of urinary tract infections: guaA and argC are known to be
of importance due to the requirement for guanine related products for sur-
vival and growth in urine [112] and recent work has focused on the role of
D-serine uptake and metabolism during colonisation [113, 114, 115, 116].
UPEC have also developed several mechanisms for scavenging metals, for
instance zinc [117], but especially iron which is incredibly scarce in the
urinary tract (as reviewed by Wiles et al [99]).
1.5.1 E. coli CFT073 as a model of uropathogen metabolism
CFT073 contains 5379 predicted ORFs, only about half of which are bioin-
formatically characterised, let alone have an experimentally veriﬁed func-
38tion. However, a closely related strain, E. coli K-12 MG1655 is very well
characterised, being the standard laboratory strain of E. coli in use around
the world. Given the high homology between corresponding genes and syn-
teny conservation between CFT073 and MG1655 it seems likely that many
of the bioinformatically inferred gene functions of CFT073, which rely on
MG1655 annotation, are correct. As well as the genes with some annota-
tion, even as unspeciﬁc as ’putative oxidoreductase’ (c4981), there are 2516
hypothetical proteins, that is, open reading frames in the genome sequence
with no similarity to any characterised or partially characterised gene so far
discovered. With this number of genes of unknown function some sort of
screening process is required to obtain a feasible number of genes to inves-
tigate for metabolic capabilities.
1.6 Aims
Broadly, the aims of this project have been to use genome sequences of E.
coli and other bacteria to aid the discovery of uncharacterized metabolic
genes by relative occurrences of these genes in various bacteria, to inves-
tigate the method of adaptation of bacteria to the addition of heterologous
metabolic genes and to assess the applicability of a stoichiomteric model of
MG1655 for inferring models of closely related bacteria.
391.6.1 Genomecomparisonsforthecharacterisationofnovelmetabolic
genes
An initial gene synteny comparison of bacteria will be carried out in order
to ﬁnd genes that are putatively metabolic in their function, but without spe-
ciﬁcfunctionalassignment. Thesegenes, anduncharacterisedgenesinclose
proximity to these, will be assessed by various bioinformatic techniques in
order to determine more clearly their function. Genes annotated as a puta-
tive sorbose or mannose PTS system is determined by BLAST comparison
with Klebsiella pneumoniae to be a putative L-sorbose PTS system and this
will be experimentally tested.
1.6.2 Bacterial adaptation to heterologous metabolic genes
Metabolic genes encoding a carbon source uptake and utilisation operon
from one strain of E. coli will be cloned into another E. coli using a plasmid
vector in order to assess the ability of the E. coli to adapt to genes conferring
novel metabolic capabilites on the strain, and the metabolic adaptation of
this strain over a period of passage in deﬁned media with that carbon source
as sole carbon source.
1.6.3 A survey of shared metabolic capabilities of bacteria with com-
pletely sequenced genomes
A technique of whole genome gene-by-gene comparisons and synteny in-
ferences based on sequence identity of neighbouring genes will be used to
40assess genes shared between MG1655 and 36 other bacteria of the fam-
ily Enterbacteriaceae. This comparison will be used to compare in silico
metabolic capabilities of these strains and to determine the applicability of
gene essentiality characteristics in closely related bacteria.
1.6.4 Reliable inferences of bacterial metabolic models
One of the gene synteny inferences for an E. coli strain produced in this
work will be used to reconstruct a metabolic model for that strain, using a
subset of the reactions in model iAF1260 of Feist et al [1], and will be tested
against data on growth and acetate production of that strain. Also a model
of a derivative of wild-type E. coli which is commonly used in cloning, will
be constructed and tested against experimental data from this work.
41Table 1.1: Strains of genus Escherichia with genome sequences deposited in GenBank as of 1st January
2009. Unless otherwise stated the strain is Escherichia coli, the RefSeq accession number is the number
for the sequence in Genbank and the sequence status distinguishes complete chromosomal sequences (‘C’)
from whole genome shotgun sequences (‘W’). The length of ‘W’ sequences is the sum of the lengths of
the contigs making up that sequence entry. Where there has been a publication reporting the completed
genome sequence this has been indicated, however many of the genome sequences do not have associated
publications so articles detailing the isolation of those strains have been included; these are marked with an
asterisk. Where there is no published literature according to PubMed on a particular strain the sequencing
centre has been indicated: JCVI (The J Craig Venter Institute) or JGI (The Joint Genome Institute).
Strain Pathotype RefSeq Accession Number Sequence Length [bp] Reference
Status
Escherichia albertii TW07627 EPEC NZ ABKX00000000 W 4698533 [36]*
101-1 EAEC NZ AAMK00000000 W 4979767 JCVI
536 UPEC NC 008253 C 4938920 [37]
53638 EIEC NZ AAKB00000000 W 5071018 JCVI
55989 EAEC NC 011748 C 5154862 [38]*
APEC O1 APEC NC 008563 C 5082025 [39]
B171 EPEC NZ AAJX00000000 W 5426568 [40]*
B7A ETEC NZ AAJT00000000 W 5300242 [41]*
ATCC 8739 Ethanologenic NC 010468 C 4746218 JGI
CFT073 UPEC NC 004431 C 5231428 [42]
E110019 EPEC NZ AAJW00000000 W 5376211 [43]*
E24377A ETEC NC 009801 C 4979619 JCVI
ED1a Commensal NC 011745 C 5209548 [44]*
F11 UPEC NZ AAJU00000000 W 5215961 [45]*
HS Commensal NC 009800 C 4643538 [46]*
IAI1 Commensal NC 011741 C 4700560 [47]*
IAI39 UPEC NC 011750 C 5132068 [47]*
str. K12 substr. DH10B Commensal NC 010473 C 4686137 [48]
str. K12 substr. MG1655 Commensal NC 000913 C 4639675 [35]
str. K12 substr. W3110 Commensal AC 000091 C 4646332 [49]
E22 EPEC NZ AAJV00000000 W 5528238 [45]*
O127:H6 str. E2348/69 EPEC NC 011601 C 4965553 [28]
O157:H7 str. EC4024 EHEC NZ ABJT00000000 W 6199307 JCVI
O157:H7 str. EC4042 EHEC NZ ABHM00000000 W 5617728 JCVI
O157:H7 str. EC4045 EHEC NZ ABHL00000000 W 5634850 JCVI
O157:H7 str. EC4076 EHEC NZ ABHQ00000000 W 5705645 JCVI
O157:H7 str. EC4113 EHEC NZ ABHP00000000 W 5655847 JCVI
O157:H7 str. EC4115 EHEC NC 011353 C 5572075 JCVI
O157:H7 str. EC4196 EHEC NZ ABHO00000000 W 5620606 JCVI
O157:H7 str. EC4206 EHEC NZ ABHK00000000 W 5629932 JCVI
O157:H7 str. EC4401 EHEC NZ ABHR00000000 W 5733133 JCVI
O157:H7 str. EC4486 EHEC NZ ABHS00000000 W 5933166 JCVI
O157:H7 str. EC4501 EHEC NZ ABHT00000000 W 5677181 JCVI
O157:H7 str. EC508 EHEC NZ ABHW00000000 W 5656666 JCVI
O157:H7 str. EC869 EHEC NZ ABHU00000000 W 5731065 JCVI
O157:H7 str. Sakai EHEC NC 002695 C 5498450 [50]
O157:H7 str. TW14588 EHEC NZ ABKY00000000 W 5670297 JCVI
O157:H7 EDL933 EHEC NC 002655 C 5528445 [51]
S88 ECNM NC 011742 C 5032268 [52]*
SE11 Commensal NC 011415 C 4887515 [53]
SMS-3-5 Environmental NC 010498 C 5068389 [54]
UMN026 UPEC NC 011751 C 5202090 [55]*
UTI89 UPEC NC 007946 C 5065741 [56]
Escherichia fergusonii Commesal NC 011740 C 4588711 [57]*
ATCC 35469
Escherichia sp. 3 2 53FAA Crohn’s associated NZ ACAC00000000 W 5094952 Broad Institute
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Experimental Materials and Methods
2.1 Strains
Strains used throughout this project were stored in 15 % glycerol stocks at -
80 C between experiments. When experiments were undertaken a metal
loop was used to scrape a little of the frozen stock and spread it on an
agar plate with antibiotic where appropriate. An individual colony was then
picked from this plate for use in each experiment. The following strains
were used:
(i) E. coli strain CFT073 (American Type Culture Collection, Manassas,
VA, US), ATCC 700928;
(ii) E. coli strain K-12 MG1655 (from the strain collection of JM Ward),
ATCC 47076;
(iii) E. coli strain DH5, ATCC 700790 (Invitrogen), genotype: F  fhuA2
(lacZ-argF)U169 80dlacZM15 endA1 hsdR17 deoR nupG thi-1
43supE44 gyrA96 relA1 recAI phoA  ;
(iv) E. coli strain TOP10 (provided as One Shot R  TOP10 E. coli from In-
vitrogen), genotype: F-mcrA(mrr-hsdRMS-mcrBC)80lacZM15
lacX74recA1ara139(ara-leu)7697galUgalKrpsL(StrR)endA1
nupG;
(v) Klebsiella pneumoniae producing KpnI restriction enzyme (KP1; from
the strain collection of JM Ward).
2.2 Buffers
The following items were made up from base chemicals in the lab:
(i) Loading Buffer for agarose gel electrophoresis (6x solution): 4 g of
sucrose, 2 ml of 0.5 M EDTA (ethylenediaminetetraacetic acid) and 1
ml of 1.5 mg/ml BPB (bromophenol blue), topped up to 10 ml with
puriﬁed water.
(ii) Standard Reaction Buffer for restriction enzyme digestion (10x solu-
tion): 500 mM Tris, 500 mM NaCl and 50 mM MgCl in puriﬁed water.
The following buffers were all provided by New England Biolabs, Hitchin,
UK:
(i) Antarctic Phosphatase Reaction Buffer (10x solution): 500 mM Bis-
Tris-Propane-HCl, 10 mM MgCl2, 1 mM ZnCl2 (pH 6.0 at 1x concen-
tration at 25 C);
44(ii) T4 DNA Ligase Reaction Buffer (10x solution): 500 mM Tris-HCl,
100 mM MgCl2, 10 mM ATP, 100 mM Dithiothreitol (pH 7.5 at 1x
concentration at 25 C);
(iii) NEBuffer 1 (10x solution): 100 mM Bis-Tris-Propane-HCl, 100 mM
MgCl2, 10 mM dithiothreitol (pH 7.0 at 1x concentration at 25 C);
(iv) NEBuffer 2 (10x solution): 100 mM Tris-HCl, 100 mM MgCl2, 500
mM NaCl, 10 mM dithiothreitol (pH 7.9 at 1x concentration at 25 C);
(v) NEBuffer 3 (10x solution): 500 mM Tris-HCl, 100 mM MgCl2, 1000
mM NaCl, 10 mM dithiothreitol (pH 7.9 at 1x concentration at 25 C);
(vi) NEBuffer 4 (10x solution): 200 mM Tris-Ac, 100 mM Mg-Ac, 500
mM K-Ac, 10 mM dithiothreitol (pH 7.9 at 1x concentration at 25 C).
2.3 Molecular Biology Components
Enzymes are described as they are used throughout the methods section, in-
cluding restriction enzymes. These enzymes are all provided by New Eng-
land Biolabs, Hitchin, UK, unless otherwise stated.
2.3.1 Sterile deionised water
Sterile distilled water was used in many preparations during this project.
This water was produced by an Elga Option 4 Water Puriﬁer (Elga, Marlow,
Buckinghamshire, UK) to 14 M
cm 1 and either autoclaved for 20 minutes
45at 121 C or passed through a 0.22 m sterile ﬁlter (Millipore, Billerica,
MA). It will henceforth be referred to as puriﬁed water.
2.3.2 Media Components
VariousmediacomponentswererequiredforMolecularBiologyandgrowth
testing, and in all cases component chemicals were dissolved into puriﬁed
water and either autoclaved at 121 C for 20 minutes, or passed through a
0.22 m sterile ﬁlter depending on the chemical.
Where rich media was required for growth, Nutrient Broth 2 (Oxoid,
Hampshire, UK), henceforth referred to as NB2, was used. Other media
required by some kit protocols are (made up to 1x): ’Lab-Lemco’ Powder
10 g/L, Peptone 10 g/L, NaCl 5 g/L. LB medium was used in some cases
(1x): tryptone 10 g/L, yeast extract 5 g/L and NaCl 10 g/L. SOC medium
was also required for some molecular work (Invitrogen): tryptone 20 g/L,
yeast extract 5 g/L, NaCl 10 mM, KCl 2.5 mM, MgCl2 10 mM, MgSO4 10
mM and glucose 20 mM.
For growth in deﬁned minimal media a variant of M6 minimal medium
(henceforthreferredtoasM6*), optimisedforgrowthofE.coli, wasused. It
hasthefollowingcomposition: 5.20gl 1 (NH4)2SO4, 3.86gl 1 NaH2PO4.H2O,
4.03 gl 1 KCl, 4.16 gl 1 Citric Acid, 1.04 gl 1 MgSO4.7H2O, 0.25 gl 1
CaCl2.2H2O,20.6mgl 1 ZnSO4.7H2O,27.2mgl 1 MnSO4.4H2O,8.1mgl 1
CuSO4.5H2O,4.2mgl 1 CoSO4.7H2O,100.6mgl 1 FeCl3.6H2O,0.3mgl 1
H3BO3, 0.2 mgl 1 Na4MoO4.2H2O adjusted to pH 7.3 using 5M NaOH.
Antibiotics used in all experiments were provided by Sigma-Aldrich,
46Gillingham, Dorset, UK. Ampicillin was stored at 1000x concentration (100
mg/ml) at -20 C. Kanamycin monosulfate was stored at -20 C as a 50
mg/ml (1000 ) stock.
Several carbon sources were used for growth tests, all were added to 1%
w/v:
(i) D-Glucose (BDH Laboratory Supplies, Poole, UK),
(ii) L-Sorbose (Merck, Beeston, UK),
(iii) Creatinine (Sigma-Aldrich),
(iv) Urea (VWR International, Poole, UK) and
(v) DL-Malic Acid disodium salt (Sigma-Aldrich).
2.4 Agar plates for bacterial growth
Where plates were required for bacterial growth and selection, a standard
mixture of 1.5 % w/v agar (Difco, Livonia, MI, US) and 25 g/L NB2 was
added to puriﬁed water and autoclaved at 121 C for 20 minutes. This was
then left to cool to approximately 50 C and poured immediately, or stored
in at 50 C until required. Plates poured without supplements will be re-
ferred to as NB2 agar plates and those with supplements referred to with the
supplement(s) preﬁxed as an abbreviation, for instance kana NB2 agar plate
for a plate containing kanamycin for selection.
The following standard ﬁnal concentrations were used for each supple-
ment (abbreviations are shown), unless otherwise stated in the text:
47(i) Kanamycin 50 g/ml (kana),
(ii) Ampicillin 100 g/ml (amp),
(iii) X-Gal (Bioline, London, UK) 20 g/ml (X-Gal),
(iv) Isopropyl -D-1-thiogalactopyranoside (Melford, Ipswich, UK) 100
M (IPTG).
Where other supplements are used their ﬁnal concentrations are noted in
the relevant section.
2.5 Growth Screening Tests (5 ml in universal tubes)
Where it was required to screen E. coli CFT073 and MG1655 for growth
on various substrates as sole carbon sources (those listed in Section 2.3.2),
M6* media was used supplemented with the carbon sources as required.
Strains were taken directly from stocks and inoculated into 5 ml NB2 media
in 20 ml universal tubes, then grown to stationary phase overnight at 37 C
shaken at 150 rpm in a KF-4 Chest Incubator (Infors HT, Hilden, Germany).
The following morning, 25 l of each strain was inoculated into 5 ml fresh
NB2 media and grown in the same conditions for 6 hours until exponential
phase growth was achieved.
25 l of the resulting material was inoculated into separate 20 ml uni-
versal tubes containing 5 ml pre-warmed M6* containing a single carbon
source at 1 % w/v. These universal tubes were then returned to the KF-4
and again grown overnight at 37 C shaken at 150 rpm. These tubes were
48observed at 24, 40 and 115 hours to determine whether there was growth of
the strains using the relevant carbon source as a sole carbon source.
2.6 Growth Tests (200 ml in shake ﬂasks)
Growth tests were conducted in 200 ml working culture volume in 2 l shake
ﬂasks to quantify uptake of substrates, growth and excretion of products
of several bacteria at two temperatures using two different molecules, L-
sorbose and D-glucose, as sole carbon sources. The two temperatures used
were 30 C and 37 C and for each particular growth test the same temper-
ature was used throughout the growth, from growing single colonies from
stocks to the end of the shake ﬂask observation. Ampicillin was used at
a concentration of 100 g/ml throughout all experiments involving E. coli
containing plasmid pQR793 or a control plasmid, but this was not added for
experiments involving E. coli CFT073.
To minimise stress on the bacteria before they were placed in the test
medium care was taken not to expose them to stressful conditions, such
as changes in temperature and starvation, while initial cultures were grown.
Thiswasachievedbykeepingthebacteriaataconstanttemperaturethrough-
out growth, using rich media in starter cultures and ensuring that the starter
cultures were in exponential growth phase at the point where they were
transferred to shake ﬂasks for growth observation.
Each strain was taken from a thawed 15 % glycerol stock and a loop
placed into 5ml Nutrient Broth 2 (NB2; Oxoid) in a 20ml Universal, which
wasshakeninanincubatorovernightattheappropriatetemperatureat150rpm;
49this was allowed to grow to stationary phase. 50 l of this was then trans-
ferred to a starter culture of 20 ml of NB2 in a 50 ml falcon tube, again
at the appropriate temperature. Preliminary testing determined approximate
growth rates and ﬁnal optical densities (used throughout as a surrogate for
cell concentration) of the strain in these conditions and these data were used
to monitor the growth of the starter culture. When the bacteria were in late
exponential growth, deﬁned as approximately three quarters of ﬁnal cell
density, 500 l of this was transferred to 200 ml pre-warmed deﬁned mini-
mal medium in a 2 litre shake ﬂask.
M6* medium was used for these experiments. 0.001 % thiamine supple-
ment was added for all DH5 strains, which do not grow in the absence of
thiamine. To this medium was added either 1 % w/v D-Glucose or 1 % w/v
L-Sorbose, which each contain the same molar quantity of carbon.
Samples were taken at intervals through the growth, two 1 ml simulta-
neous samples at each time point. One sample was taken to test the optical
density, which was measured at 600 nm using a CO8000 Cell Density Me-
ter (WPA). For samples of optical density above 1, the sample was diluted
to the range 0.2 to 0.7 and the actual optical density inferred by multiply-
ing the reading by the dilution factor. The other sample was used to test
the supernatant for glucose, L-sorbose and acetate. This sample was trans-
ferred to a microcentrifuge tube and spun for 10 minutes at 13,000 rpm in
anaccuSpinTMmicrocentrifuge(FisherScientiﬁc, Loughborough, Leicester-
shire). The supernatant was then extracted by pipette and placed in a clean
microcentrifuge tube and placed at -20 C.
502.6.1 OD and biomass equivalence
Biomass was not directly measured in growth tests, but was taken to be pro-
portional to OD. To determine this equivalence MG1655 was grown to OD
2 in 5 ml NB2 at 37 C shaken at 150 rpm and trtiplicate 1 ml samples were
taken. These samples were placed in preweighed 1.5 ml Eppendorf tubes
that had been specially prepared by dessication for 48 hours. These sam-
ples were spun down in 1.5 ml Eppendorf tubes for 10 minutes at 13,000
rpm in the accuSpinTMmicrocentrifuge, the supernatant decanted, then tis-
sue was used to absorb excess moisture left on the pellets. These were dried
at 100 C in an oven for 48 hours and then difference in weight between the
tubes before and after the addition of samples were calculated. The resul-
tant equivalence was that 2 OD was equivalent to 0.6  0.1 gDW, therefore
mass during the project was calculated as 0.3 gDW/OD unit.
2.7 HPLC
High precision liquid chromatography was used for quantiﬁcation of con-
centrations of glucose, L-sorbose and acetate in supernatant samples from
growth tests. When all samples were collected from a single growth experi-
ment, all 1 ml supernatant samples were removed and thawed on the bench
for 20 minutes, then two aliquots of 260 l from each sample were placed
in wells in a 96-well 0.22um multiwell sterile ﬁlter plate (Pall Corporation,
Port Washington, NY) and attached to the top of a 96-well plate (with a ca-
pacity of 300 l per well) to collect ﬂow-through. Samples were spun at 700
rpm in a 5804R centrifuge (Eppendorf, Hamburg, Germany) for 3 minutes.
51These samples were then transferred to 2 ml sample containers for HPLC
analysis.
If HPLC was immediately available samples were loaded immediately,
and if not, they were stored at -20 C, then thawed thoroughly and mixed
using a Top Mix FB15024 (Fisher Scientiﬁc, Loughborough, UK) before
loading. The HPLC equipment used was as follows: a P680 HPLC pump
(Dionex, Sunnyvale, Ca), an ASI-100 Automated Sample Injector (Dionex,
Sunnyvale, Ca), an STH 585 Column Oven (Dionex, Sunnyvale, Ca), a
UVD170U ultraviolet detector (Dionex, Sunnyvale, Ca), an RI-101 refrac-
tive index detector (Shodex, Munich) and controlled by a UCI-100 Univer-
sal Chromatography Interface (Dionex, Sunnyvale, Ca). Software used was
Chromeleon Version 6.4 SP8 Build 800 (Dionex, Sunnyvale, Ca).
ThecolumnusedwasanHPX-87HAminex(Bio-Rad, Hemel-Hempstead,
UK) ion exclusion and partition column, which is capable of separating both
carbohydrates and organic acids. The HPLC analysis was run under the
following conditions: eluent was 5 mM H2SO4, pH 2.2 (Fluka Chemika,
Buchs, Switzerland) in puriﬁed water; column was kept at 60 C through-
out; ﬂow rate was maintained at 0.6 ml/min; all sample injections were 20
l; all wash cycles used 10 l of 50% acetonitrile, 50% puriﬁed water. All
water used in these samples was puriﬁed water, ﬁltered through a 0.22 m
sterile ﬁlter. Sample standards were made up as follows: one vial of puriﬁed
water, D-glucose dissolved in water at concentrations of 10, 8, 6, 4 and 2
g/L, L-sorbose dissolved in water at concentrations of 10, 8, 6, 4 and 2 g/L
and sodium acetate dissolved in water to the concentrations of 30, 24, 18,
12 and 6 mM. All vials were sampled 3 times and each sample was run for
5225 minutes through the column. UV absorbance was measured at 215 nm.
2.8 Protein Activity Assay
The protein activity assay described here was used to assess the tempera-
ture sensitivity of the activity of the glucitol-6-phosphate dehydrogenase in
the L-sorbose degradation operon in CFT073 (gene locus c4986). Temper-
ature sensitivity of a homologous glucitol-6-phosphate dehydrogenase in
Klebsiella pneumoniae previously noted by Sprenger and Lengeler [118].
Sprenger and Lengeler observed impaired growth of K. pneumoniae at tem-
peratures above 35 C.
All growth media using cells containing constructs had ampicillin added
to the concentration of 100 mg/ml. Cells were taken using a loop from
frozen stocks, placed in 5 ml of prewarmed Nutrient Broth 2 (NB2;Oxoid,
Basingstoke, Hampshire) and placed in either a KF-4 for 37 C growth or
an Amperetabelle Multitron 2 incubator for 30 C growth, both at 150 rpm.
This was left overnight to grow to stationary phase. Testing the heat sensi-
tivity of the glucitol-6-phosphate dehydrogenase required that the cells be
harvested at approximately mid-exponential phase, when the highest con-
centration of that enzyme per cell was presumed to be extant. This required
that inoculum volumes were varied at this stage to ensure that overnight
growth would result in mid-exponential phase growth in the carbon limited
medium the following morning, thus that harvesting, processing and testing
of the enzyme activity were all achieved in a single day. The relevant inocu-
lum volume was therefore used for each set of conditions, depending on OD
53in the NB2 media at stationary phase and growth rate in the fresh minimal
media at the relevant temperature. This volume was inoculated into 20 ml
of M6* minimal media with 1 % w/v carbon source concentration in 50 ml
falcon tubes. This was then placed in the relevant incubator for the correct
temperature and left overnight. The following morning a single 1 ml sample
was taken to check OD and if it was in the range 1.5 to 2.0 then the process-
ing would begin. If the optical density was lower then the cells were left
for the relevant period of time before being resampled and if then within the
OD range required would be processed.
2.8.1 Protein extraction from bacterial cells
Crude extracts of intracellular material were used to assess the temperature
dependence of the glucitol-6-phosphate dehydrogenase activity. For each
sample the falcon tube was removed directly from the incubator into ice and
all steps were done at 4 C or on ice; all added chemicals were pre-cooled on
ice before use in this method. The cells were then pelleted by centrifugation
in a 5804R centrifuge at 5000 rpm for 10 minutes. The supernatant was
decanted and the pellet was resuspended in 20ml ice cold 0.1 M Tris HCl
(pH 9) to wash off the cells, then was spun again at 5000 rpm for 15 minutes
to repellet. The supernatant was again decanted and the cell concentration
was increased by resuspension in 10 ml 0.1 M Tris HCl (pH 9), which was
transferred to a 15 ml falcon tube, to which was added 40 l of 10 mg/ml
lysozyme (Sigma-Aldrich). This was then transferred to a water bath at 37
C for exactly 15 minutes, then removed to ice.
54The suspension was then sonicated using a Soniprep 150 (MSE, Lower
Sydenham, UK)at an amplitude of9 microns, 10 secondson and 12 seconds
off, repeated 8 times, to break open the cells. The resultant material was
transferred to a Sorvall tube (Sorvall, part of Thermo Scientiﬁc, Waltham,
MA) and spun down in an RC6 Plus Superspeed Centrifuge (Sorvall) at
RCF 30000 for 15 minutes to remove cell debris from the suspension. This
suspension was then transferred to a universal tube on ice ready for the
protein activity assay.
2.8.2 Assay of heat sensitivity of activity of Glucitol-6-Phosphate de-
hydrogenase
The protein activity assay method used for assessing the heat dependence
of the activity of glucitol-6-phosphate dehydrogenase was adapted from
Novotny et al’s [119] method, though in this investigation only crude lysate
as per the procedure described in Section 2.8.1 was used, rather than puri-
ﬁed protein. The assay was conducted in 0.1 M Tris HCl (pH 9) with the
addition of glucitol-6-phosphate (Sigma) and NAD+ (Sigma). These con-
centrations were determined by testing various concentrations to ﬁnd con-
centrations high enough to make the reaction insensitive to small variations
in these concentrations, but not so high as to be inhibitory. The glucitol-
6-phosphate and NAD+ were kept on ice before addition to the solution,
as was the crude extract. The Tris HCl buffer was preheated to the relevant
temperature before each sample was tested for activity, and the crude extract
sample was preheated for 1 minute at the relevant temperature as well.
55UV absorbance was determined using a U-1800 Spectrophotometer (Hi-
tachi, Tokyo, Japan) with heated water provided by a GD120 waterbath and
circulator (Grant Instruments Ltd, Cambridge, UK) to maintain the temper-
ature required for each sample. The four components of the reaction sample
were mixed together in a UV transparent cuvette (Fisher Scientiﬁc Ltd) in
the following order: 920 l 0.1 M Tris HCl (pH 9), NAD+ solution to 1 mM,
glucitol-6-phosphate to 40 mM, then 50 l crude cell extract. The resulting
solution was mixed 3 times by pipetting. This was done as quickly as pos-
sible and then the lid of the spectrophotometer was closed and observation
of the UV absorbance increase was observed. The time between mixing the
crude extract into the buffer solution and beginning observation was about
4 seconds. The absorbance of the sample at 340 nm was observed for a
minute. If the reaction worked, the ﬁrst 10 seconds of observed absorbance
change were used to determine an initial rate of reaction. This method was
repeated twice at several temperatures between 30 C and around 50 C to
produce a graph of protein activity as a function of temperature.
2.8.3 Glucitol-6-Phosphate dehydrogenase heat dependence assay
In order to determine the temperature dependence characteristics of the
glucitol-6-phosphate dehydrogenase present in the L-sorbose uptake and
utilisation operon in CFT073, the model of Lee et al [120] was used. The
Equilibrium Model of enzyme activity temperature dependence takes into
account inactivated but not denatured enzymes and takes into account the
change in equilibrium coefﬁcient between active and inactive enzyme due
56to changes in temperature. The method in Section 2.8 produces data in
the form of initial activity values at particular temperatures for Glucitol-6-
phosphate dehydrogenase, which can be modelled as followed. Using the
Arrhenius equation and assuming Michaelis-Menten kinetics for the initial
activity of an enzyme in excess substrate,
Vinit = kcat:[Ea] (2.1)
= Ae H0
RT :[Ea] (2.2)
where Vinit is the initial reaction rate, kcat is the rate constant for the
reaction, [Ea] is the concentration of active enzyme, A is the (Arrhenius)
prefactor, H0 is the standard enthalpy of the reaction, R is the gas constant
and T is the temperature at which the reaction is taking place.
From [120] the balance between active and heat inactivated (though not
denatured) enzyme also follows Michaelis-Menten like kinetics with a pro-
cess of activation/inactivation with an equilibrium constant Keq. Although
that work also treats denatured proteins, activity measurements in this work
were taken with the absolute minimum of prior exposure to high temper-
atures and only initial activity readings were taken. Each set of activity
measurements for a particular sample were done at the same time and read-
ings of activity at lower temperatures both at the beginning and end of the
measurement process were checked to ensure the activity was not signiﬁ-
cantly reduced by denaturation over the time period of the analysis. Further,
although only the ﬁrst minute of activity was measured for each sample,
activity was regularly monitored for up to 10 minutes with no change in
activity, so heat dependent denaturation was discounted as a signiﬁcant pro-
57cess in this work. The chemical equation :
Ea
Keq     ! Ei (2.3)
where Keq is the equilibrium constant and Ei is the inactive form of the
protein, the concentration of which can be written as total enzyme concen-
tration [Et] minus active enzyme concentration [Ea], so
[Ei]
[Ea]
= Keq (2.4)
[Et]   [Ea]
[Ea]
= Keq (2.5)
[Ea] =
[Et]
1 + Keq
: (2.6)
Also from [120],
Keq = e
Heq
R

1
Teq  1
T

(2.7)
where R is the gas constant, Heq is the enthalpy at of the reversible equi-
librium between active and inactive enzyme. Therefore
[Ea] =
[Et]
1 + e
Heq
R

1
Teq  1
T
 (2.8)
and
Vinit = Ae H0
RT :
[Et]
1 + e
Heq
R

1
Teq  1
T
 (2.9)
=
Be H0
RT
1 + e
D

1
Teq  1
T
 (2.10)
where B = A[Et], D = H0
R , H0 and Teq are unknowns to be tuned to
ﬁt the available data. This model of initial activity as a function of temper-
ature was then ﬁtted to the observed data using a downhill simplex method
58(adapted from Nelder and Mead [121]) to minimise the sum of the residual
squares of the differences between the observed values of activity and the
model.
These parameters were determined independently for each assay and
from them Tmax, the temperature of maximum activity, was determined.
Figure 5.8 shows the values of Tmax determined for each of the strains
tested. Strain Klebsiella pneumoniae KP1 was used as a control since it
has been shown previously [118] that the glucitol-6-phosphate dehydroge-
nase of the L-sorbose operon of this strain is heat sensitive and it was the
operon from which the CFT073 operon inferred its own function.
2.9 Cloning
Two putative operons in the genome of CFT073 were targeted for cloning,
using one (in the case of the putative L-sorbose operon genes c4981-4987,
see Section 4.3.3) or all (in the case of the putative 5- or 6-carbon sugar
metabolism operon genes c3750-3756, see Section 4.3.4) of the below pro-
tocols for cloning.
2.9.1 Chemically competent cell preparation
Chemically competent cells were prepared in the following way:
(i) cells were grown overnight to stationary phase in 5 ml NB2 culture, at
37 C shaken at 150 rpm,
59(ii) this culture was added to 20 ml NB2 supplemented with 20 mM MgCl2
and returned to the incubator for 1 hour,
(iii) itwasremovedtoiceandspundownat4 Cat5000rpmfor10minutes
in a 5804R centrifuge,
(iv) the supernatant was decanted and the cells were resuspended in 2 ml
75 mM CaCl2 with 15 % w/v glycerol (all on ice) and
(v) 100 l aliquots were transferred to eppendorf tubes and frozen at -80
C.
2.9.2 Electrocompetent cell preparation
Where chemical transformation was inadequate for producing stable plas-
mid transformants, electroporation was used. Cells for this process required
a different preparation, to reduce the ionic strength of the cell suspension to
an absolute minimum:
(i) cells were grown overnight to stationary phase in 5 ml NB2 culture, at
37 C shaken at 150 rpm,
(ii) the culture was added to 20 ml NB2 and returned to the incubator for
1 hour, (from this point all preparatory steps were done at 4 C or on
ice, with all components prechilled)
(iii) the cells were then transferred to ice and left to chill for 30 minutes,
(iv) they were then spun down at 4 C at 5000 rpm for 10 minutes in a
5804R centrifuge,
60(v) the supernatant was decanted and the cells were resuspended in 20 ml
puriﬁed water,
(vi) the cells were again spun down at 4 C at 5000 rpm for 10 minutes in
a 5804R centrifuge,
(vii) steps vi) and vii) were repeated twice more,
(viii) the pellet was then resuspended in 20 ml 10 % w/v glycerol solution,
(ix) the cells were spun down a ﬁnal time at 4 C at 5000 rpm for 15 min-
utes,
(x) they were then resuspended in 2 ml 10 % w/v glycerol solution and
(xi) aliquots of 50 l were placed in prechilled 1.5 ml Eppendorf tubes and
either used immediately or frozen at -80 C.
2.9.3 Primers
Primers were ordered from Operon (Ebersberg, Germany). The following
primers were ordered:
(i) Putative operon including c4981 forward primer: 5’-GCCAGCGAC-
ATGCAGAGTTAAGTAGCGCGA-3, which has a melting tempera-
ture of 71.5C;
(ii) Putative operon including c4981 reverse primer: 5’-AAATCTCCT-
GTAAAACGCGGAATATACC-3, which has a melting temperature of
63C;
61(iii) Putative operon including c3750 forward primer: 5’-TTTGCTTCC-
AGAAATGGTAAAAAAATAATC-3, which has a melting tempera-
ture of 59C;
(iv) Putative operon including c3750 reverse primer: 5’-TAATGGACC-
AATTCAATGCCCCACAGAGTG-3, which has a melting tempera-
ture of 67.5C.
2.9.4 Preparation of Genomic DNA
PCR of DNA fragments of CFT073 was done directly from the CFT073
genome. The method used to prepare the genomic DNA for PCR was by
growing cells overnight to stationary phase in 10 ml 1  NB2 at 37 C at
150 rpm, then boiling at 100 C for 20 minutes. The resultant material was
either used immediately or stored at -20 C until required.
2.9.5 Minipreps
WhereplasmidDNAwasrecoveredforanalysisitwasachievedbyminiprep.
Recovery was made from 1 ml samples of growth material. The standard
protocol of the QIAprep Spin Miniprep Kit (Qiagen, Crawley, UK) was
used for minipreps and resultant DNA was eluted into 50 l EB Buffer for
running in gels or freezing at -20 C for future use. All buffers used for
minipreps came from a Qiagen miniprep kit. The LyseBlue provided with
the Qiagen kit was not used for any minipreps.
Where minipreps were done using a non-standard protocol the changes
are noted in the relevant section below, but in all cases during the elution
62step, when Buffer EB was added to the QIAprep spin column it was left to
stand for 2 minutes before centrifuging and was centrifuged for 2 minutes,
rather than 1 minute, to achieve maximum DNA recovery.
2.9.6 DNA PCR ampliﬁcation of putative L-sorbose operon (c4981-
c4987)
PCR of DNA fragments of interest was conducted using a TC-512 gradient
thermal cycler (Techne, Burlington, NJ, USA). The polymerase used was
the Phusion High-Fidelity DNA Polymerase (Finnzyme), which is a Pyro-
coccus-like enzyme fused with a processivity-enhancing domain and has a
very low error rate (base duplication errors per base duplicated) in Phusion
HF Buffer of 4:410 7. This polymerase produces blunt ended DNA prod-
ucts.
10 l of genomic DNA prepared as in Section 2.9.4 was added to 990
l of puriﬁed water, a 1/100 DNA solution and half of this was added to a
further 500 l of sterile distilled to produce a 1/200 DNA solution. Primers
were diluted to 100 M as per their datasheet from Operon, then 2.5 l of
each primer solution was diluted separately into 97.5 l puriﬁed water.
Eachreactionrequired0.5lof2U/lPhusionDNApolymerase(Finnzyme)
and 10 l of 5x PhusionTMHF Buffer (Finnzyme), which was measured into
a PCR tube. To this was added 5 l of each primer solution and 1 l of 10
mM dNTPs solution. The PCR annealing step was conducted at three tem-
peratures: 53, 58 and 63 C, using each of the two concentrations of DNA
(1/100 and 1/200  dilutions), of which 5 l of the relevant solution was
63added to the PCR tubes. 23.5 l sterile distilled was added to the PCR tubes
to make the solution up to 50 l. The PCR cycle was programmed thus:
(i) 3 minutes at 95 C for initial denaturation,
(ii) 15 seconds at 95 C for denaturation,
(iii) 15 seconds at annealing temperature for annealing,
(iv) 3.5 minutes at 72 C for polymerisation and
(v) 10 minutes at 72 C for ﬁnal polymerisation.
Steps ii) to iv) were repeated 30 times in order before the ﬁnal polymeri-
sation step. The hot start option on the PCR machine was disabled for this
programme and the ‘heat lid’ option was set at 105 C.
2.9.7 DNAPCRampliﬁcationofputative5-or6-carbonoperon(c3750-
c3756)
PCR of the c3750-c3756 DNA fragment was achieved using the same pro-
cedure as in Section 2.9.6, with the following modiﬁcations: the PCR an-
nealing step was conducted at four temperatures: 49, 52, 55 and 58 C,
due to the lower melting temperatures of the primers. The PCR cycle was
programmed thus:
(i) 30 seconds at 98 C for initial denaturation,
(ii) 10 seconds at 98 C for denaturation,
(iii) 15 seconds at annealing temperature for annealing,
64(iv) 240 seconds at 72 C for polymerisation and
(v) 420 seconds at 72 C for ﬁnal polymerisation.
Steps ii) to iv) were repeated 30 times in order before the ﬁnal polymeri-
sation step.
2.9.8 Puriﬁcation of PCR products
DNA puriﬁcation of PCR products was achieved by gel extraction. 5 l of
PCR product solution was run in a gel with 1 l loading buffer alongside
a  HindIII ladder (New England Biolabs), and the band at approximately
7 kb was cut out of the gel. DNA extraction from the gel was achieved
using the standard protocol of the QIAquick Gel Extraction Kit using an
accuSpinTMMicro microcentrifuge (Fisher Scientiﬁc, Loughborough, UK).
Resulting DNA was eluted into 50 l EB Buffer; 5 l was run on a gel to
check recovery and the rest was immediately frozen at -20 C to be stored
for later use.
2.9.9 Cloning kits and techniques
Cloning of PCR products into a multicopy plasmid vector was done in sev-
eral ways, depending on the success of each cloning strategy. Two different
cloning kits were used according to availability during the project, and when
the kit failed to produce cloned products an alternative protocol using non-
kit elements was attempted.
Advice in the relevant manuals concerning procedures for long PCR
products (such as those cloned in this project which were both over 6 kb
65long) was followed. Both kits use blunt ended DNA fragments and vectors
for ligation, and Phusion High-Fidelity DNA Polymerase was used (as de-
scribed in Section 2.9.6) to produce these blunt ended long DNA fragments.
2.9.9.1 StrataClone Blunt PCR Cloning
In the ﬁrst case the StrataClone Blunt PCR Cloning Kit (Stratagene, La
Jolla, CA) was used with the blunt ended StrataCloneTMPCR Cloning Vec-
tor pSC-B (Stratagene, La Jolla, CA) as host vector. This system uses a
topoisomerase and Cre recombinase to achieve ligation of two DNA arms
with a heterologous DNA acceptor, then circularisation. All selection was
then done using ampicillin. The protocol for ligation of long PCR products
that came with the cloning kit was followed.
Transformation of vectors produced by cloning of the DNA fragment
were achieved using the standard protocol of the Strataclone Blunt PCR
Cloning Kit:
(i) 2 l of cloned material was added to one tube of StrataClone SoloPack
competent cells (provided with the kit) and mixed gently,
(ii) The transformation mixture was incubated on ice for 20 minutes,
(iii) The mixture was then heat-shocked at 42 C for 45 seconds and re-
turned to ice for 2 minutes,
(iv) 250 l SOC medium (prewarmed to 42 C) was then added and the
mixture placed in an incubator at 37 C shaken at 150 rpm for 1 hour.
Blue/whitescreeningoftransformantsforrecombinantvectorswasachieved
66as described in Section 2.9.10, however since the lacZ gene is engineered
to constitutively express -galactosidase, IPTG was not required to induce
expression on the screening plates.
2.9.9.2 Zero Blunt R TOPO R PCR Cloning
The second kit used was the Zero Blunt R TOPO R PCR Cloning Kit (In-
vitrogen, Eugene, OR, US) which used the blunt ended pCR R -Blunt II-
TOPO R , which comes as a linearised vector with a Vaccinia virus DNA
topoisomerase I covalently bound to each of the 30 ends. This kit therefore
also dispenses with the need for a DNA ligase enzyme. This vector also has
the advantage that it does not require colour screening as it contains a fusion
of the C-terminus of the LacZ fragment and lethal gene ccdB [122]. If re-
combination does not occur, cells containing the non-recombinant plasmid
are killed on plating. This vector carries a kanamycin resistance gene, rather
than ampicillin, so all plating was done on kana NB2 plates, and X-Gal and
IPTG were not required as the vector is self-screening.
Chemically competent cells were used for transformation so the high salt
cloning protocol provided in the kit manual was used. A single cloning step
was required by the kit: 4 l fresh PCR product (the maximum recom-
mended amount was added to 1 l salt solution (supplied in the kit) and 1
l pCR R II-Blunt-TOPO R . This was incubated at 23 C in a waterbath for
10 minutes then immediately transferred to ice.
One Shot R TOP10 Chemically Competent E. coli (Invitrogen) was used
for transformations following the protocol set out in the manual:
(i) 2 l of cloned material from the previous step was added to a vial of
67One Shot R TOP10 E. coli and incubated on ice for 20 minutes,
(ii) The cells were heat shocked at 42 C for 30 seconds and immediately
transferred to ice,
(iii) 250 l of room temperature SOC medium was added to the vial and
this was mixed thoroughly and then incubated at 37 C shaken at 150
rpm for 1 hour,
(iv) 10, 20, 40 and 50 l aliquots of the transformation material was spread
(with puriﬁed water to add up to 50 l) onto pre-warmed kana NB2
plates and grown overnight at 37C.
2.9.9.3 Cloning of DNA fragments into pUC19 vector
Where pUC19 was used in cloning DNA fragments the following protocol
was used. pUC19 (Fermentas, St. Leon-Rot, Germany) was cut using re-
striction enzyme SmaI (New England Biolabs) to produce linearised DNA:
10 l of 1000 g/ml pUC19 (Fermentas) was placed in solution with 1 l
SmaI, 2 l Reaction Buffer 4 and 7 l puriﬁed water in a 1.5 ml Eppendorf
and placed in a waterbath at 37 C for 90 minutes. 5 l was then run on a
gel to check digestion against a control sample of pUC19.
The vector was then dephosphorylated: 15 l of the digest was added
to 2.5 ml Antarctic Phosphatase Buffer (New England Biolabs) and 7.5 ml
Antarctic Phosphatase (New England Biolabs), and this solution was left
in a waterbath at 37 C for 30 minutes. The phosphatase was then heat
inactivated at 65 C for 5 minutes. At the end of this step, the vector had
been diluted to a concentration of 3 g/l.
68A ligation step was then done which required all constituents and reac-
tion vessels to be prechilled on ice. 1 l of cut, dephosphorylated pUC19
solution was added to 5 l of PCR product, 2 l T4 DNA Ligase Reaction
Buffer, 4 l T4 DNA Ligase (New England Biolabs) and 8 l puriﬁed water
all in a 1.5 ml Eppendorf tube. The reaction mixture was brieﬂy spun down
and ﬂicked gently to mix, then left at 4 C overnight.
Chemically competent E. coli (both of strain MG1655 and DH5) was
used for transformation of the ligated vector. The following standard proto-
col was used for non-kit transformations:
(i) an aliquot of 50 l or 100 l of chemically competent cells and the
ligated vector were thawed on ice,
(ii) 10-20 l of vector was added to the competent cells, mixed gently and
left for 45 minutes (on ice),
(iii) the cells were then heat shocked in a waterbath at 37 C for exactly 5
minutes,
(iv) the cells were then transferred into 5 ml NB2 solution and incubated at
37 C at 150 rpm for 2 hours.
2.9.9.4 Transformation of cells by electroporation
Where chemical transformation failed electroporation was used for electro-
transformation of several strains of E. coli in an attempt to produce viable
clones. A MicroPulserTM(BioRad, Hercules, CA, US) was used to produce
the electrical pulses required for the electroporation. An aliquot of 50 l
69of electrocompetent cells prepared in the manner described in Section 2.9.2
were thawed on ice for the electroporation and the following procedure was
used for the transformation:
(i) 2 l of DNA fragment ampliﬁed by PCR was added to the cells, it was
mixed well and left for 1 minute,
(ii) The MicroPulser was set to ’Ec1’,
(iii) thematerialwastransferredtoa0.1cmelectroporationcuvette(prechilled
on ice) which was placed in the chamber and pulsed once,
(iv) the cuvette was removed immediately, 1 ml SOC medium was added
and the cells were mixed thoroughly,
(v) the material was then transferred to a 20 ml universal tube and incu-
bated at 37 C shaken at 225 rpm for 1 hour.
The resultant transformed cells were then ready for selection and screen-
ing as with those cells transformed by chemical means.
2.9.10 Transformant Screening by amp/IPTG/X-Gal
Various amounts of transformation material from transformation reactions
from 10 l to 100 l were then plated onto amp/X-Gal/IPTG NB2 agar
plates for blue/white screening to detect cells containing recombinant vec-
tors. The principle of blue/white screening depends on the fact that E. coli
lacking the lacZ gene cannot metabolise X-Gal, the metabolism of which
produces a blue chemical. Vectors, such as pUC19, have a lacZ gene en-
coded across their multiple cloning site (MCS, wherein the restriction site
70for SmaI is situated) which is disrupted on the successful ligation of a DNA
fragment into the MCS. There are then up to three sets of cells in the conse-
quent transformed material: those without a transformed vector, those with
a non-recombinant (self-ligated) vector and those with a recombinant vector
(although if DNA has not been cleaned up properly this is not a guarantee
that any recombinant vectors contain the DNA fragment of interest).
The selection and screening is then achieved using amp/IPTG/X-Gal
NB2 agar plates. Ampicillin causes those bacteria without the vector at
all to lyse, but allows all vector-carrying cells to grow. IPTG is a non-
metabolisable inducer for transcription of the lacZ gene, which produces -
galactosidase. -galactosidase cleaves X-Gal into galactose and 5-bromo-4-
chloro-3-hydroxyindole. 5-bromo-4-chloro-3-hydroxyindole then oxidises
into 5,5’-dibromo-4,4’-dichloro-indigo, an insoluble blue product that turns
a colony blue when produced. Thus only colonies that have retained their
white colour during growth contain recombinant vectors, with a disrupted
lacZ gene.
Inoculatedplateswereleftovernightat37 Ctoscreenforwhitecolonies.
When found these colonies were picked and inoculated into 5 ml NB2
medium containing ampicillin in a universal tube and grown overnight at
37 C shaken at 150 rpm. 2 samples of 1 ml of material were then taken
from the universal (to provide plenty of vector DNA for analysis and re-
transformation) and miniprepped according to the standard QIAprep proto-
col, including the Buffer PB wash step, eluting the DNA into 50 l of Buffer
EB.
When MG1655 was used for transformation blue/white screening could
71not be used. MG1655 contains a wild-type lacZ gene on its chromosome
whichhasexpressioninduciblebyIPTG,thuscoloniesoftransformedMG1655
would always be blue in the presence of X-Gal, irrespective of whether the
vector was recombinant or not. Where MG1655 was used for a large recom-
binant transformation efﬁciency was very low, so all colonies produced on
an amp/IPTG/X-Gal NB2 plate were picked for growth, miniprepping and
restriction analysis of the vector.
2.9.11 Restriction digests
All restriction digests were done according to a standard procedure, unless
otherwise stated. The procedure was as follows: 10 l DNA solution from
miniprep (or other source if required) was added to 2 l of 10x reaction
buffer of the type appropriate for the restriction enzyme, 1 l of restriction
enzyme and 7 l of puriﬁed water. This was then incubated for 90 min-
utes at 37 C in a waterbath. For digestion with more than one enzyme the
appropriate buffer was determined from the NEBuffer Activity Chart (New
England Biolabs) table of buffers, and the amount of water added was ad-
justed to produce a 20 l solution. Controls were produced in parallel, but
replacing the reaction buffer and enzyme with puriﬁed water and freezing
for the 90 minute period during which the samples were being digested be-
fore being thawed to run on a gel. After digestion 5 l loading buffer was
added to each solution and mixed gently; 5 l of this was then transferred to
a gel and run alongside an appropriate DNA ladder to determine fragment
lengths.
722.9.12 Gels
Allgelsusedforelectrophoresisweremadewithelectrophoresisgradeagarose
(Invitrogen), at a concentration of 1.5 % w/v, with 3 l of 10,000x SYBR
Safe DNA Gel Stain (Invitrogen, Eugene, OR, US) in each 30 ml gel slab.
Although this agarose concentration is quite high for large DNA fragments
no problems were encountered when using it, so agarose concentration was
not changed for electrophoresis of large fragments. Electrophoresis was
carried out using a Horizon 58 Gel Tank (Biometra, Goetingen, Germany)
powered by a Model 200 powerpack (Biometra). Photographs of gels were
taken by a Gene Genius Bio Imaging System (Syngene, Cambridge, UK)
with a short wave UV light transilluminator, using GeneSnap software ver-
sion 7.05 (Syngene, Cambridge, UK). Loading buffer as described in Sec-
tion 2.2 was used for all electrophoresis experiments. 5 l of sample and
1 l of Loading Buffer were used in each lane, run against 6 l of a DNA
ladder appropriate for the sample. DNA markers used are listed below:
(i) 100 bp DNA ladder (New England Biolabs),
(ii) 1 kb DNA ladder (Promega),
(iii)  DNA-HindIII Digest (New England Biolabs).
2.10 Errors
Unless otherwise stated in the data presented throughout the Results Chap-
ters error bars are all standard errors derived from standard deviations of the
73samples taken of each measurement. Most measurements were taken in trip-
licate, so standard error on each value was calculated as standard deviation
divided by the square root of 3. Expressed mathematically,
I1
2 = SE =

p
n
(2.11)
where I1
2 is the difference between the mean value and the upper and
lower bounds of the interval, SE is the standard error,  is the standard
deviation of the sample values and n is the number of samples. All rates
of bacterial growth are calculated as doubling rates as this can be related to
other quantities more clearly than growth rate.
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Computational Methods
3.1 General computer programs and programming lan-
guages
Many computer programs were used in data analysis and research during
this project. Where programs had speciﬁc roles in the project they are de-
scribed in the relevant Section below, but several programs were used for
multiple tasks and are described here. Due to the rate of change of com-
puter programs various versions of each program were often used during
the course of this project, however only the latest versions used during the
project will be mentioned and where they are not commercial programs the
author(s) and/or relevant website is noted.
Spreadsheets were used extensively both to do multiple parallel calcula-
tions and for conversion of data (e.g. to put in a database). Spreadsheets
were all manipulated using the OpenOfﬁce Calc program (version 3.0.1;
Sun Microsystems Inc., Santa Clara, CA, US).
75MATLAB (The MathWorksTM, Cambridge, UK) was used extensively
both in its own right for ﬁnding solutions to technical mathematical prob-
lems, such as sets of differential equations, and as an interface with various
other programs, allowing automation of many tasks. These uses will be
described in more detail in the relevant Sections below.
CLC Sequence Viewer (version 5.0.1; CLC bio, Hemyock, Devon, UK)
was used for in silico restriction mapping of vectors, ClustalX (version 1.81;
www.clustal.org) was used for multiple alignments of DNA and pro-
tein sequences of the order of kilobases in length, the GNU Image Ma-
nipulation Program (version 2.4.2; www.gimp.org) was used for image
processing, TreeView (version 1.6.6; Roderic D. M. Page) produced phy-
logenetic trees from alignments outputted by ClustalX, Artemis Release 10
[123] was used for visualisation of genome sequences and selection of sub-
sets of genome sequences for further analysis and SigmaPlot (version 11.0;
Systat Software Inc., Chicago, IL, US) was used for graph creation.
Perl (ActivePerl version 5.10.0; ActiveState, Vancouver, BC, Canada)
was used to interface with biological databases online through the BioPerl
(version 1.5.2; www.bioperl.org) toolkit of Perl modules. It has also
been used to perform some ﬁle manipulation and automation of BLAST
searches. Python (version 2.5.1; www.python.org) has been used for
its GenomeDiagram module (version 0.21; Leighton Pritchard, http://-
bioinf.scri.ac.uk/lp/programs.php)whichproducesdiagrams
of genomes and sections of genomes. Both of these programming languages
have been edited and run through Komodo Edit (version 4.0; Activestate).
Databases were produced and manipulated in the MySQL (version 5.0;
76Sun Microsystems Inc.) database language using both OpenOfﬁce Base
(version3.0.1; SunMicrosystemsInc.) andphpMyAdmin(version2.11.8.1;
www.phpmyadmin.net) which is an internet browser based MySQL in-
terface. Databases were stored on an Apache HTTP server (version 2.2.9;
The Apache Software Foundation, www.apache.org).
3.2 Genomic Comparisons
Many genome sequence comparisons were required during this project and
they were standardised so that they would be reproducible and comparable.
Between any set of more than two genomes multiple comparisons between
each pair of genomes were possible, but in practice a single genome se-
quence was chosen as a reference genome and all other genome sequences
werecomparedtothatone, unlessparticularcomparisonsbetweentwostrains
were required. One of two strains of E. coli were chosen to be reference
strains depending on the requirements of each comparison, MG1655 be-
cause of the large body of knowledge about it and CFT073 as the ﬁrst UPEC
to have a complete published genome sequence [42].
The Basic Local Alignment Search Tool (BLAST [23]) has been used in
this project both online and as a standalone program on a local computer.
Where whole genome sequence comparisons were conducted the query and
reference sequences were both downloaded from GenBank at the time of
comparison and used the local BLAST program, as this was amenable to
automation of BLAST runs and BLAST output.
In outline the procedure for comparing genome sequences was by using
77open reading frame (ORF) sequences from the query genome sequence and
using BLASTp to ﬁnd the closest related proteins in the reference organ-
ism. Early comparisons were done by manual inspection, replaced by Di-
agHunter (described below) later in the project, to determine whether sets
of genes encoding these proteins were retained in similar places on each
genome or whether they were retained in groups of adjacent genes, but in
different places on the genomes of the two bacterial strains.
Genome sequences were all taken from Genbank [25], although due to
the constant revision of Genbank ﬁles sometimes comparisons earlier in the
project were rendered obsolete. Where possible comparisons were redone
with the latest sequence ﬁles, if they were going to be used for further anal-
ysis.
3.3 Discovery of Putative Metabolic Genes and sets of co-
linear genes adjacent to them in CFT073
3.3.1 Genomic comparisons for CFT073 metabolic comparisons
The initial genome sequence comparisons for the project were carried out
by Preben Krabben (unpublished), and the putative metabolic genes were
initially identiﬁed by him. All further work including bioinformatic analy-
sis of the clusters and experimental veriﬁcation of the identiﬁed genes were
carried out by the author. These comparisons were used to look for unchar-
acterised metabolic genes that might have a role in CFT073 metabolism in
the urinary tract. For this CFT073 was used as the reference genome and
78other genome sequences were compared to it.
TheCFT073genome[42]wascomparedgene-by-geneusingTBLASTN
[23]togetasequenceidentityvalue. ThispercentageidentityfromTBLASTN
was combined with the position and percentage identity of nearest neigh-
bours and overall position in the genome to infer synteny conservation. The
use of BLAST scores to determine gene conservation is well established
(such as the BSR technique [124]) and this process was reﬁned by adding
a neighbour dependent analysis to determine gene synteny. For sets of two
or more genes in a similar position on two genomes, retention of function
of each gene was inferred by identity with a cut-off of 90% over the whole
length of each gene. Single genes in similar positions on the two genomes
were inferred as conserved only if their mutual identity was above 95% over
their whole length.
3.3.2 Selection of genes for further analysis
Genes that were in CFT073 but not present in MG1655 according to the
initial genomic comparison were selected for further analysis, since the
MG1655 phenotype and genotype are very well characterised, and it does
not colonise the urinary tract [125]. This produced an initial list of candidate
genes that could be implicated in the metabolism of CFT073 in the urinary
tract, but have not yet been characterised. This set of genes was inspected
manually for those genes which appeared to have a metabolic function from
their GenBank annotation [126], but without a deﬁnite, speciﬁc biological
function, henceforth referred to as putatively metabolic genes (PMGs).
79Where there was a PMG surrounded by uncharacterised genes, this re-
gionofthegenomesequencewasviewedusingtheNCBI’sSequenceViewer
2.1 and all adjacent genes transcribed in the same direction as the PMG and
lessthan100basepairsseparatedwereinferredtobepartofasetofadjacent
colinear (SAC) genes and included in the analysis as they could potentially
be parts of an unidentiﬁed operon. The algorithm for inferring whether each
set of genes was present in each of the Escherichia genomes considered was
as follows: where the set was greater than 3 genes in length it was consid-
ered present if at most one of the genes was absent according to the synteny
comparison; where there were 3 or fewer genes, all genes had to be present
to conclude that the operon was present.
BLASTp was then used on each gene in the sets of genes against the
full non-redundant database of Genbank [127] to try to ﬁnd homologies
to already annotated genes. Where homologs could not be found protein
domain similarities were sought using Pfam [128] and SEED (http://-
theseed.uchicago.edu/FIG/index.cgi) in an endeavour to elu-
cidate their function. Further, the NCBI’s Conserved Domain Database
[129] was searched for conserved domains.
80Figure 3.1: This is example output of an individual BLASTp comparison using the parameters described in
the text. See text for description of the columns.
3.4 Full genome comparisons for metabolic network com-
parison
3.4.1 Gene-by-Gene Comparisons
For the genome synteny comparisons used in Chapter 6 individual compar-
isons between ORFs were required. BLASTp was used with the following
non-default arguments: ‘-IT -m8 -b3’, which produces output such as that
seen in Figure 3.1. Although automation of the BLAST comparisons was
used so multiple BLASTp comparisons were done together, each BLAST
was conducted identically as if it had been run by itself. Results were then
concatenated into a single ﬁle for further analysis, as described below.
ORFs were then taken one at a time and compared to the protein database
81of the reference strain. Non default parameter values were required for out-
put from the program to be in the form of a list of at most three hits on
the reference genome sequence per ORF (in the interests of computational
efﬁciency) and in the form of a summary table without comments, which
was conducive to automatic parsing for DiagHunter. Figure 3.1 shows sam-
ple output from the BLAST search conducted. The ﬁrst column is the GI
number of the query ORF and the second is the GI number of the ORF
with a similarity in the reference protein database. The third and fourth
columns are values X and Y respectively in the expression Z = X  10 Y
where Z is the expectation that the two sequences have this level of sim-
ilarity by chance. So for instance if the second line of Figure 3.1 is taken
Z = 110 90 so it is very likely that the sequences have a common ancestor
gene. Where both columns have the value 0 this represents an expectation
value too close to zero to be expressible in the format illustrated above. The
ﬁnal column is a BLAST score value.
3.4.2 Gene position data and DiagHunter (the DH method)
DiagHunter [130] was used to ﬁnd sets of genes transcribed in the same
relative orientation and in similar relative positions (genes adjacent to each
other) in two genomes. A standard method and set of parameters was used
for gene synteny inferences as described below, apart from the ‘lmin’ pa-
rameter, which determined minimum numbers of adjacent genes to use for
the inference of synteny by DiagHunter. This will be set on comparison with
other methods of gene synteny inference in Section 6.4.1.3. This method
of gene synteny inference will be termed the DH method for convenience
82through the course of this Thesis.
DiagHunter takes as input specially formatted BLASTp output, along
with relative position and orientation data of genes in two compared bac-
terial strains, which is not part of the BLASTp output. This has required
custom formatting that was achieved using MATLAB and a purpose built
(MySQL) database of gene information for each strain. Each database con-
tained a record for each inferred protein coding gene in the strain. The
record contained the protein GI number which was used as a reference for
ﬁnding the two appropriate records for each particular BLASTp result. The
record also contained a counting index number indicating the order of all
genes in a particular strain as well as the orientation of the gene, either on
the Crick or Watson strand. For each BLASTp hit contained in the BLASTp
output from Section 3.4.1 the GI numbers of the relevant genes (both query
and reference) were looked up in the appropriate database and position and
orientation data were collected and placed in a parsed ﬁle in the correct
format for input into DiagHunter.
An example of the correct input format for DiagHunter can be seen in
Figure 3.2, which is the output if the values in Figure 3.1 were parsed. The
ﬁrst and third columns are the GI numbers of the relevant proteins, but the
signiﬁcant addition to this ﬁle is the position and orientation data in the
second and fourth columns. In each of these columns the numerical value
is the number of genes counted from the origin of the genome to that gene,
in the direction of transcription of the Thr operon leader peptide, which
is encoded by gene 1 in this counting scheme. The letters in these columns
represent the strand on which the protein is encoded, either the Watson (‘w’)
83Figure 3.2: This is example input ready for DiagHunter, parsed from BLAST results such as those shown in
Figure 3.1. For description of columns see text.
or the Crick (‘c’) strand. The ﬁnal three columns are taken directly from the
ﬁnal three columns of the BLASTp output, indicating expectation value and
BLAST score for each hit.
DiagHunter wasthen runusing thisparsed listof BLASThits asits input.
The performance settings used for DiagHunter were:
(i) Compress factor: 1, because gene order rather than absolute position
was used,
(ii) Use orientation: 1, to use the orientation data available,
(iii) Score cutoff: 20, to remove BLAST hits with poor BLAST scores,
(iv) Min diag len: variable, to assess the impact of this factor on gene in-
ferences
(v) Min diag qual: 11, the running average sensitivity required for elon-
gating a diagonal run of genes.
84The outputs of DiagHunter are a diagram of gene synteny hits and a ﬁle
listing sets of adjacent genes conserved between the two strains in the com-
parison. This list is then analysable itself looking at various comparisons
and giving genes conserved across strains, but these lists of genes can also
be used to infer metabolic models through knowledge of metabolic gene
function.
3.5 Metabolic Models
There are many types of metabolic model taking into account various levels
of knowledge about the physicochemical constraints within the system of
interest, usually a cell. A summary of these models can be found in Section
1.3, but the models used in this project are stoichiometric whole-cell mod-
els, with very little by way of metabolic regulation constraining the model
capabilities. Such models consist of several parts that when combined can
be interrogated to ﬁnd solutions that satisfy certain objective functions, by
the minimisation or maximisation of such functions.
This solution in the case of stoichiometric models is a set of rates for
every reaction that produces the desired objective. In the case of stoichio-
metric models covering the whole metabolism of a bacterium, it includes
rates of metabolite uptake from the cell surroundings, rates of excretion of
all waste products and, when included, the growth rate of the bacterium.
The ﬁrst piece of the model is a matrix where each row represents a
metabolite and each column represents a reaction; where a metabolite i is
used up (or produced) in a reaction j the cell (j;i) has a value equal to minus
85(or plus) the amount used (or produced) in the reaction when the reaction
is stoichiometrically balanced. For instance, in the reaction catalysed by
acetolactate synthase two pyruvate molecules and one hydrogen ion react
to produce one 2-acetolactate molecule and one carbon dioxide molecule.
Thus in the column representing this reaction, in the cell representing pyru-
vate the value would be -2, in that for the hydrogen ion it would be -1 and
for both 2-acetolactate and carbon dioxide the value would be 1. All other
cells have values of 0.
Each reaction has limits to its rate: some reactions cannot run backwards
(irreversible reactions) and all are limited by the capabilities of the enzyme
catalysing the reaction. Further physicochemical conditions (such as pH,
temperature and reactant and product concentration) have an effect on the
rate of all reactions, but these are not taken into account for the purposes of
wholegenomemetabolicmodels. Theconstraintsonreactionratesareinthe
form of minimum and maximum rates for each reaction. Unless speciﬁcally
constrained for a speciﬁc task at hand reaction limits are set to 1 and  1
in the forward and reverse directions respectively except where a reaction is
irreversible in which case the minimum rate is set to zero. Further, where
external metabolites are taken up by the cell care is needed to limit the rate
of uptake of these metabolites to realistic levels.
The last parts of the model required deﬁne the nature of the metabolite
balancing achieved in the model. Solutions to models of this type rely on
metabolite balancing, representing a steady state solution to the problem,
where there is no net production or consumption of any individual metabo-
lite. The right-hand side coefﬁcients and senses (equal to, greater than or
86less than) of the equations (equality or inequality) produced from the dot
multiplication of the stoichiometric matrix and the solution (vector of reac-
tion rates) must be deﬁned before a solution can be sought. Usually a steady
state assumption is made about the cell, that no metabolites are net produced
or net consumed in the cell during the period modelled. Thus all senses are
set to equality and all right hand side coefﬁcients are set to 0.
3.5.1 iAF1260 and related models
The model used as a basis of all the models in this project is that of Feist et
al [1], called iAF1260. The aspects of the model described here are those
which are important for the speciﬁc uses for which the model has been used,
or modiﬁcations to the original model. It is the most complete stoichio-
metric model of E. coli metabolism publicly available and includes gene-
protein-reaction (GPR) relationships for all the reactions for which these
data are known. GPR relationships relate the genes present in an organism’s
genome (in this case that of E. coli K-12 MG1655) to the reactions which
the bacterium is capable of catalysing. This link comes from the enzymes
catalysing the reactions in question, which are coded for in the genes of
the bacterium. So for instance the gene locus tag b0063, gene name araB
encodes the enzyme L-ribulokinase which catalyses the reaction with EC
number 2.7.1.16, the phosphorylation of ribulose. This represents infor-
mation about other bacteria which also contain this gene, that they are in
principle capable of catalysing the same reaction within themselves. Com-
plications to GPR relationships occur in the form of multi-subunit enzymes
and multiple enzymes catalysing the same reaction, but these are taken into
87Figure 3.3: This diagram shows the compartments used in the stoichiometric models used in this project.
account in the iAF1260 GPR relationships.
An important aspect of the model iAF1260 is that it is partitioned into
physically distinct compartments, that is, the cytosol, the periplasm and the
extracellular environment. Metabolites present in any particular compart-
ment are distinct from identical metabolites in other compartments as they
are the only metabolites available for reactions within that compartment,
and are not available for reactions in other compartments. The model there-
fore distinguishes metabolites in each different compartment. ‘Metabolites’
used in construction of the stoichiometric matrix are therefore deﬁned not
only by the metabolite itself, but by the position of the metabolite in the sys-
tem. Transport across boundaries (membranes) between compartments (or
reactions involving metabolites in more than one compartment) can occur
by several processes, but each process must be deﬁned by a reaction in the
model, so diffusion across a membrane would be represented by a reaction
like: 1 acetoacetate (extra-cellular) , 1 acetoacetate (periplasm).
88A further compartment has added to the model, that of the boundary,
producing the layout seen in Figure 3.3. This compartment represents the
region distant from the cell with which the cell cannot interact directly. This
necessitates two sets of reactions, one set being diffusion between the extra-
cellular compartment and the boundary compartment and another set repre-
senting the destruction or creation of ‘boundary’ metabolites in the bound-
ary compartment. The boundary thus represents the medium in which the
cells exist and from which the cells can draw nutrients - which can be de-
pleted or added to in a modelling situation, as in a real situation. The de-
struction or creation of metabolites is represented in the model by one-sided
reactions like the following: 1 water molecule (boundary) , .
3.5.2 Inferring metabolic models from synteny comparisons
The steps to creating an inferred metabolic model for a fully sequenced
bacterium are fairly simple in principle. The genes inferred to be present by
the method described in Section 3.2 are used to see which reactions could
be catalysed by enzymes encoded by those genes according to the GPR
relationships given with the iAF1260 model. Information about the GPR
relationships in the model are in the form as shown in this example: ‘( (
b0936 and b0933 and b0934 ) or ( b0365 and b0366 and b0367 ) )’ where
bXXXX is the Blattner number, as deﬁned in GenBank, of the gene for
a single reaction (in this case butanesulfonate transport via ABC system -
periplasm). In these relationships ‘or’ means either one or the other or both
and ‘and’ means that all of the genes connected in a row by ‘and’ must
be present for an enzyme to be present. Thus either the enzyme complex
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Figure 3.4: The database structure containing the information making up iAF1260. Rectangles with rounded
cornersrepresententitiesandovalsrepresentlinksbetweenthoseentities. Linesrepresentingtherelationships
between the tables show the 1 to many relationships that exist in this database. Further details of the tables
can be found in the text.
encoded by b0936, b0933 and b0934 together or the complex encoded by
b0365, b0366 and b0367 together will catalyse the transport reaction. It
does not matter for the purposes of this model if both sets of genes are
present in the same genome.
These logical relationships between genes, proteins and reactions was
represented for the purposes of building new metabolic models in a MySQL
database with the structure detailed in Figure 3.4. The database consists of
7 tables split into entity tables and link tables. The entities are: reactions,
compartments, molecules (including single atom species and gene products)
and protein complexes (enzymes).
The ﬁrst linking table represents the stoichiometry of the reactions. Each
reaction has a set of records in the Stoichiometry table, one for each metabo-
lite (molecule) in a speciﬁc compartment in that reaction. The record there-
fore consists of a reaction index number, a molecule index number, a com-
partment index number and the stoichiometry of that particular metabolite
90in the reaction. This table is for the purposes of populating the stoichiomet-
ric matrix when the reactions in a particular model are known. The records
in ‘Stoichiometry’ associated with each present reaction are used to retrieve
the correct stoichiometry for the model.
The second linking table is ‘Reaction catalysts’ that holds a record for
each enzyme that catalyses each reaction. Each record therefore consists of
the enzyme index number and the index number of a reaction catalysed by
that enzyme. This table enables the presence or absence of available reac-
tions in a model to be inferred from the complement of enzymes available in
the model. The records in ‘Reaction catalysts’ associated with each present
enzyme produce a list of reactions available.
The third linking table is ‘Complex constituents’, which describes the
molecules required for the creation of each viable enzyme. Each record con-
tains the index of a ‘Protein complex’ and the index of one of its ‘Molecule’
constituents. These constituents are the peptides encoded in the genes con-
tained on the genome of the relevant organism.
This completes the necessary information to produce a metabolic model
from the gene complement of an organism. The genes present determine
the enzymes that have all their constituents and are functional; this list of
enzymes constrains the list of reactions to those catalysable by the func-
tional enzymes; the stoichiometric matrix can then be built according to the
reactions available for the organism.
Several points are worth noting about this database. It contains quite a
few reactions that are not catalysed by enzymes, or for which the catalysing
genes have not been identiﬁed. The inference mechanism therefore checks
91each time it is run to see whether there are any enzymes (present or absent)
that catalyse each reaction and where there are no potential enzymes the
reaction is assumed to be present in the model.
There is also a limitation on the applicability of the model because using
only the GPR relationships any reactions not present in MG1655 cannot be
inferred to be present in the model. Where this was the case and further
reactions were required these were added along with their GPR relations
into the database and the presence of the required genes was determined
manually.
AnSQLdumpofthedatabasecanbefoundinSupplementaryFile‘iaf1260.sql’
and an Excel dump can be found in Supplementary File ‘iaf1260.xls’.
3.6 Growth Models
Growth models were produced through the GPR relationships in iAF1260
for E. coli CFT073 for the simulations in Chapter 7. These were achieved
with an additional table in the database consisting of a list of GI numbers
of genes in MG1655 for which there were functional eqivalent genes in
CFT073 (according to the genome comparisons carried out in Chapter 6),
called ‘gene list’. The exact SQL query for production of the database can
be seen in Supplementary File ‘combined presence.qry’, but is described
here for clarity. This is the algorithm used for producing new models:
(i) enzyme complexes with all their genes ‘gene list’were found,
(ii) allreactionswithoutassociatedcomplexes(uncatalysedreactions)were
found,
92(iii) all reactions either in the uncatalysed list or catalysed by complexes
found in step i) were combined to give a complete list of reactions,
(iv) all metabolites present in each of these present reactions were added to
give a list of metabolites,
(v) the stoichiometries from the linking table ‘stoichiometry’ were then
added to a list of all stoichiometries present.
Models were passed straight from the MySQL database to MATLAB and
were used in MATLAB for linear optimisations and other model calcula-
tions. The simulations produced in Chapter 7 are described in that Chapter
for convenience so that the simulation results and underlying calculations
can better be compared.
93Chapter 4
Isolating metabolic genes of interest: a
bioinformatic and experimental
approach
4.1 Preface
The complete genome sequence of E. coli CFT073 has opened further the
possibility of investigating the metabolic basis (through metabolic genes) of
bacterial survival during colonisation of the urinary tract. This is of great
interest as a thorough knowledge of the metabolism of such UPEC would
have the potential to offer new ways of treating urinary tract infections. The
approach to functional genomics of using multiple genome sequences to
infer commonalities and differences between bacterial strains living in dif-
ferent habitats has been used in the context of UPEC to an extent by others.
Several strains’ genome sequences have been compared to ﬁnd common
metabolic genes [62] and in this project the approach has been expanded to
use all the available sequences of closely related strains (at the time of orig-
94inal comparison) and to investigate partially characterised metabolic genes
and operons.
In this Chapter a complete gene synteny comparison has been carried out
between nineteen fully sequenced strains from the genus Escherichia with
the aim of ﬁnding as yet uncharacterised genes implicated in the metabolism
of uropathogenic strains of E. coli (UPEC). Several sets of adjacent col-
inear genes have been identiﬁed which are present in all four UPEC in-
cluded in this study (CFT073, F11, UTI89 and 536), annotated with putative
metabolic functions, but are not found in any other strains considered.
An operon closely homologous to that encoding the L-sorbose degra-
dation pathway in Klebsiella pneumoniae has been identiﬁed in E. coli
CFT073; this operon is present in all of the UPEC considered, but only
in 6 of the other 15 strains. The operon’s function has been conﬁrmed by
cloning the genes into E. coli DH5 and testing for growth on L-sorbose.
The functional genomic approach combining in silico and in vitro work pre-
sented here can be used as a basis for the discovery of other uncharacterised
genes contributing to bacterial survival in speciﬁc environments.
4.2 Results and Discussion
4.3 Genome sequences
ThegenomesequencesusedinthisChaptercanbefoundinTable4.1, which
indicates pathotype where known and indicates which have an inferred L-
sorbose uptake and utilisation operon. The set of genome sequences used in
this Chapter will be referred to as the EGSS (Escherichia genome sequence
95Table 4.1: Strains of genus Escherichia used in this study, all with completely sequenced genomes or whole
genome shotgun sequences freely available from GenBank. ‘GI tract’ is the gastrointestinal tract. Unless
otherwise indicated they are Escherichia coli.
Strain Type Sorbose Operon Source /
Accession Number
CFT073 UPEC (uropathogenic) + AE014075
F11 UPEC + AAJU00000000
536 UPEC + CP000247
UTI89 UPEC + CP000243
042 EAEC (enteroaggregative) – Sanger Center
B7A ETEC (enterotoxigenic) – AAJT00000000
E24377A ETEC – CP000800
B171 EPEC (enteropathogenic) – AAJX00000000
E22 EPEC – AAJV00000000
E2348 EPEC – Sanger Center
E110019 EPEC – AAJW00000000
53638 EIEC (enteroinvasive) – AAKB00000000
MG1655 Commensal (GI tract) – U00096
HS Commensal (GI tract) – CP000802
O157:H7 str. Sakai EHEC (enterohaemorrhagic) + BA000007
O157:H7 EDL933 EHEC + AE005174
Shigella sonnei 53G Bacillary Dysentery + Sanger Center
Shigella ﬂexneri 2a str. 301 Bacillary Dysentery + AE005674
Shigella dysenteriae Sd197 Bacillary Dysentery + CP000034
set) for convenience, although in later Chapters the analysis is widened to
include further bacteria, the sequences of which became available more re-
cently than this analysis was done.
4.3.1 Multiple genome comparison
The results of the complete synteny comparison of the genome of CFT073
against the rest of the EGSS can be seen in Supplementary Table 1.
Overall 133 putatively metabolic genes (PMGs - as deﬁned in Section
3.3.2) were inferred; they can be seen in Supplementary Table 2, along with
the results of an NCBI Conserved Domain Search, and are summarised in
Table 4.2. All of the individual genes marked with putative metabolic func-
96Figure 4.1: Positions of the SACs identiﬁed in the genome sequence of E. coli CFT073, as labelled in Table
4.2.
tions in the CFT073 genome sequence were positioned adjacent to genes
transcribed in the same sense, so sets of adjacent genes colinear to these
PMGs (SACs) were included in the investigation, a summary of which can
be seen in Table 4.2, and positions of which in the CFT073 genome can be
seen in Figure 4.1. It should be emphasised that the criterion for considera-
tion of these genes was only that the genes marked with putative functions
be absent from E. coli K-12 MG1655, without any further consideration of
whether they would speciﬁcally be useful in the lifecycle of CFT073. 18
of these genes are present in all of and only in the UPEC and 49 genes are
among those identiﬁed by Lloyd et al [101], which compared the gene con-
tent of 7 additional UPEC and 2 different faecal strains of E. coli by com-
parative genomic hybridisation against CFT073 to ﬁnd those genes unique
to uropathogens.
Thesyntenycomparisonshowsseveralcharacteristicsindicatingahigher
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98prevalence of the genes from CFT073 in the other UPEC than in the other
strains. Itisworthnotingthatthesetsofadjacentcolineargenesidentiﬁedin
thisstudyarenotingeneralpartsofthelargepathogenicityislandsidentiﬁed
in CFT073 by others [101, 42], with the exception of those marked with an
asterisk in Table 4.2.
SAC No. 6 (as labelled in Table 4.2) is within a large pathogenicity
island, PAI-CFT073-metV (according to the nomenclature set out recently
by Lloyd et al [101]), in which the SAC is restricted to the area c3405 to
c3410. These genes are retained in all the UPEC and in E. coli E2348, but
not in any other strain. Retention of the sorCDFBAME genes (SAC No. 15)
in some of the EAEC and EPEC and all of the Shigella is consistent with
the ﬁndings of Lehmacher and Bockem¨ uhl [131] who despite the negative
phenotype showed that they retain the DNA for many of these genes.
It was found that 121 of the 133 PMGs identiﬁed are present in the same
position in all four UPEC; these include the putative genes for L-sorbose
degradation. The only SAC not present in any of the UPEC other than
CFT073 is No. 1. Those found in the same place in all UPEC, but in none of
the other strains, are 8, 12 and 19. The SACs identiﬁed here have a tendency
to be present or absent as a whole, rather than on a gene-by-gene basis,
which implies that their functions might be co-ordinated and co-dependent,
eg. as enzymes for transport and metabolism of the same chemical.
An investigation of each of the PMGs present in all UPEC and absent
from all others was conducted using BLAST, the SEED tool, Pfam and the
NCBI Conserved Domain Database, in an attempt to identify putative func-
tions for all the genes. SAC No. 8 (genes c4013 to c4018) has several genes
99annotated putatively already, c4015 to c4017 as part of a ribose ABC trans-
porter, and c4018 as a tagatose 1,6-diphosphate aldolase. The hypothetical
genes bear similarities to other sugar metabolism encoding genes: c4013
to a dehydrogenase and c4014 to a sugar kinase, possibly a fructokinase.
These genes could encode enzymes for the uptake and catabolism of a 5- or
6-carbon sugar or sugar derivative.
SAC No. 19 (c5346 to c5351) has previously been identiﬁed as an
arginine catabolic operon [62]. It contains three hypothetical proteins and
the following annotated proteins: c5348 is annotated as an ‘ornithine car-
bamoyltransferase chain I’, c5349 as a ‘carbamate kinase’ and c5350 as
an ‘arginine deiminase’. Gene c5346 resembles an ArgR arginine tran-
scriptional repressor and c5347 bears a strong similarity to DcuC, a ‘C4-
dicarboxylate anaerobic carrier’, though it is annotated in SEED as con-
taining an ‘arginine/ornithine antiporter ArcD’. According to the MetaCyc
[132] species comparison tool there are very few CFT073 genes annotated
for arginine catabolism, but the synteny comparison carried out here im-
plies that there are genes encoding the catabolism of L-arginine to succinate
via agmatine, putrescine, 4-aminobutarol, 4-aminobutyrate and succinate
semialdehyde. MG1655 contains an arginine ABC transporter, but lacks
a veriﬁed L-arginine/L-ornithine antiporter, putatively present in CFT073.
This leaves the pathway catalysed by this set of genes unknown; poten-
tially according to SEED annotations, c5350 could produce citrulline from
L-arginine and c5348 could produce L-ornithine from citrulline, bypassing
L-arginino-succinate in the urea cycle. The third reaction (c5349), puta-
tively producing carbamoyl-phosphate from ammonia, would seem to be
100necessary only if ﬁne control of this reaction needed to be coupled to the
other reactions encoded by this set of genes, as there is a gene of the same
function elsewhere in the genome (c0635).
Since there is a limited number of carbon sources present in urine - pre-
dominantly urea, uric acid and creatinine (and L-sorbose in small amounts)
- it might seem plausible that the sets of genes identiﬁed here may encode
proteins for the utilisation of these chemicals. However, an analysis of
the genes investigated here has so far failed to ﬁnd any good matches to
known metabolic pathways for these three carbon containing compounds.
The putative arginine utilisation operon described above encodes enzymes
that catalyse reactions whose metabolic functions are close to those of urea
catabolism though the only product of urea possible in the reactions anno-
tated in MetaCyc is ammonia. UPEC are not conﬁned to using the carbon
sources in urine; they adhere primarily to the epithelial cells in the urinary
tract so potentially the mucus produced by these cells could be used to fulﬁl
the metabolic needs of UPEC.
The beneﬁt of D-serine utilisation genes for UPEC has been suggested
[62], so these genes were investigated in the UPEC included in this study
to assess their relative prevalence. It was noted that according to the initial
synteny comparison (Supplementary Table 1) these genes are not present in
E. coli F11 or 536. However there are D-serine utilisation genes in both F11
and 536 at an alternative position in the genome identiﬁed by Brzuszkiewicz
et al. Moreover, UTI89 also has D-serine utilisation genes in this alterna-
tive position on its genome as well as those found in this study. None of the
non-UPEC in the EGSS had this alternative operon, which is characterised
101by a particularly large intergenic region (1 kb) adjacent to it, conserved
between F11, 536 and UTI89. This D-serine utilisation operon is therefore
unique within these strains to the UPEC, indicating that it was present in a
common ancestor of only these strains. The two D-serine operons present
in UTI89 have a mutual identity along their entire length of 96 %, which
indicates that there may have been a duplication event at some point in its
history. This also indicates that the differing positions of the D-serine oper-
onsarenotduetomovementofthegenes, butbyduplicationandsubsequent
loss of the ﬁrst operon.
4.3.2 Putative L-sorbose utilisation operon in silico analysis
SAC 15 is noted in Table 4.2 as a putative L-sorbose metabolism operon.
This was based on the annotations of the CFT073 genome sequence of the
genes c4981-c4987, which indicated a sorbose, mannose or related com-
pound PTS system. L-sorbose [133] can be present in urine (and in the
gastrointestinal tract). It can be seen from Table 4.2 that it is predominantly
the UPEC and Shigella strains which contain the operon enabling use of
L-sorbose as a carbon source.
The putative L-sorbose operon in CFT073 was compared to that of Kleb-
siella pneumoniae using BLASTp. Both of these strains are in the family
Enterobacteriaceae and the function of Klebsiella’s operon has been exper-
imentally veriﬁed [118]. The results of this comparison are shown in Table
4.3, which shows identity above 90% for all but one of the genes.
AphylogeneticcomparisonbetweentheputativeL-sorboseoperonsfrom
those sequenced bacteria of the genus Escherichia, using Klebsiella pneu-
102Table 4.3: Comparison of SAC No. 15 in CFT073 to the Klebsiella pneumoniae L-sorbose degradation
operon.
CFT073 CFT073 name Klebsiella name Klebsiella Percentage
gene ID annotation Identity
c4981 Putative oxidoreductase L-sorbose 1-phosphate SorE 91
reductase
c4982 PTS system, mannose-speciﬁc second subunit of EII-Sor SorM 97
IID component
c4983 PTS system, mannose-speciﬁc ﬁrst subunit of EII-Sor SorA 95
IIC component
c4984 Putative sorbose PTS component EIII-B Sor PTS SorB 92
c4985 Putative sorbose PTS component EIII-F Sor PTS SorF 82
c4986 sorbitol-6-phosphate D-glucitol-6-P SorD 92
2-dehydrogenase -Dehydrogenase
c4987 Putative transcriptional regulator Sor regulator SorC 92
of sorbose uptake and utilisation genes
moniae (GI: 150953431) and Klebsiella oxytoca (see acknowledgments for
reference) as an outgroup, was conducted using ClustalX [134]. BLAST
was used to extract the putative L-sorbose operons for most of the bacte-
ria, but Artemis [123] was required to extract the relevant parts of both the
Klebsiella strains and F11, which did not at the time have complete single
contig genome sequences.
This ClustalX comparison of the putative sorbose operons of 14 strains
of bacteria produced the phylogenetic tree shown in Figure 4.2. These bac-
teria are all of genus Escherichia (except the Klebsiella strains) and in-
clude several Shigella strains, Shigella boydii Sb227 (Accession Number:
CP000036.1) andShigella sonneiSs046 (Accession Number: CP000038.1),
not used in the full genome analysis because their genomes are not com-
pletely sequenced. The operons were located in the genome sequence thus
far generated for them and extracted to compare to the others in the EGSS.
Also included is the inferred L-sorbose operon from the recently published
103Avian Pathogenic Escherichia coli O1:K1:H7 (APEC 01) [39] (Accession
Number: CP000468.1), which clusters with the UPEC, separate from the
enterohaemorrhagic E. coli (EHEC) and Shigella strains. The EHEC and
Shigella L-sorbose operons are grouped together. Two of the operons are
split (those of O157:H7 strain Sakai and Shigella dysenteriae Sd197) by
DNA insertions, but for the purposes of the ClustalX computation the inser-
tions were removed and the homologous parts of the respective genes were
allowed to line up independently.
4.3.3 Experimental veriﬁcation of function of genes c4981 to c4987
from Escherichia coli CFT073
The genes c4981 to c4987 were successfully cloned into the pSC-B plasmid
for experimental veriﬁcation of function according to the method in Section
2.9 and conﬁrmed by sequencing as being oriented as shown in Figure 4.3.
The growth of the three strains in minimal media containing either glucose
or L-sorbose as sole carbon source can be seen in Figure 4.4. The negative
control, DH5 with pUC19, was unable to utilise this carbon source. DH5
containing the pQR793 plasmid (called DH5L from now for convenience)
grew using L-sorbose as the sole carbon source.
The functions of genes c4981 to c4987 from Escherichia coli CFT073
have therefore been conﬁrmed as those encoding a pathway for the util-
isation of L-sorbose as a sole carbon source. The very high similarity be-
tween this operon (along its entire length) with the operon identiﬁed and ex-
perimentally characterised in Klebsiella pneumoniae [135] implies that not
only do the two operons both utilise L-sorbose, but that the same pathway
1040.1
Klebsiella Oxytoca
Klebsiella Pneumoniae
Shigella SD197
CFT073
APEC 01
UTI89
F11
536
8401
301
2457T
Shigella Boydii Sb227
Shigella Sonnei Ss046
EDL933
O157H7
Figure 4.2: Phylogenetic tree of L-sorbose operons (both conﬁrmed and putative) in the genus Escherichia
and in two Klebsiella strains. The scale is in units of substitutions per site. Unless otherwise stated the strain
is Escherichia coli.
is used by both. The phylogenetic analysis of the L-sorbose operon con-
ducted as part of this research shows how this operon ﬁts in the phylogeny
of L-sorbose operons in the genus Escherichia. The Glucitol-6-phosphate
dehydrogenase found in Klebsiella pneumoniae has been shown to be tem-
perature sensitive [118], which might account for the long lag phase and
slow growth of DH5 containing the plasmid.
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Figure 4.3: Structure of the pSC-B plasmid with the putative L-sorbose operon insert from CFT073.
4.3.3.1 The L-sorbose pathway and its link with central metabolism in E.coli
The cloning of the L-sorbose operon from CFT073 into DH5 resulted in a
positive phenotypic response of DH5 in L-sorbose minimal medium, and
close similarity between this operon and the L-sorbose utilisation operon in
Klebsiella pneumoniae imply that the reactions catalysed by the products
of these genes, as shown in Figure 4.5, were added to the metabolism of
DH5, linking to it where D-glucitol 6-phosphate is converted to D-fructose
6-phosphate.
This Figure also shows in overview how these reactions are linked to
both biomass production (driven by energy transfer conducted through the
TCA cycle) and to acetate production, a nuisance metabolite in many cir-
106Figure 4.4: Growth curves for DH5 containing plasmid pQR793, compared to CFT073 and DH5 with an
empty pUC-19 plasmid. DH5 with pQR793 is represented by  and , DH5 with pUC19 by M and N and
CFT073 by  and  where empty symbols represent growth on glucose and ﬁlled symbols represent growth
on L-sorbose. Where duplicate samples were taken readings varied by less than 0.01 OD600 units using a
CO8000 Cell Density Meter (WPA).
cumstances and the reduction of which in engineering contexts has been the
subject of much work (for instance [136, 137]). Changes in acetate produc-
tion in response to a novel carbon source for a bacterium, and changes due
to serial passage have both been investigated in the course of this project, so
it has been included in this Figure.
107Figure 4.5: Showing in overview the link between L-sorbose degradation and central metabolism, entering
the glycolysis I pathway at D-fructose 6 phosphate. Solid lines represent single reactions linking metabolites
and dashed lines represent pathways and more general transitions. Where single reactions are shown, relevant
genes have been indicated, underlined if they are not present in MG1655.
108Table 4.4: Comparison of SAC No. 7 in CFT073 - putatively involved in the metabolism of a 5- or 6-carbon
sugar - with the NCBI Conserved Domain Database. Current annotation can be seen alongside the domain
inferences.
GI number Locus tag Annotation Conserved Domain
Database entry
26249581 c3750 Putative regulator FadR, Transcriptional regulators
26249582 c3751 Hypothetical oxidoreductase ydfI MtlD, Mannitol-1-phosphate
/altronate dehydrogenases
26249583 c3752 Hypothetical zinc-type alcohol Tdh, Threonine dehydrogenase and
dehydrogenase-like protein yjjN related Zn-dependent dehydrogenases
26249584 c3753 Ureidoglycolate dehydrogenase Ldh 2, Malate/L-lactate dehydrogenase
26249585 c3754 Putative c4-dicarboxylate transport SBP bac 7, Bacterial extracellular
system binding protein solute-binding protein, family 7
26249586 c3755 hypothetical protein c3755 DctQ, Tripartite ATP-independent
periplasmic transporters, DctQ component.
26249587 c3756 c4-dicarboxylate permease ArsB NhaD permease,
Anion permease ArsB/NhaD
4.3.4 Bioinformatic analysis of genes c3750-c3756
Current annotations of genes c3750-c3756 are quite general, and the NCBI
Conserved Domains Database provides more speciﬁc putative functions - as
shown in Table 4.4. There are several potential metabolic functions, such as
mannitol, malate and L-lactate degradation, as well as a potential regulator
gene (c3750) and transporter genes (c3755 and c3756). It was therefore
selected for cloning and further characterisation.
4.3.4.1 Cloning of genes c3750-c3756 into E. coli
Cloning of this cluster of genes was attempted using the methods in Section
2.9. Cloning was not achieved using any of the methods described in the
methods so biochemical characterisation was not possible for these genes.
1094.3.5 A putative type VI protein secretion system
Adjacent to SAC No. 6 was a set of genes of mostly unknown function that
was initially considered part of that SAC for this analysis. However, when
the PTS system genes were investigated it showed that this set of genes was
not a single set of genes. The genes that were not part of the putative PTS
operon contained two poorlycharacterised genes, c3391 and c3392, that had
annotations, ’Secreted protein Hcp’ and ’ClpB protein’ respectively. Hcp
is a haemolysin coregulated protein and ClpB is a protein disaggregation
chaperone.
It therefore looked like a candidate for some sort of protein secretion
system, rather than an operon encoding a metabolic function. The genes
comprising this set, c3385 to c3403, were BLASTed against the GenBank
protein database and it was found that many of them are related to the Type
VI protein secretion system (T6SS) recently elucidated by Pukatzki et al
[138]. This could be a novel Type VI protein secretion system, but it was
beyond the scope of the work presented here to investigate it further at this
point.
4.4 Conclusions
In this Chapter multiple genome sequence analysis has been used to identify
several sets of adjacent colinear genes in E. coli CFT073 that are not present
in E. coli MG1655 and might be implicated in metabolism in the human uri-
nary tract. Speciﬁcally a previously incompletely annotated operon encod-
ing proteins involved in L-sorbose catabolism has been identiﬁed and ex-
110perimentally conﬁrmed encompassing genes c4981 to c4987 of the genome
of uropathogenic Escherichia coli strain CFT073.
The sets of genes from CFT073 found solely in UPEC include an argi-
nine metabolic operon and one that is potentially a 5- or 6-carbon sugar
catabolic operon, though the substrate speciﬁcity for any of the encoded en-
zymes is currently unknown and awaits investigation. The use of such sets
of genomic data will become increasingly important as the rate of sequenc-
ing increases while experimental veriﬁcation of gene function lags consid-
erably behind. Although elucidation of novel gene function cannot be done
purely through comparative genomics it can, as shown here, aid searches for
important genes, not necessarily previously characterised in other species or
strains.
111Chapter 5
Bacterial response to novel metabolic
genes: a case study
5.1 Preface
Increasingly metabolic engineering of bacteria involves the addition of het-
erologous genes to construct novel pathways and to add existing pathways
to add important capabilities to engineered bacteria. This is combined with
controlled change of expression of various genes to channel metabolites to-
wards target products and away from waste products(for instance in [139]).
Because of the complexity of problems in understanding the behaviour of
large scale metabolic networks many of these control mechanisms are only
semi-rational, that is, there is a certain amount of trial and improvement in-
volved in ﬁnding optimal reaction ﬂuxes and the highest level of production
of a target product is not necessarily known, so incremental improvements
do not necessarily have a benchmark. This problem is solved to an extent
by whole genome stoichiometric metabolic models since the stoichiometric
limitssetbysuchmodelsareaminimalsetofconstraintsonametabolicnet-
112work and can potentially give the maximum yield of a target product, when
the models are adapted to take into account the changes in the metabolic net-
work achieved by the addition and removal of metabolic genes undertaken
in engineering the bacterium.
Bacteria have been adapting to novel conditions and gene complements
for billions of years and as such are very efﬁcient evolvers. Their evolu-
tionary goals have been different to what is required of them for biotech-
nological applications, but nonetheless understanding the relative effects of
various techniques of adaptation bacteria apply and how they integrate novel
metabolic capabilities into their metabolism might shed light on current and
future attempts to engineer bacteria for such applications. In this Chapter
a model system, that of the metabolic operon encoding proteins for the up-
take and catabolism of L-sorbose (from CFT073) cloned into a DH5 host,
has been investigated in an attempt to elucidate how these metabolic genes
are integrated into the host metabolism. This is of interest partly because
of the very poor growth seen in the previous chapter of DH5L initially in
M6L containing L-sorbose. This analysis has been conducted using a single
medium (M6L), which contains L-sorbose as a sole carbon source, to apply
a selection pressure on the bacterium in a medium optimised for fast E. coli
growth.
Those aspects of growth most easily quantiﬁed have been used to follow
the adaptation of a bacterial strain (in DH5) containing the pSC793, from
now on referred to as DH5L, to a strain that has a high, steady growth rate
in the deﬁned medium, referred to as DH5M. These have been compared
to CFT073, which is used as a reference strain. Growth rate, carbon source
113uptake rate and acetate production have all been measured at the beginning
and end of adaptation over approximately 100 generations of DH5L to
characterise the adaptation of this strain to its novel gene complement.
5.2 Results
5.2.1 Passage
To produce the new strain DH5M, DH5L was subjected to selective con-
ditions in serial passage through a series of identical shakes ﬂasks, all grown
in the same conditions as those described in Section 2.6, in minimal medium
with 1 % L-sorbose as the sole carbon source at 37 C. During each shake
ﬂask experiment doubling rate was measured in order to monitor the change
in doubling rate during adaptation. The doubling rates of DH5L during
passage can be seen in Figure 5.1.
This Figure uses effective generations as the independent variable. This
has been calculated in a simple way: at the end of each growth, just as
the inoculum from the culture was about to be transferred to fresh media,
the optical density at 600 nm of the old culture was taken and the factor by
which the inoculum was diluted was calculated for the fresh media. Because
themediawasclear(OD600 = 0:00comparedtowater)thisgaveaneffective
optical density of the culture at the beginning of growth in the fresh media.
Optical density at the end of growth in a particular culture was then divided
by the optical density at the beginning of that culture to give a multiplicative
factor by which the culture had grown. The logarithm to the base 2 of that
factor was then equal to the number of times the culture had doubled in
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Figure 5.1: Doubling rates of E. coli DH5L passaged over approximately 100 generations. The media used
was M6L supplemented with 1 % L-sorbose and growth was carried out at 37 C, identical conditions to
those used to produce the results shown in Figure 5.4. Doubling rates were determined by testing OD during
growth in each shake ﬂask as the passage was taking place. Error bars indicate a 95% conﬁdence interval (2
standard errors).
amount during the course of growth in that shake ﬂask. Overall number
of generations was then calculated by summing the number of generations
grown in all previous cultures and the current culture.
5.2.2 Strain growth in deﬁned media
The three strains considered here, E. coli CFT073, DH5L and DH5M,
were grown in four different conditions, of varying temperature and using
different carbon sources. Cultures were grown according to the method de-
scribed in Section 2.6 and samples for quantiﬁcation of glucose, L-sorbose
and acetate were analysed by the method described in Section 2.7. The
reason for growing the strains at two different temperatures was that it has
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Figure 5.2: This ﬁgure shows the growth characteristics of each of three strains of E. coli - DH5L (a),
DH5M (b), CFT073 (c) - in M6L medium supplemented with 1% L-sorbose, grown at 30 C. Each graph
shows three biological replicates of the conditions, sampled at different points through their growth to get
data on a wide spread of the growth period. Optical density measurements are labelled by ’x’, extracellular
concentration of L-sorbose by ’’, and extracellular concentration of acetate by ’’. Measurements of each
point were made in triplicate and error bars represent one standard error on these triplicate measurements.
All errors are plotted (1 standard error), though some are so small that they only cover a single pixel on the
graphs, so are not visible. The three growth curves of each strain from the three biological replicates are lined
up (as described in the text) to clarify their patterns. Optical density is plotted on a logarithmic axis to show
the exponential nature of the bacterial growth.
been reported that the glucitol-6-phosphate dehydrogenase encoded by the
L-sorbose operon Klebsiella pneumoniae, from which the function of the
CFT073 operon was inferred, was heat sensitive and initially it was thought
that the orignal difference between growth rates of DH5L and CFT073
might have something to do with this temperature dependence.
For repeated experiments, because different inoculum sizes were used to
116-5
-4
-3
-2
-1
 0
 1
 2
 3
-10  0  10  20  30  40  50  60  70  80
 0
 10
 20
 30
 40
 50
 60
l
n
 
O
p
t
i
c
a
l
 
D
e
n
s
i
t
y
 
(
6
0
0
 
n
m
)
C
h
e
m
i
c
a
l
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
[
m
M
]
Time [h]
a)
-5
-4
-3
-2
-1
 0
 1
 2
 3
-10  0  10  20  30  40  50  60  70  80
 0
 10
 20
 30
 40
 50
 60
l
n
 
O
p
t
i
c
a
l
 
D
e
n
s
i
t
y
 
(
6
0
0
 
n
m
)
C
h
e
m
i
c
a
l
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
[
m
M
]
Time [h]
b)
-5
-4
-3
-2
-1
 0
 1
 2
 3
-10  0  10  20  30  40  50  60  70  80
 0
 10
 20
 30
 40
 50
 60
l
n
 
O
p
t
i
c
a
l
 
D
e
n
s
i
t
y
 
(
6
0
0
 
n
m
)
C
h
e
m
i
c
a
l
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
[
m
M
]
Time [h]
c)
Figure 5.3: This ﬁgure shows the growth characteristics of each of three strains of E. coli - DH5L (a),
DH5M (b), CFT073 (c) - in M6L medium supplemented with 1% Glucose, grown at 30 C. Each graph
shows three biological replicates of the conditions, sampled at different points through their growth to get
data on a wide spread of the growth period. Optical density measurements are labelled by ’x’, extracellular
concentration of Glucose by ’’, and extracellular concentration of acetate by ’’. Measurements of each
point were made in triplicate and error bars represent one standard error on these triplicate measurements.
All errors are plotted (1 standard error), though some are so small that they only cover a single pixel on the
graphs, so are not visible. The three growth curves of each strain from the three biological replicates are lined
up (as described in the text) to clarify their patterns. Optical density is plotted on a logarithmic axis to show
the exponential nature of the bacterial growth.
view different parts of the growth curve, the growth patterns do not line up if
only time from inoculation is used. Therefore the growth curves were lined
up using their optical density measurements during exponential growth. The
slopes of ln(OD) were roughly the same for each strain in each condition so
vertical offset of the exponential lines at time = 0 hours and the mean slope
between the lines was used to calculate a horizontal offset. All experiments
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Figure 5.4: This ﬁgure shows the growth characteristics of each of three strains of E. coli - DH5L (a),
DH5M (b), CFT073 (c) - in M6L medium supplemented with 1% L-sorbose, grown at 37 C. Each graph
shows three biological replicates of the conditions, sampled at different points through their growth to get
data on a wide spread of the growth period. Optical density measurements are labelled by ’x’, extracellular
concentration of L-sorbose by ’’, and extracellular concentration of acetate by ’’. Measurements of each
point were made in triplicate and error bars represent one standard error on these triplicate measurements.
All errors are plotted (1 standard error), though some are so small that they only cover a single pixel on the
graphs, so are not visible. The three growth curves of each strain from the three biological replicates are lined
up (as described in the text) to clarify their patterns. Optical density is plotted on a logarithmic axis to show
the exponential nature of the bacterial growth.
with all strain and condition combinations were repeated three times and the
times for the ﬁrst one of these repetitions were used as reference times. The
times for the other two repetitions of each carbon source and temperature
combination were modiﬁed by their individually calculated horizontal offset
to better compare the other data obtained during growth.
Figures 5.2, 5.3, 5.4 and 5.5 show the results of the growths split by
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Figure 5.5: This ﬁgure shows the growth characteristics of each of three strains of E. coli - DH5L (a),
DH5M (b), CFT073 (c) - in M6L medium supplemented with 1% Glucose, grown at 37 C. Each graph
shows three biological replicates of the conditions, sampled at different points through their growth to get
data on a wide spread of the growth period. Optical density measurements are labelled by ’x’, extracellular
concentration of Glucose by ’’, and extracellular concentration of acetate by ’’. Measurements of each
point were made in triplicate and error bars represent one standard error on these triplicate measurements.
All errors are plotted (1 standard error), though some are so small that they only cover a single pixel on the
graphs, so are not visible. The three growth curves of each strain from the three biological replicates are lined
up (as described in the text) to clarify their patterns. Optical density is plotted on a logarithmic axis to show
the exponential nature of the bacterial growth.
growth conditions into L-sorbose at 30 C, Glucose at 30 C, L-sorbose at
37 C and Glucose at 37 C respectively. Table 5.1 shows the doubling rates
calculated from each of the conditions and each of the different strains con-
sidered and Table 5.2 shows t values for the differences between each strain
in each of the different conditions; the t-statistic value for each of these
comparisons of 2.776. (This value is the same for all of the comparisons
119Table 5.1: Doubling rates of the three strains grown at 30 and 37 C on L-sorbose and Glucose. Growths
were done in triplicate, and the values in brackets indicate the uncertainty in the last digit of the quoted value
(one standard error).
Temperature DH5L [h 1] DH5M [h 1] CFT073 [h 1]
Glucose
30 oC 0.39(1) 0.63(8) 0.94(3)
37 oC 0.49(2) 0.71(10) 1.12(4)
Ratio 1.26 1.13 1.19
L-sorbose
30 oC 0.16(1) 0.44(1) 0.40(6)
37 oC 0.24(2) 0.42(6) 0.50(5)
Ratio 1.5 0.95 1.25
Table 5.2: T-statistics comparing each of the strains’ doubling rates to the other strains in the same conditions,
taken from Table 5.1. Since each growth rate was calculated from 3 biological replicates, for the t-test there
were 4 degrees of freedom, using a 2-tailed 95 % conﬁdence test, the value of the test statistic is 2.776. Values
shown in this table that are greater than 2.776 therefore represent a statistically signiﬁcant difference between
the doubling rates of the two strains compared in the conditions stated, at the 5 % level.
Conditions DH5L vs. DH5L vs. DH5M vs.
DH5M CFT073 CFT073
L-sorbose, 30 C 19.799 3.946 0.658
Glucose, 30 C 2.977 17.393 3.628
L-sorbose, 37 C 2.846 4.828 1.024
Glucose, 37 C 2.157 14.087 3.807
because the number of degrees of freedom and signiﬁcance levels are the
same.) All datapoints have associated errors, but some errors calculated are
so small that they fall within the datapoints themselves and are not visible.
Biological replicates of each growth where plotted on the same axes;
although they observed different parts of the growths all had a sufﬁcient set
of data points taken during the exponential growth phase to infer a reliable
doubling rate. Table 5.3 shows the optical density achieved at the end of the
exponential growth phase for each of the conditions and strains - with errors
obtained in the same way as for the growth rates in Table 5.1.
120Table 5.3: Optical density of cells at the beginning of stationary phase of the three strains grown at 30 and 37
C on L-sorbose and Glucose. Growths were done in Biological triplicate, and the values in brackets indicate
the uncertainty in the last digit of the quoted value (one standard error).
Temperature DH5L DH5M CFT073
Glucose
30 oC 4.6(3) 3.92(4) 5.3(7)
37 oC 4.70(7) 4.3(7) 4.1(3)
Ratio 1.0 1.1 0.8
L-sorbose
30 oC 3.5(2) 3.7(5) 5.9(5)
37 oC 3.0(10) 4.4(5) 5.9(4)
Ratio 0.78 1.2 0.99
5.2.3 Re-transformation of the passaged plasmid into naive DH5
Retransformation of the plasmid from DH5M was achieved into naive
DH5 in order to examine whether changes in growth rate were related to
changes in the plasmid sequence or the chromosome of the passaged DH5.
The new strain, DH5LM, was tested for growth in M6* minimal medium
supplemented with 1 % L-sorbose (the same as the passage conditions) and
it was found that the doubling rate for this strain was 0.26(2) h 1 at 37 C.
This strain was serially passaged over 80 generations in the same conditions
as the original passage and within that time achieved a maximum doubling
rate of 0.47(4) h 1 at 37 C.
5.2.4 Acetate production
Acetate production was evaluated by measuring its concentration in the su-
pernatant at each time point where OD was measured during growth. These
measurements can be seen in Figures 5.2 - 5.5. Where there was no peak
visible in the HPLC traces at the appropriate time acetate concentration was
121Table 5.4: Showing total extracellular acetate concentration measured at the end of growth (in mM/L). Errors
are taken from biological replicates and represent uncertainty in the ﬁnal digit (one standard error).’ND’ (not
detected) is indicated where no acetate peak was detected in the HPLC traces taken for those samples, so it is
inferred that no net acetate production occured in these conditions.
Conditions DH5L DH5M CFT073
L-sorbose, 30 C 0.5(3) 7.5(6) ND
Glucose, 30 C 15(2) 26(7) 21(3)
L-sorbose, 37 C ND 12(1) 18(2)
Glucose, 37 C 24(2) 27(3) 31(5)
assumed below the limit of detection of the HPLC, so was plotted as zero
concentration. Table 5.4 shows the acetate concentrations at the beginning
of the stationary phase for each strain and condition combination, where
these data could be taken from the acetate data from the HPLC. This repre-
sents net acetate production during growth and is compared with a model of
overﬂow metabolism in Chapter 7.
Korz et al [140] have shown that below a certain growth rate threshold
in a glucose medium acetate is not excreted from E. coli; this threshold
is around a doubling rate of 0:2   0:25h 1, which ﬁts well with the ob-
servations of DH5L shown above, where at and below this threshold (in
L-sorbose) little or no acetate is excreted. There is some indication from
the data above that there is a linear relationship between growth rate of
each strain and acetate production above a certain threshold, independent of
growth conditions and even strain. A graph of net acetate production as a
function of growth rate for the growths studied is presented here as Figure
5.6.
Acetate production as a result of overﬂow metabolism during carbon up-
take has been observed in E. coli in continuous culture [141], related to
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Figure 5.6: Final extracellular acetate concentrations as a function of doubling rate for all combinations of
strains and conditions tested. L-sorbose growths are marked as ’’, and glucose growths by ’’. Errors are
plotted for both growth rate and acetate concentration (1 standard error).
the speciﬁc rate of carbon uptake, rather than growth rate, but the glucose
uptake data presented here are not sufﬁciently precise to determine this re-
lationship for these growth experiments. Further analysis of acetate produc-
tion as a result of carbon overﬂow metabolism accompanies the modelling
of growth in these conditions in Chapter 7.
5.2.5 Glucitol-6-phosphate dehydrogenase activity
The change of growth characteristics of strain DH5aL over the 100 genera-
tion passage period could have been achieved in several ways. One of these
is a change in the characteristics of the enzyme presumed to be the bottle-
neck in the pathway for L-sorbose utilisation. Since the activity of the close
homolog of the glucitol-6-phosphate dehydrogenase in Klebsiella pneumo-
niae has been reported to be temperature dependent, the corresponding en-
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Figure 5.7: An example of the results of activity tests on glucitol-6-phosphate dehydrogenase found in the
crude lysate of cells after growth on a medium with L-sorbose as the sole carbon source. The activity was
tested at various temperatures around 37 C to determine the dependence of the activity of this enzyme on
temperature. This example shows results from DH5L grown at 37 C plotted as crosses. The line shows a
line of best ﬁt of the model of Lee et al [120]. In this case Teq is 40.95C.
zyme in the CFT073 L-sorbose operon was tested for heat sensitivity both
before and after passage. To test the change in glucitol-6-phosphate activity
temperature dependency over the period of 100 generations of passage the
glucitol-6-phosphate activity of crude lysate from freshly grown cells was
measured using the method described in Section 2.8.
Figure 5.7 shows an example of one of the datasets produce to calcu-
late the heat sensitivity of the Glucitol-6-phosphate dehydrogenase. Crosses
show measurements and the solid line shows the model derived from Lee et
al [120] with parameters ﬁtted using the downhill simplex method of Nelder
and Mead [121].
The ﬁtted model gave a temperature of maximum activity, Tmax. Fig-
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Figure 5.8: The results of all of the glucitol-6-phosphate dehydrogenase experiments carried out to test heat
sensitivity of this enzyme in unpassaged and passaged strains. Growth temperatures in the x labels show what
temperature the cells were grown at before crude extracts were taken. DH5L was grown initially at 30 C
to ensure that no adaptive pressure towards the higher temperature was placed on the bacterium before the
activity test was carried out. Errors represent 95 % conﬁdence intervals of Teq values according to the Lee
model of enzyme heat dependence used in data analysis. All values of Teq were inferred from line ﬁtting (of
which Figure 5.7 is an example) and errors were obtained from biological replicates for each strain.
ure 5.8 shows the values of Tmax determined for each of the strains tested.
Strain Klebsiella pneumoniae KP1 was used as a control since it has been
shown previously [118] that the glucitol-6-phosphate dehydrogenase of the
L-sorbose operon of this strain is heat sensitive and it was the operon from
which the function of the CFT073 operon was inferred.
1255.3 Discussion
5.3.1 Passage
The ﬁrst notable result in this Chapter is that DH5 did indeed change its
behaviour over the 100 generations as shown in Figure 5.1 increasing its
doubling rate in the face of consistent selective conditions - using L-sorbose
as a sole carbon source growing at 37 C. The doubling rate increased al-
most fourfold during the course of adaptation and the Figure shows that
doubling rate changed mostly over the ﬁrst 40 or so generations to its higher
level. This change appears to have happened over a period of 40 genera-
tions, rather than in few discrete jumps in doubling rate.
Growth curves for these passages (not shown) did not show any discon-
tinuities in doubling rate which might indicate abrupt changes in capability,
although if considering the mechanism of change (some genetic alteration
which would initially occur in just a single cell) the effects on overall dou-
bling rate of a change conferring a markedly greater growth rate in that cell
would be massively diluted by the large number of unadapted cells already
growing in the culture. It is therefore not possible to eliminate the possi-
bility that just a few key adaptations were the cause of the large change in
doubling rate, especially when considering the error bounds marked on the
Figure. What is perhaps more clear from the Figure is that once the adap-
tation to a doubling rate of 0:4h 1 there was a plateau in doubling rate ca-
pability (constant within the experimental error) with no further signiﬁcant
increase.
Modelling of the growth of this bacterial strain will not be discussed until
126Chapter 7, where theoretical limits of growth rate will be calculated using a
stoichiometric model of this strain. In work by Ibarra et al [108] 500 gen-
erations of E. coli adaptation were observed in chemostat culture using a
sole carbon source with the express goal of determining how close growth
rates on that carbon source could come to theroetical maxima according to
stoichiometric models. In that study doubling rate on malate was shown to
increase 21 %, on glucose by 18 %, on succinate by 17 % and on acetate by
20 %. The work presented here shows a far larger increase in doubling rate
of around 150 % (if the initial growth at 0 generations on Figure 5.1 is ig-
nored since there may have been residual effects from the cloning procedure
affecting its growth).
Fong et al [142] have similarly investigated the relationship between the
adaptation and the approach to optimal ﬂux distributions in genetically en-
gineered bacteria. Their passage took place over 1000 generations and in-
volved knockout mutants, rather than the addition of novel metabolic genes,
but similar selective pressure would have been placed on the strains during
growth as they used M9 media supplemented with glucose, similar to that
used in the work in this Chapter which used M6* minimal media supple-
mented with L-sorbose. Interestingly increases in growth rate observed by
Fong et al of up to 133 % were of the same order as those seen above, even
though adaptation in that Chapter was only observed over 100 generations.
Changes in the adapted strains observed by Fong et al over the ﬁrst 100
generations were far less pronounced than the data shown here. This differ-
ence could be because of the nature of the changes in the metabolic network
- since the L-sorbose uptake and utilisation genes were novel to DH5 its
127ﬂux distribution to begin with was far further from optimal for growth rate
than the gene deletion mutants used by Fong et al.
One factor that may have inﬂuenced this large rate increase is the ex-
perimental conditions. Although every effort was made to keep consistent
conditions during each growth there is a chance that media and cell treat-
ment were improved unwittingly during the course of the passage. Evidence
for this is in the form of the growth tests performed later on DH5L, during
which the mean doubling rate was 0.24 h 1, rather than 0.16 h 1; so taking
this into account, DH5M may only be growing 70 % faster than DH5L
in the same conditions, but this is still considerably greater a jump than that
observed by Ibarra et al. Two further explanations for the large difference
in scale of these changes seem feasible: ﬁrstly that different mechanisms
might be at work in the adaptation of the bacteria, or secondly that the same
mechanisms are at work, but that there is more room for evolution to oc-
cur via these mechanisms in DH5L. The second of these two explanations
seems more plausible, as bacteria will use any and all available strategies for
adaptation so even if there are several mechanisms whereby faster growth
could be achieved, they would be explored both in continuous culture and
in serial passage.
Ferenci[143]hasrecentlyreviewedthemechanismsofevolutioninchemo-
stat cultures in bacteria and concluded that both regulatory and enzymatic
changes are important in adaptation in these conditions. Although contin-
uous chemostat culture has not been used in this work, the principles of
evolution elucidated in experiments of this sort should be valid at least to an
extent. In continuous culture cells experience a constant environment with a
128low carbon source concentration, whereas in this work the cells alternate be-
tween a carbon-rich and a carbon-poor environment, so selection pressures
will be somewhat different. However, the mechanisms used to adapt to these
different conditions should be the same. Without further investigations how-
ever, such as expression proﬁles for the strains involved to determine how
regulation has changed to cope with the culture conditions there is no way
to know to what extent regulation rather than enzyme characteristics have
changed to produce the observed change in growth rate.
Two evolutionary mechanisms could have occurred to produce the ob-
served change in growth rate: the integration of the genes on the pQR793
plasmid into the regulatory architecture of the cell or a change in the charac-
teristicsofoneoftheproteinsinvolvedinL-sorboseuptakeand degradation.
The purpose of the glucitol-6-phosphate dehydrogenase activity assay (dis-
cussed below) was to determine whether this enzyme (presumed to be the
most signiﬁcant bottleneck in growth at least in the early stages of passage)
had changed its behaviour as a function of temperature or not, to elucidate
how much this might have affected growth rate during the course of the
passage. Observations of glucose uptake and build-up of extracellular ac-
etate were made in order to elucidate more of the metabolic changes brought
about by the passage.
Another feature of Figure 5.1 is the plateau between about 40 and 100
generations where growth rate doesn’t change (within the error bounds).
Ibarra et al’s observations of E. coli showed a steady climb in growth rate
for almost the entire 500 generation period of adaptation towards the point
of theoretical maximum growth rate (as determined by a genome scale sto-
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starvation to excess and back selected against ever faster growth rates to
balance with ability to cope in the nutrient poor conditions experienced by
the bacteria during serial passage.
5.3.2 Adaptation
Adaptation is an ongoing process, so there is a chance that growth rate
would continue to increase after the 100 or so generations observed here (to
a maximum constrained by the physicochemical limitations on the strain),
but it can be seen that the doubling rate appears to have stabilised (in the
conditions used for the passage) to around 0:4h 1 and remained there over
60 generations (see Figure 5.1). At 100 generations the passaged strain,
named DH5M, was sampled and used for growth tests as seen above.
Figures 5.2 to 5.5 show the results of these growth tests and provide
many interesting glimpses of the changes that have taken place over the 100
generations. Table 5.2 shows that there is a signiﬁcant difference between
DH5L and CFT073 doubling rates, even when grown on Glucose (where
there is no metabolic dependence on the genes encoded on pQR793). The
L-sorbose genes on this plasmid are not artiﬁcially inducible, but the operon
was cloned with its upstream region and all the regulatory region control-
ling the expression of the L-sorbose uptake and utilisation enzymes in this
operon. The regulator, SorC, has no close homologues within DH5, so
it would not be expected that there would be any regulatory cross-talk in-
terfering with the growth of DH5L. There is no genotypic reason why
DH5L would grow any slower on glucose and metabolic burden of plas-
130mids is small when there is not very high expression of genes encoded on a
plasmid, so the reason for this poor growth in all conditions is unclear.
When DH5L and DH5M are compared it is clear that passage on L-
sorbose has had a signiﬁcant effect on L-sorbose growth and to some extent
in glucose (the difference is signiﬁcant at 30 C, but not at 37 C). This
represents evidence that DH5M grows better in conditions not limited to
those conditions used during passage. This indicates that as a growth strain
DH5 (albeit containing a cloned plasmid) is not well adapted. Yau et al
[144] compared growth of various strains of bacteria containing a plasmid
and showed that DH5 grows about 10 % slower than a wild-type strain
(W3110), probably somewhat similar in metabolic character to CFT073.
The difference in growth rates in DH5M compared to CFT073 are not
signiﬁcantly different in L-sorbose at the 5 % level, but CFT073 still grows
faster on glucose than DH5M, clearly indicating that there is some aspect
of DH5 metabolism holding it back as yet unidentiﬁed.
It can be seen from Table 5.1 that both DH5L and CFT073 increase
their doubling rate at higher temperature when L-sorbose is the sole car-
bon source, whereas DH5M does not signiﬁcantly change its rate. E. coli
grows better at 37 C than at 30 C, all other things being equal [145] - so
there must be some temperature dependent aspect of the L-sorbose operon
that remains, or some way in which the bacteria have adapted when faced
with 37 C passage for 100 generations that renders growth at 30 C far im-
proved, more so than at 37 C (to make up for the suboptimal growth rate
due to temperature).
Doubling rate for the adapted strain in this work reached a plateau (see
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native strain CFT073. The rate observed in CFT073 is not necessarily the
maximum doubling rate achievable using L-sorbose as sole carbon source in
these growth conditions. Therefore it is known that DH5M did not reach
the theoretical maximum doubling rate. Observed consistently between the
work of Fong et al and the work presented here is that adaptation occurred
gradually and evenly, rather than in jumps of doubling rate, indicating that
changes in doubling rate were due to many small modiﬁcations (presum-
ably in regulation rather than by changes in the activity of the enzymes
responsible for L-sorbose uptake and utilisation, although this has not been
experimentally veriﬁed), rather than a few large changes.
The data presented above show clearly that adaptation occurs in bacteria
whenpresented withsome particularsetof conditionswhich isnot necessar-
ily speciﬁc to those conditions but spills over into similar situations. Adap-
tation in this case is beneﬁcial (in terms of growth rate and ﬁnal OD) for the
passage conditions but may be even more beneﬁcial for other conditions, as
shown above in the high growth rate of DH5M in L-sorbose medium at 30
C compared to 37 C. However, comparing the established strain, CFT073,
with the strain passaged for improved performance, DH5M, the rate of
growth and ﬁnal OD are not the same even after 100 generations of adapta-
tion. There is therefore some aspect of genetics that eludes DH5M either
in terms of a lack of certain genes (a comparison of gene complements will
be done in a later chapter), or in terms of regulatory adaptation to make full
use of the L-sorbose genes provided on the plasmid pQR793. Growth com-
parisons on glucose show that DH5M does not grow as well as CFT073
132on this carbon source either, but the conditions of the passage mean that
it is unclear whether DH5L could have adapted towards a growth ability
comparable to CFT073 if the passage conditions had been different.
The question of where the adaptation took place, whether it was on the
plasmid or on the chromosome, was addressed by re-transformation of the
plasmid from the serially passaged strain DH5M into a naive DH5. The
growth rates observed for this new strain, before and after passage, are not
statistically different to DH5L and DH5M respectively, indicating that a
large part of the adaptation may have occurred on the chromosome of DH5
during passage, rather than on the plasmid.
5.3.3 Glucose and L-sorbose uptake
It is clear from Figures 5.2 to 5.5 that glucose and L-sorbose (the carbon
sources) in the supernatant was not very well measured by the HPLC in
the conditions used for these experiments, however clear patterns emerge
as to the changes that have taken place in the course of the passage. Two
features of many of the glucose traces shown are striking: the ﬁrst obvi-
ous - that the faster growing bacteria take up the carbon sources faster than
slower growing ones; the second is that there seem to be several cultures
in which the carbon source is not completely consumed, but remains in the
supernatant unused by the cells, often for tens of hours after the cells have
reached stationary phase. This is most often the case in DH5L (seen most
obviously in Figure 5.2 ’a)’) and seems to be more pronounced in the cases
of L-sorbose uptake, rather than glucose.
Although DH5M consumes a larger proportion of the carbon source,
133in general, than DH5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Some of this failure to take up the carbon source might be to do with regu-
lation of the L-sorbose metabolic genes, which might turn off prematurely
in both strains, though later in the case of DH5M. Further, there might
be some other metabolic limiting factor such as Thiamine, which DH5
requires for growth (one of the genotypic differences between DH5 and
CFT073), so although DH5M is better adapted there is still a limiting
factor other than carbon source availability preventing further growth (and
carbon source uptake). However, whether or not glucose represses acetate
assimilation during growth, it is consistently seen that there is net acetate
production in many E. coli strains (not just those studied here) in glucose
media, as discussed by Eiteman et al [146]. It looks in general as if there is
less glucose left than L-sorbose in otherwise the same conditions for all the
strains where carbon source is left in the media.
The fact that CFT073 has left some carbon source in similar conditions
indicates that Thiamine may not be the limiting growth factor, but some
other vital media component. Growth limiting factors will be discussed fur-
ther in Chapter 7 where a stoichiometric model will be used to assess how
much of each media component is required for growth. The data further
show that the failure to take up all the carbon source in a medium is reversed
in CFT073. In this case glucose seems to be left unused where it is sole car-
bon source whereas L-sorbose is fully assimilated. A possible explanation
of this is that growth efﬁciency is sacriﬁced for growth rate in the case of
Glucose (CFT073’s doubling rate on glucose is twice that on L-sorbose),
but further conclusions about this assertion require more experimentation.
134The carbon source data in Figures 5.2 to 5.5 also show the variability
of uptake of these carbon sources. The ﬁlled squares represent three lots
of data from three biological replicates which have been grouped for clar-
ity in these ﬁgures, but where there is a spread of carbon source results
this is mostly inter-replicate variability rather than inconsistency in a sin-
gle replicate that has been the cause. Where there were inconsistent results
between replicates HPLC traces were reanalysed manually to check that
the inferred peaks were indeed measurements of the carbon source, and in
the case where no carbon source was seen that there had not been otherwise
unidentiﬁed peaks that did in fact indicate the presence of the carbon source.
Also, several runs were repeated to check that this was not an error in the
sample analysis - which in all cases it was not. This inconsistency is appar-
ent in Figures 5.3 ’b)’ and ’c)’ and 5.5 ’a)’, all with glucose as sole carbon
source.
The ﬁnal optical densities achieved by cells show some variability over
both strain and growth conditions. The most striking result illustrated in
Table 5.3 is the low ﬁnal optical density of CFT073 compared to the other
strains in conditions a priori seen as the best conditions for growth - in
glucose medium at 37 C. This result ﬁts well with the observation of in-
complete use of carbon source by CFT073, which indicates that perhaps
there is some growth inhibition independent of glucose, for instance acetate
levels in the medium.
1355.3.4 Acetate production
The variation between net production rates of acetate in the strains and con-
ditions presented here is stark. Some strain and condition combinations
produce no acetate at all, such as DH5L grown at 37 C with L-sorbose,
others producing as much as 39 mM net extracellular concentration over the
course of growth, such as CFT073 at 30 C with glucose.
CFT073 produces somewhat more acetate during growth on glucose than
on L-sorbose, a trend maintained in DH5L but if not reversed, then at least
reduced in DH5M. There is a pronounced change in initial acetate produc-
tion rates from DH5L to DH5M when grown in the passage conditions,
L-sorbose at 37 C, whereby acetate production is increased. CFT073 data
for these conditions show very low initial acetate production and DH5M
production is rather high. Although this increased production of acetate is
associated with an increase in the ﬁnal OD for DH5L, this higher ﬁnal OD
is still well short of that of CFT073, only 75 % of that value.
Itseemsthattheadaptationobservedherehasprioritisedgrowthrateover
ﬁnal OD and this has come with an associated cost in terms of production of
acetate. For many strains of E.coli high growth rate on a medium of glucose
as sole carbon source is associated with high acetate production and low
yield and introduction of acetate into a medium inhibits both growth rate
and ﬁnal yield [147], so this assertion seems plausible.
Final extracellular acetate concentrations measured at or near the begin-
ning of stationary phase are shown in Table 5.4. The size of the errors on
some of these values is not necessarily because of difﬁculty in measuring
acetate concentration (which was mostly highly accurate), but probably be-
136cause the measurements were not necessarily taken at the same time in each
biological replicate (for the reasons discussed above).
The ﬁrst notable result in this Table is the lack of net acetate produc-
tion of DH5L when using L-sorbose as a carbon source at 37 C. With
acetate production of the same order of magnitude in CFT073 and DH5L
when grown on glucose, it is apparent that both strains do produce acetate
and in similar amounts in some circumstances, but this is not the case for
the L-sorbose. Net acetate production is also drastically reduced on growth
in L-sorbose at 30 C. The reactions catalysed by the enzymes from the L-
sorboseoperonlinkwithE.colicentralmetabolismatfructose-6-phosphate,
whichshouldnotinitselfreduceacetateproduction. Thispresentsthepossi-
bility that when the bacterium, due to difﬁculty in growth because L-sorbose
is difﬁcult to metabolise when the relevant genes are not well regulated, has
a reduced growth rate (as has been seen by others [147]) and acetate pro-
duction is not upregulated.
For all of the strains and conditions in this study Figure 5.6 shows ac-
etate production as a function of growth rate. This Figure indicates minimal
acetate production at low growth rates and a steep curve up from doubling
rates of about 0:3h 1 to 0:6h 1, then fairly steady production of acetate
above that doubling rate. Growth on L-sorbose and growth on glucose are
shown as separate data series in this Figure, to compare the two carbon
sources. The production amounts do not appear to be much different be-
tween the two carbon sources where they overlap, but this overlap is quite
small (0:3 0:5h 1) so only a trend can be seen and no ﬁrm conclusions can
be made about the dependence of acetate production on carbon source at a
137given growth rate. Although there are not enough datapoints here to come
to quantitative conclusions about the relationship between acetate produc-
tion and growth rate this Figure shows strikingly the qualitative invariance
of response between the E. coli strains and between different conditions.
An alternative hypothesis that L-sorbose fails to suppress acetate reas-
similation use as a carbon source is supported by the low but measureable
acetate concentrations in DH5L growths in L-sorbose during the expo-
nential phase of growth, which then drop to zero shortly thereafter. The
increased production of acetate in DH5M over DH5L in all conditions,
faster growth rates and higher ﬁnal ODs in L-sorbose indicate that some-
thing regulated in parallel with the acetate production is worth the cost in
terms of energy, carbon and growth inhibition at high concentrations, al-
though as mentioned above there is no evidence that acetate production is
disproportionately greater in DH5M, when the change in growth rate is
taken into account. This adaptation comes at a price though, in the form of
lower ﬁnal ODs in glucose, the specialisation of DH5M to the L-sorbose
carbon source; whereas higher acetate production rates are seen in CFT073,
ﬁnal ODs are higher than in either DH5L or DH5M.
5.3.5 Adaptation and ﬂux changes in DH5L
The above observations clearly show that ﬂux distributions are quite dif-
ferent between DH5L and DH5M, even in very similar environmental
conditions. The use of linear optimisation to model this change of ﬂux dis-
tribution has been done in Chapter 7.
1385.3.6 Glucitol-6-phosphate dehydrogenase activity
Figure 5.7 shows the activity proﬁle of crude extract from DH5L grown
at 37 C in L-sorbose as a function of temperature. The model from Lee et
al [120] shown as the solid line on this ﬁgure ﬁts well with the parameters
determined by minimisation of sum least squares differences between the
data and the model. With four parameters it could be possible to ﬁt many
implausible shapes, but the shape of all the ﬁtted lines against the datapoints
was peaked at consistent and reasonable values, and the tails of all the lines
go to zero at high and low temperatures. These factors provide evidence that
the model is plausible as a representation of the underlying phenomena of
enzymatic action and the actual characteristics of the enzymes tested.
ThedatapresentedinFigure5.8showclearlythatthereislittledifference
in the temperature sensitivity of the glucitol-6-phosphate dehydrogenase be-
fore and after passage. This indicates that the changes during passage are
not due to change in this enzyme, but due to some other factor or factors.
The Klebsiella pneumoniae as a positive control shows that differences can
be distinguished between temperature sensitivities of different enzymes. All
of the other strains are not signiﬁcantly different, but Klebsiella pneumoniae
is statistically signiﬁcantly different at the 5 % level. Sprenger and Lengeler
[118] noted heat sensitivity of this enzyme and determined heat inactivation
of it after 10 minutes at particular temperatures, indicating this sensitivity.
Although those results are not directly comparable to the results presented
here, due to the differing methods of enzyme extraction and type of heat
sensitivity tested, the two results appear to corroborate one another.
1395.4 Conclusions
In this Chapter it has been shown that a bacterium presented with novel
metabolic genes will adapt to these genes over a period of tens of genera-
tions when passaged in selective media. However it has also shown that in
this case it does not achieve the efﬁciency of use achieved by the wild-type
strain over 100 generations, even in the particular conditions in which the
passage was undertaken.
This adaptation does not appear to have affected the metabolic relation-
ship between carbon source uptake and acetate production that comes from
overﬂow metabolism. One reason that might account for the change, the
heat sensitivity of the glucitol-6-phosphate dehydrogenase in the L-sorbose
operon of CT073, has been ruled out by an assay of this heat sensitivity
around the temperatures at which the experiments were undertaken.
The mechanisms behind the adaptation of DH5L over the period of
passage to DH5M are yet to be elucidated. Remaining possibilities to ex-
plain the differences in growth rates and ﬁnal ODs achieved are: changes in
some other genes - such as those encoding transport proteins for L-sorbose
(changes in transport proteins have been observed during continuous cul-
ture as shown by Tsen et al [148]) - or regulatory changes. Whether any
part of the adaptation is speciﬁc to the L-sorbose genes, rather than a gen-
eral improvement in metabolic capability (observed above by improvement
in growth characteristics on glucose) is yet to be elucidated.
140Chapter 6
The use of genome sequence
comparisons for inferring metabolic
models in bacteria
6.1 Preface
Bacterial genomes are being sequenced and published at an exponentially
increasing rate. Figure 6.1 shows published genomes of bacteria according
to GOLD (Genomes OnLine Database v2.0) as of June 8, 2009 [149] and
clearly shows the exponential increase in this number, though it should be
borne in mind that increasingly genomes are sequenced without subsequent
publication. The current rate of publication is around 200 per year and the
slope of the best ﬁt line calculated from Figure 6.1 ‘b)’ indicates that this
number is doubling every two years, implying that by 2010 there will be at
least one newly sequenced bacterial genome per day being published. This
rate of sequencing presents amazing opportunities for probing many fun-
damental principles of bacterial evolution, including the evolution of their
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Figure 6.1: Showing the number of bacterial genome sequences published per quarter since 2000. ‘a)’ shows
actual values and ‘b)’ shows them on a natural logarithm scale, showing a clear exponential pattern. The line
of best ﬁt for these data assuming an exponential increase has been included on plot ‘b)’.
metabolic networks.
Reliableinferencesofgenefunctionarecrucialtoestablishingthemetabolic
networks of newly sequenced bacteria and much effort has been channelled
intoestablishingreliableannotationstrategiesforcertainkeyreferencegenomes
(such as using gene ontologies [150]), although BLASTp against the non-
redundant protein database (nr, NCBI) is still generally used to annotate
newly sequenced E. coli (for instance [28, 53]). Genome comparisons are
usuallydonewithoutreferencetoannotation, butratherbyusingtheBLAST
score ratio (BSR) method of Rasko et al [151], which has been used to
survey many of E. coli with complete genome sequences to look at the
pangenome of E. coli [124].
MetaCyc’s Pathologic program [82] produces gene complement compar-
isons and metabolic networks by comparison of annotation, but if annota-
tion is based only on BLASTp comparisons against NCBI’s non-redundant
database, then it is vulnerable to the problem of successive inferred anno-
142tation. This problem can potentially be overcome by limiting comparisons
to only experimentally characterised genes, although identiﬁcation of these
can be difﬁcult as there is no ﬁeld in GenBank entries to indicate the source
of a gene annotation. Feature notes are often used to indicate close or-
thologs to other genes, but do not in themselves determine which gene’s
function was experimentally elucidated. One potential way of overcoming
this problem when attempting to reconstruct a metabolic model is to ﬁnd
a well characterised model organism on which a great amount of work has
been done to experimentally verify gene functions (such as E. coli MG1655
in the case of E. coli) and take inferences of gene function from just that
strain.
The amount of information gathered about MG1655 has allowed whole
genome-scalemodelsofmetabolisminthisorganismtobeestablishedbased
on these biochemical characteristics, for instance model iAF1260 [1] which
takesintoaccount1260ORFs(outof4149proteincodinggenesinMG1655)
to produce a stoichiometric metabolic model of the metabolism of MG1655.
Using the data relating these ORFs to chemical reactions within the cell,
and assuming that in general reactions in closely related strains of bacteria
are associated with the same ORFs, it should be possible to reconstruct the
subset of the reactions found in MG1655 that are also present in any other
bacterium if the set of genes common to the two strains is known.
The work presented in this chapter shows the application of a gene func-
tioninferencestrategytoestablishingcommongenesbetweenasetofclosely
related bacteria and MG1655, thus through the GPR relationships compiled
by Feist et al for iAF1260 [1] inferring the subset of the metabolic network
143of MG1655 that is present in each of these bacteria. This procedure has
been automated so that a new comparison can be achieved through knowl-
edge only of the GI number of the nucleotide entry in GenBank of a new
bacterial genome sequence. All but one of the programs used to achieve
this are freely available for download from the Internet, the exception be-
ing MATLAB, which has been used to combine the steps in the inference
process.
The tools required for the process are achieved using freely available
computer applications and languages: MySQL, Perl, DiagHunter, a local
BLAST server and several of the Bioinformatics-speciﬁc modules available
for Perl, which are named in the following way: ‘Bio::Perl’, which contains
bioinformatic tools for Perl and ‘Bio::DB::GenBank’ which contains tools
for communicating with the GenBank website for downloading the genome
sequences required for this work. This process of inferring a metabolic
model takes of the order of 10 minutes per organism and thus a large number
of genome comparisons and therefore metabolic networks and models can
be compared quickly.
MetaCyc [78] has been used to validate the comparisons done in this
study, as it is the most comprehensive publicly available resource of gene
complement comparisons with MG1655 for the purposes of metabolic re-
search. Lists of essential genes from various sources have also been used to
validate these comparisons. The model iAF1260 [1] has been used as the
basis of all the models produced in this work.
1446.2 Data
6.2.1 Bacterial Genome Sequences
The strains used for the metabolic inference are listed in Table 6.1 which
gives strain names, their pathotype (where available), the GI numbers of the
GenBank entries for their genome sequences and whether they have been
analysed by Pathologic and posted on the MetaCyc website.
Phylogenetic relationships between the strains studied here (according to
16S rRNA comparisons) are shown in Figure 6.2, calculated on the Riboso-
mal Database Project website [152, 153].
6.3 Results
6.3.1 Genomic comparison data
Genomic comparisons were conducted according to the method detailed in
Section 3.4, using DiagHunter to combine positional and identity data for a
more robust inference than BLAST data alone. Variations of the minimum
diagonal length for inference of gene synteny were used in each comparison
in DiagHunter in order to assess the effect of this criterion on gene synteny
inferences. Minimum diagonal lengths of 1, 2 and 3 were used for these
comparisons. Data for these three different comparisons can be seen in
Supplementary Table 4.
Tables 6.2 and 6.3 give an overview of the data contained in Supplemen-
tary Table 4, the complete set of inferences carried out in this study. For
comparison details of the equivalent comparison held on the MetaCyc web-
145Table 6.1: All bacterial strains the complete genome sequences of which have been compared in this study.
Where the strain is E. coli this species label has been omitted for clarity. Pathotype has been included where
possible. Accession number and GI number refer to the Genbank nucleotide entries which include complete
sequences and annotated genes for these strains. The indication of existence of an entry for each strain in
MetaCyc has been included to show the coverage of these across the species included in this study.
Strain Name Type Accession Number GI number In MetaCyc?
ATCC 8739 Commensal CP000946 170018061 -
BW2952 Commensal CP001396 238899406 -
IAI1 Commensal CU928160 218552585 -
K-12 DH10B Commensal CP000948 169887498 -
K-12 HS Commensal (Gastrointestinal) CP000802 157159467 -
K-12 MG1655 Commensal (Gastrointestinal) U00096 49175990 +
SE11 Commensal (Gastrointestinal) AP009240 209917191 -
SMS-3-5 Commensal (environmental) CP000970 170679574 +
ED1a Avirulent O81 CU928162 218687878 -
CFT073 UPEC (uropathogenic) AE014075 26111730 +
536 UPEC CP000247 110341805 +
IAI39 UPEC CU928164 218698419 -
UMN026 UPEC CU928163 218430358 -
UTI89 UPEC CP000243 91209055 +
E2348 EPEC FM180568 215485161 -
E24377A ETEC CP000800 157154711 -
55989 EAggEC CU928145 218693476 -
O157:H7 str. Sakai EHEC (enterohaemorrhagic) BA000007 15829254 +
O157:H7 EDL933 EHEC AE005174 56384585 +
O157:H7 str. EC4115 EHEC CP001164 209395693 -
S88 ECNM (neonatal meningitis) CU928161 218556939 -
APEC 01 Avian pathogenic CP000468 117622295 -
Shigella boydii CDC 3083-94 Bacillary Dysentery CP001063 187730020 -
Shigella boydii Sb227 Bacillary Dysentery CP000036 82542618 -
Shigella dysenteriae Sd197 Bacillary Dysentery CP000034 81239530 -
Shigella ﬂexneri 2a str. 2457T Bacillary Dysentery AE014073 30061571 +
Shigella ﬂexneri 2a str. 301 Bacillary Dysentery AE005674 24080789 +
Shigella ﬂexneri 5 str. 8401 Bacillary Dysentery CP000266 110804074 +
Shigella sonnei Ss046 Bacillary Dysentery CP000038 74310614 +
Edwardsiella ictaluri 93-146 Enteric septicaemia (Catﬁsh) CP001600 238917983 -
Escherichia fergusonii ATCC 35469 UTI and wound, bacteraemia CU928158 218547440 -
Klebsiella pneumoniae subsp. UTI and Pneumonia CP000647 150953431 +
pneumoniae MGH 78578
Legionella pneumophila str. Corby Pneumonia-like CP000675 148358139 -
Proteus mirabilis str. HI4320 UTI and others (opportunistic) AM942759 172046403 -
Salmonella typhimurium LT2 Gastroenteritis AE006468 16445344 +
Yersinia pestis KIM Bubonic Plague AE009952 22002119 +
site [82], which will be discussed below, have been included in these Tables.
Table 6.3 shows a breakdown of inference-by-inference differences between
MetaCyc and the DiagHunter (DH) method used in this study.
Table 6.4 shows an overview of the results obtained by the DH method
separated by category of gene. Categories were taken according to the Mul-
tiFun categorisation in GenProtEC [154] as they cover all types of gene
146Legionella str. Corby
Figure 6.2: A phylogenetic tree of the strains analysed in this Chapter inferred by 16S rRNA sequence
comparisons [152, 153], with outgroup deﬁned as Yersinia pestis.
function.
6.3.2 iAF1260 gene synteny
The subset of genes linked through the GPR relationships in iAF1260 to
metabolism was then compared, and a summary of the results for those
147Table 6.2: Summary statistics of the genome comparisons produced in this study and comparative set of
MetaCyc comparisons. This gives an idea of the number of individual gene comparisons required for this
work. Assuming each of the 36 strains used in this comparison were compared with each other, and each
has approximately 4000 genes, there would be 2.7 million comparisons, therefore comparing with a single
reference genome to begin with reduces computational burden by the order of tenfold for this number of
genome sequences.
Property Amount
Total no. of genomes used 36
Total no. of genes compared 4095
Total no. of synteny inferences 143,325
Total no. of positive inferences 114,677
No. of these genomes in MetaCyc 16
No. of genes positively identiﬁed in MetaCyc 3907
No. of gene inferences in MetaCyc 58,605
No. of positive gene inferences in MetaCyc 47,805
Table 6.3: A summary of the differences in inferences between this study and MetaCyc. These data have
been constructed those inferences for which there is a MetaCyc inference to compare with the study data.
Property Minimum diagonal Minimum diagonal Minimum diagonal
length = 1 length = 2 length = 3
No. positive inferences 49,975 47,755 47,090
% inferred by DH, but 5.2 2.5 2.0
not MetaCyc
% inferred by MetaCyc, 1.5 2.6 3.2
but not DH
% of all inferences
differing between DH 6.7 5.0 5.3
and MetaCyc
genes can be seen in Table 6.5. The genes included in this comparison are
indicated in Supplementary Table 4, Worksheet ‘Minimum diagonal length
2’, Column AO. Organisms were separated by relatedness to see how differ-
entpartsofmetabolismwereaffecteddifferentlyoverdifferentphylogenetic
distances. Table 6.6 shows a summary of the essential genes according to
the iAF1260 model.
Gene complement is important in establishing metabolic models, as it
gives an indication of which reactions are catalysed by gene products in a
particular organism. The GPR relationships in iAF1260 give the reactions in
148Table 6.4: An overview of gene synteny comparisons by gene category (as deﬁned by the MultiFun catalogue
of gene roles used in GenProtEC [154]). Where genes have been classiﬁed as unknown or not been classiﬁed
in GemProtEC they have been added to the ‘Unclass./Unknown/Other’ category as have genes from three
categories: ‘location of gene products’, ‘DNA sites’, and ‘cryptic genes’ which did not contain enough genes
to provide reliable data for the table. % conserved values have been evaluated by taking the mean retention
percentage of all genes in a particular category, and standard deviations (‘Std dev’) have been included to
indicate the spread of synteny conservation within these categories. Standard errors on the mean retentions
indicate how good the estimation of gene retention is by category. Separate data for essential genes (see
Section 6.4.2.1 and Supplementary Table 3 for details of these genes) have been included, broken down by
category.
Category All genes Essential genes
Number % conserved Std error Std dev Number % conserved Std dev
Metabolism 1597 85.74 0.43 17.08 85 96.99 2.82
Information 513 87.48 0.77 17.52 72 97.38 4.19
Regulation 59 81.31 2.26 17.33 0 - -
Transport 371 83.2 0.89 17.18 13 98.93 1.41
Cell processes 126 84.68 1.58 17.76 14 98.02 1.3
Cell structure 228 81.74 1.22 18.43 3 100 0
Extrachromosomal 214 30.75 1.74 25.4 0 - -
Unclass./Unknown 987 77.69 0.67 21.03 4 86.11 25.96
/Other
an organism, given the genes available. Table 6.7 shows the reactions con-
served across the species included in this study, broken down by category
and organism relationship to MG1655, as in Tables 6.5 and 6.6.
6.4 Discussion
6.4.1 Synteny comparisons
6.4.1.1 Reliability of comparisons using the DH method
DiagHunter has previously been used for inference of plant and human gene
synteny, buttoourknowledgeithasneverbeenappliedtoabacterialsystem.
This use of gene context data should improve reliability of gene synteny
inferences and these give signiﬁcantly different inferences of gene comple-
ments to other databases of such data, such as MetaCyc. It is therefore
149Table 6.5: A summary of how many of the genes included in iAF1260 are synteny conserved over the bacteria
in this study. Subsystems are deﬁned in iAF1260, and where genes are in multiple subsystems they have been
placed in that row of the table. The Shigella column contains several non-Shigella strains: the Escherichia
fergusonii, the Salmonella and the Klebsiella, as their 16S rRNA indicates that they are rather more closely
related to Shigella than the four more distantly related organisms. Of these four, three are also in the order
of Enterobacteriales (family of Enterobacteriaceae), whereas Legionella pneumophila str. Corby is a mem-
ber of a different order of Gammaproteobacteria, Legionellales. Results were therefore separated to reﬂect
previously inferred relatedness for ready comparison of metabolic conservation.
Subsystem No. genes Conserved Conserved in Conserved in Conserved in other Conserved in
(iAF1260) overall % E. coli % Shigella % Enterobacter– Legionella %
iaceae %
Number of strains 36 22 10 3 1
Alanine and Aspartate Metabolism 9 91.7 98.0 94.4 77.8 0.0
Alternate Carbon Metabolism 134 73.9 88.2 64.3 41.5 1.5
Anaplerotic Reactions 9 89.2 98.5 85.6 74.1 0.0
Arginine and Proline Metabolism 33 84.9 94.9 82.7 60.6 9.1
Cell Envelope Biosynthesis 48 89.1 94.1 90.8 75.7 22.9
Citric Acid Cycle 20 91.9 98.0 93.0 81.7 20.0
Cofactor and Prosthetic 125 94.1 99.3 95.5 83.2 17.6
Group Biosynthesis
Cysteine Metabolism 10 93.3 99.1 97.0 76.7 0.0
Folate Metabolism 6 96.8 99.2 98.3 88.9 50.0
Glutamate Metabolism 8 85.8 96.6 85.0 45.8 0.0
Glycerophospholipid Metabolism 17 94.1 98.9 95.9 88.2 11.8
Glycine and Serine Metabolism 8 92.4 99.4 96.3 66.7 0.0
Glycolysis/Gluconeogenesis 27 92.3 98.0 94.1 84.0 11.1
Glyoxylate Metabolism 2 70.8 97.7 40.0 0.0 0.0
Histidine Metabolism 9 99.7 100.0 100.0 100.0 88.9
Ion Transport and Metabolism 65 91.6 98.0 93.8 76.9 0.0
LPS Biosynthesis / Recycling 45 75.7 80.7 76.7 60.0 8.9
Membrane Lipid Metabolism 12 93.1 97.7 91.7 83.3 41.7
Methionine Metabolism 10 85.0 90.0 87.0 76.7 0.0
Methylglyoxal Metabolism 5 91.1 97.3 96.0 66.7 0.0
Multiple Subsystems 94 91.2 98.2 92.0 73.8 14.9
Murein Biosynthesis 8 92.4 98.3 87.5 83.3 37.5
Murein Recycling 26 92.7 97.9 97.3 82.1 3.8
Nitrogen Metabolism 16 78.3 92.3 70.0 35.4 0.0
Nucleotide Salvage Pathway 50 89.3 96.6 86.8 72.0 14.0
Oxidative Phosphorylation 86 92.5 97.7 91.5 77.9 31.4
Pentose Phosphate Pathway 11 84.8 92.1 84.5 63.6 9.1
Purine and Pyrimidine Biosynthesis 21 96.6 99.8 99.0 96.8 4.8
Pyruvate Metabolism 20 87.6 97.0 83.5 61.7 15.0
Threonine and Lysine Metabolism 13 93.6 100.0 93.1 89.7 0.0
Transport, Inner Membrane 222 84.8 94.4 81.9 65.0 8.6
Transport, Outer Membrane 17 79.4 92.2 70.6 47.1 0.0
tRNA Charging 24 94.3 97.9 96.3 86.1 33.3
Tyr, Trp and Phe Metabolism 19 94.4 98.8 96.3 84.2 36.8
Unassigned 20 83.5 95.0 75.5 55.0 5.0
Val, Leu, and Ile Metabolism 11 92.4 96.7 98.2 81.8 0.0
in principle testable whether using this additional contextual information is
more reliable than BLAST comparisons from which most annotations are
taken. Also, this potential increase of reliability comes at a very small com-
150Table 6.6: A summary of the essential genes (those without which the iAF1260 model does not function) di-
vided by category and relationship to MG1655. The order has been preserved as in Table 6.5; those functional
categories that do not contain any essential genes are indicated on the Table with dashes.
Subsystem No. essential Conserved Conserved in Conserved in Conserved in other Conserved in
Genes overall % E. coli % Shigella % Enterobacter– Legionella %
(iAF1260) iaceae %
Number of strains 36 22 10 3 1
Alanine and Aspartate Metabolism 0 - - - - -
Alternate Carbon Metabolism 1 100 100.0 100.0 100.0 100.0
Anaplerotic Reactions 0 - - - - -
Arginine and Proline Metabolism 9 94.14 100.0 100.0 63.0 0.0
Cell Envelope Biosynthesis 18 91.98 92.7 97.8 83.3 44.4
Citric Acid Cycle 2 93.06 93.2 100.0 100.0 0.0
Cofactor and Prosthetic 75 95.52 99.5 98.1 83.1 18.7
Group Biosynthesis
Cysteine Metabolism 5 95 100.0 100.0 73.3 0.0
Folate Metabolism 1 88.89 100.0 90.0 33.3 0.0
Glutamate Metabolism 0 - - - - -
Glycerophospholipid Metabolism 6 96.76 98.5 100.0 100.0 16.7
Glycine and Serine Metabolism 0 - - - - -
Glycolysis/Gluconeogenesis 2 91.67 97.7 95.0 66.7 0.0
Glyoxylate Metabolism 0 - - - - -
Histidine Metabolism 8 100 100.0 100.0 100.0 100.0
Ion Transport and Metabolism 2 94.44 100.0 100.0 66.7 0.0
LPS Biosynthesis / Recycling 28 81.15 85.2 83.2 66.7 14.3
Membrane Lipid Metabolism 5 98.89 99.1 100.0 100.0 80.0
Methionine Metabolism 4 94.44 100.0 97.5 75.0 0.0
Methylglyoxal Metabolism 0 - - - - -
Multiple Subsystems 16 95.49 98.9 96.9 89.6 25.0
Murein Biosynthesis 0 - - - - -
Murein Recycling 0 - - - - -
Nitrogen Metabolism 0 - - - - -
Nucleotide Salvage Pathway 3 100 100.0 100.0 100.0 100.0
Oxidative Phosphorylation 0 - - - - -
Pentose Phosphate Pathway 0 - - - - -
Purine and Pyrimidine Biosynthesis 18 96.6 99.7 98.9 96.3 5.6
Pyruvate Metabolism 0 - - - - -
Threonine and Lysine Metabolism 8 95.83 100.0 100.0 83.3 0.0
Transport, Inner Membrane 3 94.44 97.0 96.7 100.0 0.0
Transport, Outer Membrane 4 94.44 100.0 95.0 83.3 0.0
tRNA Charging 0 - - - - -
Tyr, Trp and Phe Metabolism 11 96.97 99.2 100.0 84.8 54.5
Unassigned 0 - - - - -
Val, Leu, and Ile Metabolism 5 93.89 94.5 100.0 100.0 0.0
putational cost, a single run of DiagHunter comparing two bacteria on an
Intel Pentium R M 1.7 GHz computer with 1 Gb RAM takes approximately
4 seconds.
151Table 6.7: A summary of reactions conserved in the iAF1260 model according to DH method. Categories are
as in Table 6.5. The reactions included in the table do not represent all reactions in iAF1260, there are 437
reactions that do not have a gene complex associated with them in the model and have been omitted from the
comparison as they are inferred to be present irrespective of gene complement.
Subsystem No. of Conserved Conserved in Conserved in Conserved in other Conserved in
reactions overall % E. coli % Shigella % Enterobacter– Legionella %
iaceae %
Number of strains 36 22 10 3 1
Alanine and Aspartate Metabolism 9 94.14 99.49 97.78 74.07 0.00
Alternate Carbon Metabolism 173 77.78 90.62 70.92 31.98 1.16
Anaplerotic Reactions 8 94.44 100.00 96.25 70.83 25.00
Arginine and Proline Metabolism 37 89.19 98.65 87.84 50.45 10.81
Cell Envelope Biosynthesis 134 93.45 97.05 96.49 77.86 30.60
Citric Acid Cycle 13 91.88 97.55 91.54 76.92 15.38
Cofactor and Prosthetic 148 94.18 99.26 95.07 79.28 18.24
Group Biosynthesis
Cysteine Metabolism 12 93.52 98.86 97.50 69.44 8.33
Folate Metabolism 6 92.13 99.24 90.00 72.22 16.67
Glutamate Metabolism 6 89.81 97.73 93.33 50.00 0.00
Glycerophospholipid Metabolism 218 94.85 99.19 96.10 87.31 9.63
Glycine and Serine Metabolism 14 92.06 98.38 97.86 54.76 7.14
Glycolysis/Gluconeogenesis 22 94.19 98.76 98.18 75.76 9.09
Glyoxylate Metabolism 4 82.64 98.86 70.00 33.33 0.00
Histidine Metabolism 10 99.72 100.00 100.00 100.00 90.00
Ion Transport and Metabolism 73 92.16 99.88 94.38 58.90 0.00
LPS Biosynthesis / Recycling 57 75.49 80.38 76.14 60.23 7.02
Membrane Lipid Metabolism 42 92.79 99.13 93.81 70.63 9.52
Methionine Metabolism 14 82.14 86.69 84.29 69.05 0.00
Methylglyoxal Metabolism 5 92.78 99.09 94.00 73.33 0.00
Murein Biosynthesis 10 99.17 100.00 100.00 100.00 70.00
Murein Recycling 34 93.95 98.26 97.94 78.43 5.88
Nitrogen Metabolism 13 66.88 80.77 56.92 20.51 0.00
Nucleotide Salvage Pathway 130 94.25 98.88 95.46 79.49 24.62
Oxidative Phosphorylation 52 90.49 98.43 88.27 66.67 9.62
Pentose Phosphate Pathway 10 93.89 98.18 97.00 76.67 20.00
Purine and Pyrimidine Biosynthesis 24 96.06 99.24 99.17 93.06 4.17
Pyruvate Metabolism 9 91.05 97.47 87.78 85.19 0.00
Threonine and Lysine Metabolism 18 94.29 99.24 98.33 75.93 0.00
Transport, Inner Membrane 277 86.33 94.96 85.13 55.23 1.81
Transport, Outer Membrane 34 87.58 97.99 85.59 47.06 0.00
Transport, Outer Membrane Porin 247 91.67 100.00 100.00 33.33 0.00
tRNA Charging 22 95.71 97.93 99.09 89.39 31.82
Tyr, Trp, and Phe Metabolism 22 94.19 98.76 94.55 77.27 40.91
Unassigned 22 89.14 97.31 86.36 65.15 9.09
Val, Leu and Ile Metabolism 15 95.56 97.27 100.00 100.00 0.00
6.4.1.2 Lists of genes in GenBank
Although every effort was made to keep up-to-date genome sequences for
comparisons this was not possible in some circumstances. For instance,
iAF1260 was based on a GenBank list of genes from 2008 so this list was
152used where necessary. The changes in the GenBank list of protein coding
genes between that time and 04/06/09 amount to the removal of 12 gene an-
notations and the addition of 28 more, less than 1 % of the total number of
genes annotated in the MG1655 genome sequence. None of these changes
affect any genes used in the iAF1260 gene-protein-reaction relationships
that determine the metabolic network structure of MG1655 (discussed in
thenextchapter). Apartfromgenesthathavebeennewlyannotatedbetween
the time of the production of iAF1260 and June 2009 (b4586 - b4689, 52
genes), there are only two genes in the list of genes from 2009 that have
not been used in the comparisons done in this study: b1500 (a two com-
ponent system connector membrane protein, EvgSA to PhoQP) and b4543
(an uncharacterised gene predicted to encode a protein). These two genes
have been omitted for the purposes of this study and 4095 of the 4149 cur-
rently annotated protein coding genes in MG1655 have been used for this
comparison.
6.4.1.3 MetaCyc comparisons and DiagHunter parameter selection
MetaCyc’s Pathway Tools have been used to infer metabolic pathways con-
served between species through their shared gene complement. These com-
parisons are freely available online and will be used here to validate and cal-
ibrate the genomic comparison implemented above. According to the Meta-
Cyc website the gene comparisons are taken from the annotations of se-
quenced genomes [82], which are usually inferred by the sequencers of the
genome sequence in question by mutual best BLAST hits from the BLAST
database. Data from MetaCyc have been downloaded through the ‘Compar-
153ative Analysis and Statistics’ page (http://metacyc.org-
/comp-genomics) comparison of orthologs. These comparisons provide
locus tags for identiﬁcation and through these it is possible to assign Blat-
tner (b) numbers [35] to the vast majority of them. Those genes for which
b numbers could be assigned unambiguously for MG1655 were compared
with those strains for which data has been posted on the MetaCyc website,
using the comparison tool on that website, and the results can be seen in
Worksheet 4 of Supplementary Table 4.
It can be seen in Table 6.2 that approximately half of the genomes have
entries in MetaCyc as do the vast majority of genes, which gives a large
overlap for the purposes of comparative validation. Table 6.3 shows the
disparities between the data obtained by this analysis and MetaCyc. With
the minimum diagonal length parameter of DiagHunter set at a value of
‘2’ the result is most consistent with MetaCyc, also it is the least biased in
terms of positive disagreements and negative disagreements. This genomic
comparison will therefore be used in the rest of this Chapter and references
to the DH method refer to the inferences based on that parameter selection
unless otherwise stated.
Setting of the minimum diagonal length to ‘2’ has been done with ref-
erence to the MetaCyc data. The physical interpretation of this parameter
is that it has eliminated all candidate genes for functional conservation that
are displaced with respect to the gene order in MG1655 without correspond-
ing movement of any adjacent genes. It therefore seems that genes do not
tend to move around the genome individually, according to MetaCyc. The
privileged position of MG1655’s gene order is not arbitrary; it is one of the
154most intensively studied organisms and has much of its biochemical func-
tion (and relationship to its genome sequence) experimentally veriﬁed so its
genes are known to function in the order in which they are positioned on
the genome. This is not true of the vast majority of other bacteria which, as
in this study, must have their biochemical functions inferred from computa-
tional comparisons with the reference organism.
For the majority of strains the results that are inconsistent between this
study and MetaCyc are split evenly between those inferred present in Meta-
Cyc and not by the DH method and those inferred present by the DH method
but not by MetaCyc. However, Klebsiella pneumoniae and Yersinia pestis
each have considerably more genes inferred present by MetaCyc. The in-
ferences are more consistent the closer the strains are in the phylogeny.
Whereas the E. coli are inconsistent in 3 % of cases, the disparity between
MetaCyc and the DH method goes up to around 11 % for Legionella. These
observations are consistent with the differing methods of inference between
Pathologic and the DH method. Since the DH method is free from any suc-
cessive inferred annotation it is more conservative in inferring shared func-
tion between distantly related organisms, so is less consistent with MetaCyc
as phylogenetic distance between the strains increases.
6.4.1.4 Applicability of synteny comparison
In general of the strains included in this study, a large number of genes
are conserved over a large majority of the strains and inferences overall
are closely consistent with those in MetaCyc. The overall positive synteny
inference is a little over 80 % and for genes included in iAF1260 it is around
15588 %, indicating that in general the metabolic genes in MG1655 are more
frequently conserved in other species than are other types of gene.
ThephylogeneticdistancebetweenMG1655andLegionellapneumophila
str. Corby has rendered the inferred gene synteny comparison very sparse.
The absence of inferred conserved genes in Legionella pneumophila str.
Corby is not necessarily indicative of lack of functional conservation, but
more that even orthologs with the same function are too dissimilar to be
conﬁdent of a positive inference. Corby is inferred to contain just 13 % of
thegenesiniAF1260and<25%oftheessentialmodelgenes. Theseobser-
vations do not necessarily indicate that functions are not conserved between
the two bacteria, but that bioinformatic evidence of synteny conservation
between the bacteria is insufﬁcient to warrant the inference of shared func-
tions for a majority of genes.
Itisapparentfromtheseobservationsthatinferringameaningfulmetabolic
modelfromasinglemodelorganismisnotpossiblebioinformaticallyacross
an entire taxonomic class, but is perhaps limited to a single order or even a
smaller set of bacteria. The DH method was used on two other gammapro-
teobacteria in different orders to test this assertion. The GenBank genome
sequencesofPseudomonasaeruginosaPAO1(GI110227054)andHaemophilus
inﬂuenzae Rd KW20 (GI 6626252) were compared to MG1655 and con-
served metabolic genes amounted to just 30 % and 21 % of the total number
of iAF1260 genes respectively and 43 % and 31 % of the iAF1260 essen-
tial genes, so even if metabolic networks were reconstructed from these
data, working stoichiometric models for these bacteria would require a huge
amount of further work.
156If Corby is removed from the comparisons, 83 % of all inferences are
positive and 90 % of iAF1260 genes are inferred to be conserved. It should
be stressed that this does not necessarily indicate typical gene overlaps
within or between orders of organisms, since the organisms here are not
necessarily a representative sample of all Enterobacteriaceae, but increas-
ing numbers of sequenced genomes in the near future will continue to ﬁll
the gaps and determine the extent to which a single reference model (such
as iAF1260) can be used to infer other metabolic models.
6.4.1.5 False negative synteny inferences from MG1655 against self comparison
AtestofMG1655againstitselfwasconductedtoassessthenumberoffalse-
negatives produced using the DH method and 4068 out of 4095 genes were
inferred as synteny conserved (99.34 %), thus the false negative rate for an
identical genome sequence is less than 0.5 %. Table 6.8 shows the genes not
inferred using the DH method. The majority of these are insertion sequence
(IS) or phage genes, and the failure of the DH method in these cases is ex-
plainable. IS and phage elements are often present in multiple places of the
genome of an individual strain, but in the interests of computational expedi-
ency the DH method is limited to 3 BLAST hit results per gene. Thus where
there are more than 3 identical copies of a particular gene (for instance there
are 5 InsE genes in MG1655) only three have been inferred to be conserved.
The genes highlighted in grey in Table 6.8 are not IS or phage elements, so
there is no obvious reason for their exclusion by this method of inference.
Although a thorough examination of the genes highlighted here would
be required for further reﬁnement of the DH method, here only the gene in
157Table 6.8: Genes wrongly inferred to be absent (false negatives) according to the DH method of gene infer-
ence.
B number In MetaCyc? GI protein Function
b0259 - 16128244 IS5 transposase and trans-activator
b0298 + 16128283 IS3 element protein InsE
b0299 + 16128284 IS3 element protein InsF
b0360 + 145698224 KpLE2 phage-like element; IS2 element repressor InsA
b0361 + 16128346 KpLE2 phage-like element; IS2 element transposase InsAB’
b0372 - 16128357 IS3 element protein InsF
b0373 - 16128358 IS3 element protein InsE
b0552 - 16128535 IS5 transposase and trans-activator
b0656 - 16128639 IS5 transposase and trans-activator
b1331 - 16129292 IS5 transposase and trans-activator
b1402 - 16129363 KpLE2 phage-like element; IS2 element transposase InsAB’
b1403 - 145698254 KpLE2 phage-like element; IS2 element repressor InsA
b1573 - 16129532 Qin prophage; predicted protein
b1588 + 145698266 oxidoreductase subunit
b1597 - 90111305 acid shock-inducible periplasmic protein
b1616 + 16129574 glucuronide transporter
b1832 + 49176157 conserved protein
b1996 - 16129937 KpLE2 phage-like element; IS2 element transposase InsAB’
b1997 - 145698282 KpLE2 phage-like element; IS2 element repressor InsA
b2030 - 16129971 IS5 transposase and trans-activator
b2192 - 16130129 IS5 transposase and trans-activator
b2558 + 16130483 predicted transglycosylase
b2598 - 16130519 pheA gene leader peptide
b2635 - 90111471 CP4-57 prophage; predicted inner membrane protein
b3643 + 157783152 defective ribonuclease PH
b3906 + 16131746 Transcriptional activator, L-rhamnose-binding
b4568 - 145698350 predicted protein
this list which is also in the iAF1260 model, b1588, is considered in further
detail. On close examination, although the BLASTp part of the analysis
worked correctly, an inconsistency in GI numbers for the protein encoded
by gene b1588 due to an out-of-date entry in the MySQL database used
to establish the gene order in MG1655 means that this particular gene is
inferred as absent. In all but Legionella genes to either side of this gene are
overwhelmingly conserved.
b1588 is part of an enzyme complex (along with b1587, b1589 and
b1590) that catalyses two reactions: dimethyl sulfoxide reduction (DM-
158SOR1) and Trimethylamine N-oxide reduction (TMAOR1). There is how-
ever an enzyme complex consisting of the protein products of b0894, b0895
and b0896 that also catalyses both these reactions. These three genes are in-
ferred to be present in all of the organisms in this study, apart from Shigella
boydii Sb227, Shigella dysenteriae Sd197. What is striking about the ab-
sence in the Shigella strains of genes required for this enzyme complex is
that even ignoring the absence of b1588 both have genes missing from both
complexes, so neither strain can catalyse these reactions. None of the other
strains are missing any of the other genes than b1588.
6.4.1.6 Speciﬁc strains against MG1655 synteny comparison
Some strains compared to MG1655 by the DH method reconstruct interest-
ing features of the relationships between the bacterial genome sequences.
Many of these features were noted in the relevant sequencing paper, and
these validate the method to an extent. Figure 6.3 is a map of gene synteny
betweenMG1655andCFT073. Thisﬁgureshowsclearlythenetadditionof
genes to CFT073 (indicated by horizontal gaps in the map) many of which
are virulence related [42], as seen by Rasko et al [124] in a similar compar-
ison of the two strains MG1655 and CFT073. There is also an absence of
rearrangements with respect to MG1655 - these are clearly closely related
strains despite large differences in gene complements. The gene comple-
ment of CFT073 with respect to that of MG1655 will be discussed further
in Chapter 7 where a stoichiometric model of CFT073 has been constructed.
Figure 6.4 shows some of the other maps of synteny inference obtained
using DiagHunter. They show how synteny conserved genes are distributed
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Figure 6.3: DiagHunter output map for E. coli CFT073 versus E. coli K12 MG1655. MG1655 protein coding
genes are each represented by a row (starting from the top at thrL) on the maps and query sequence genes
are represented by columns (starting from the left, also at the thrL gene for that organism). Where a gene is
conserved between the two strains there is a black dot in the corresponding row and column. There are 4149
rows, each corresponding to one of the MG1655 genes. Due to technical issues with DiagHunter numbering
of non-MG1655 genes had to be started at 101 rather than 1, so the ﬁrst 100 columns of this map is empty -
an artifact of the computational method and not a genuine feature of the comparison.
between the query strains and E. coli K12 MG1655. A clear backbone of
conserved genes can be seen in strains as evolutionarily distant as Klebsiella
even Yersinia pestis shows vestiges of the backbone. It should be borne in
mind that these maps do not indicate which differences between the bacte-
rial genomes have occurred in which of the two strains, merely that there
are dfferences. Changes since the last common ancestor could have occured
in the consequent ancestors of either MG1655 or the query strain.
Figures6.4(c)-(d)bothshowtheverycloserelationshipbetweenShigella
and Escherichia though it can be seen that different parts of these genomes
havebeenaffectedbygenomicrearrangements, ratherthantherebeingcom-
mon rearrangements to the Shigella strains.
160Another feature of maps (d) - (f) in this Figure are the apparent linkage
of pairs of genomic rearrangements. This can most clearly be seen in map
(d) where the two sets of genes that fall distant from the backbone of genes
appear to be two sets of genes that have swapped positions in the genome
betweenMG1655andShigellaboydiiCDC3083-94. Themostlikelyexpla-
nation for these linked differences is that they are the result of two separate
events: one in situ reorientation of a large region of DNA, then in situ re-
orientation of a subsection of this DNA back to its original orientation. Al-
though this has not been observed before in this strain, comparison of other
strains, including other Shigella [155] and Y. pestis [156], have observed a
similar phenomenon.
Figure 6.4 (f) shows that despite its disparate synteny conservation with
MG1655 the conserved genes in Yersinia pestis appear to fall primarily
along two crossed lines of synteny. This indicates that the rearrangements
between it and MG1655 are primarily due to large-scale DNA inversions,
rather than translocation in any form and conﬁrms the observations of Deng
et al [156], who did a similar comparison, of two synteny conserved ‘back-
bones’ corresponding to the two replichores of Y. pestis.
There are many other observations on a genome scale to be made here,
indicatingmechanismsofgenomeadaptationandrelationshipsbetweenvar-
ious bacteria, but much of this analysis has been covered by others in orig-
inal genome sequence publications such as Yang et al [155] and Deng et al
[156]. Also the BLAST score ratio method of Rasko et al [151] has recently
been used to produce similar comparisons at the genome level [124], so the
rest of the focus of this Chapter will be on conservation of metabolic genes
161(a) Escherichia coli IAI1 (b) Escherichia coli CFT073
(c) Shigella sonnei Ss046 (d) Shigella boydii CDC 3083-94
(e) Klebsiella pneumoniae subsp. pneumo-
niae MGH 78578
(f) Yersinia pestis KIM
Figure 6.4: DiagHunter output maps of synteny conserved genes for selected genome sequences used in this
study, compared with Escherichia coli K12 MG11655. For an explanation of the plots see the caption for
Figure 6.3.
included in the iAF1260 model.
1626.4.2 Gene and reaction retention in the Enterobacteriaceae
6.4.2.1 Essential genes
It is difﬁcult to determine with bioinformatic comparisons of genome se-
quences whether numbers of inferred genes are over- or under-estimated.
Currently experimental validation is required for any deﬁnitive evidence
about whether genes have conserved function. However, there are a set of
genes that have been experimentally determined to be required for survival
of E. coli K12 and its very close relatives (including MG1655). Due to the
complexity of the interactions between the many parts of the E. coli and the
apparent high gene retention between strains it seems plausible that these
essential genes will be essential across closely related strains, so they have
been used here to validate the comparisons undertaken. The list of essen-
tial genes was compiled from several sources as described in Section 1.4
[88, 89, 90] and the list of the 191 genes determined by all three sources to
be essential can be seen in Supplementary Table 3.
The essential genes present in all the Enterobacteriaceae amount to 146
of the 191 experimentally determined essential genes. 45 essential genes
are therefore not present in all of the strains. One of these genes, b1085,
is absent in the majority of strains and one is absent in a quarter, b1718.
b1085 is annotated as a predicted protein, and has an unknown function.
However b1718 is protein chain initiation factor IF-3 infC, adjacent to a 50S
ribosomal subunit downstream and threonyl-tRNA synthetase upstream on
the MG1655 genome. Its absence in E. coli DH10B is notable as this strain
is a derivative of the same wild-type E. coli as MG1655. Further, the only
163strains lacking this gene are other E. coli and Escherichia Fergusonii. This
raises the question of whether the gene is indeed essential in E. coli and if
not why has it been identiﬁed by all of the experimental approaches used to
produce the list of essential genes.
In terms of using experimentally derived lists of essential genes to deter-
mine the reliability of the DH method in inferring gene complements, the
large number of highly conserved essential genes (especially across closely
related strains) indicates the effectiveness of this method at inferring pos-
itive gene synteny. Further, both the DH method and MetaCyc inferences
provide very similar inferences for all of the essential genes identiﬁed across
the strains analysed here. Essential genes cannot aid in determination of
whether gene synteny comparisons are too sensitive and incorrectly infer
genes as present (false positives), so it remains an open question the best
way to determine this bioinformatically.
6.4.2.2 Gene types conserved
It can be seen from Table 6.4 that retention of genes across the sample of
strains used in this analysis is inﬂuenced in a small but signiﬁcant way by
the category of function of the genes.
The standard deviations of each of the known categories (except extra-
chromosomal), indicating the spread of conservation of genes is consistent
across categories. This indicates that the rate at which new genes are ac-
commodated in genomes and at which (non-essential) genes are eliminated
from them is not dependent on the broad functional categories in which the
genes fall, but more probably on some general gene mixing mechanism.
164This implies that metabolic and transport genes are no more likely to be
permanently removed or added than genes encoding cell structure compo-
nents. This result is surprising given the heterogeneity in metabolic capa-
bilities (even between different strains of E. coli). This evidence of func-
tional category independent gene mixing is further supported by the simi-
lar values of conserved genes and spread of conservation in the Unclassi-
ﬁed/Unknown/Other category to the other categories.
The extrachromosomal category of genes represents those genes that are
insertion element, prophage, plasmid and colicin related and it can be seen
that these are far less consistently conserved, which is expected as they are
associated with mobile genetic elements. As expected, The essential genes
as identiﬁed in Section 6.4.2.1 are to a very great extent present irrespective
of category. The low percentage conserved in the ‘unclassiﬁed’ category is
duetothelackofgeneb1085inmanystrains, buttheotherthreeunclassiﬁed
genes are very highly conserved.
Genes from iAF1260 were further broken down into the subsystems
identiﬁed by Feist et al [1] and summaries of these genes can be seen in
Tables 6.5 and 6.6. Although this included a large number of genes, it does
not include all 1597 genes in the metabolism category according to GenPro-
tEC, due to insufﬁcient experimental data to relate the extra genes to speciﬁc
metabolic functions.
Table 6.5 shows several interesting features. The least well conserved
genesarethoseimplicatedinalternatecarbonmetabolism, glyoxylatemetabolism
andlipopolysaccharidebiosynthesis/recycling. Alternatecarbonmetabolism
includesmanypathwaysspeciﬁctoparticularcarboncontainingcompounds,
165without being essential to core metabolic processes, so heterogeneity in car-
bon source uptake and utilisation enzymes is to be expected. Glyoxylate
metabolism consists of only two genes, the products of which catalyse two
of the reactions converting glyoxylate to 3-phosphoglycerate, which is part
of the Embden-Meyerhof pathway. This can also be attributed to the hetero-
geneity of carbon source utilisation mechanisms required in various envi-
ronments. The poor conservation of lipopolysaccharide genes is because of
differing lipopolysaccharide coats produced in even closely related bacteria
for the purposes of virulence as has been seen in Shigella [157] and in E.
coli, sufﬁcient that a database of structures has been created [158].
These Tables also show that in many subsystems Shigellae contain as
many common genes with MG1655 as other E. coli, with the advent of se-
quencing it has been possible to group E. coli and Shigella than their genera
might indicate [159]. The genes of one subsystem, that of valine, leucine
and isoleucine metabolism is in general better conserved in the Shigella
strains than the E. coli strains. This information by itself does not have an
obvious explanation, but rather by looking at the reactions and pathways
that are missing due to these genes gives a better idea of how well these
inferences will translate into new metabolic models.
6.4.3 Metabolic model construction
There is currently no absolute method of determining gene synteny - except
through experimental comparisons. In the case of sets of organisms, or even
single organisms, thousands of experiments would have to be carried out to
validate the bioinformatic gene comparisons presented here and elsewhere
166(e.g. MetaCyc). However, the use of another source of synteny compar-
isons (MetaCyc) and experimentally elucidated essential genes have both
provided evidence that the synteny inferences made using DiagHunter are
of comparable reliability to those of Pathologic.
6.4.3.1 Essential metabolic genes conserved and models
For models of growth it is necessary that all genes essential to the model are
present, or some alternative is found for each one, or that growth media are
changed to accommodate the strain being modelled (for instance DH10B is
auxotrophic for leucine). There are 234 essential metabolic genes according
to iAF1260 (as determined with model medium used in the next Chapter).
Their retention across various subsystems can be seen in Table 6.6. The
most striking result that comes out of this Table is that according to this
analysis, essential genes relating to cell envelope biosynthesis are less well
conserved in other E. coli than in Shigella even though more genes in this
subsystem are conserved overall in E. coli.
These values are due almost entirely to the absence of two genes from
most E. coli, that are conserved across most of the Shigella, b2038 (rfbC)
and b2040 (rfbD) encoding a dTDP-4-deoxyrhamnose-3,5-epimerase and
a dTDP-4-dehydrorhamnose reductase subunit of dTDP-L-rhamnose syn-
thase respectively. Both genes are essential in dTDP-rhamnose biosynthesis
[160] which is part of the O-antigen production pathway in gram-negative
bacteria. Although the structure of the O-antigen of E. coli K12 (and there-
fore MG1655) has been reported [161], it was found by reconstruction of
the rfb operons of K12, since K12 does not express O-antigens due to two
167deleterious mutations in the rfb operons presumably accumulated during
early experiments after it was originally isolated. Neither of these genes is
essential according to the list of essential genes compiled from the sources
described in Section 1.4. It is therefore not clear why the reactions catal-
ysed by the products of genes b2038 and b2040 are present in the model of
MG1655 and why these reactions are essential for biomass accumulation in
the model.
The other relatively poorly conserved essential genes are mostly due to
individual strain attributes. For instance, DH10B’s relationship as a labo-
ratory adapted strain from the same original K-12 as MG1655 explains the
low leucine biosynthesis subsystem retention. DH10B is auxotrophic for
leucine, due to deletion of its leucine biosynthetic genes (b0071 to b0074),
so these are in fact essential for growth on glucose minimal medium, though
not on rich media.
Since rich media do not have fully deﬁned constituents it is not possible
to determine which metabolic genes according to iAF1260 are absolutely
essential for growth. The subset of genes in iAF1260 that are essential for
growth in the model has been determined to be consistent with experimental
determinations of essential genes, as was noted when the model was pub-
lished [1]. There are 63 iAF1260 genes that are essential according to all
of the sources mentioned in Section 1.4, and are also essential according to
the iAF1260 model. According to this analysis, 16 of the 22 E. coli strains
contain all 63 of these, as do 7 out of the 10 Shigella strains. Even the strain
from these two groups with the lowest number of conserved essential genes,
CFT073, still has 60 out of 63 of them. This makes the production of work-
168ing metabolic models feasible with the comparisons presented here, since
only a very few anomalous results (resulting in models that do not predict
growth in any circumstances) need be addressed. This is also the case with
the other Enterobacteriaceae, which each contain at least 57 of the 60 es-
sential genes, but is not the case for Legionella as it is inferred to have only
15 of the 63 genes in its genome.
6.4.3.2 Reactions conserved and gene redundancy in derived strains
The aim of this gene synteny comparison is to produce metabolic models
for newly sequenced bacteria, purely from metabolic model iAF1260 and
the genome sequences of MG1655 and the query strain. Therefore the gene
synteny comparisons carried out here were used through the Gene-Protein-
Reaction relationships set out in iAF1260 to infer metabolic networks and
models, based on those of MG1655. The reactions conserved can be seen in
Table 6.7 broken down by subsystem (as in Feist et al [1]).
This Table of reactions excludes all those reactions that do not yet have
an assigned gene dependency. For those without a gene dependency there
are several reasons. In some cases the relevant genes have not been charac-
terised, in others the reactions are spontaneous and do not require catalysis.
These second type include diffusion across cell membranes and exchange
reactions which interface the model of the cell to a model environment.
These are therefore not considered in the calculations for Table 6.7.
Possibly the largest problem with the models presented in this Chapter is
the limitation to reactions present in MG1655, rather than all known path-
ways, as is attempted by MetaCyc. According to MetaCyc MG1655 con-
169tains 1793 reactions out of a total of 6483 in the database (as of 2007 [78]).
According to the comparative analysis on that page (calculated by Patho-
logic), comparing the available annotations of the bacteria in this study,
there are on average 400 reactions in each strain that are not in MG1655,
ranging from 0 extra reactions in Yersinia Pestis KIM to 809 in Klebsiella
pneumoniae subsp. pneumoniae MG78578. Although these additional reac-
tions ostensibly amount to 30 % of metabolism in the worst case, inference
of these extra reactions rely on annotation, so might be over-estimations of
extra reaction content due to successive inferred annotation.
6.5 Conclusions
InthisChapteraquickmethodofreliablyinferringbacterialmetabolicmod-
els from a reference model (iAF1260, a model of MG1655 metabolism) and
the genome sequence of a novel bacterium has been analysed to determine
to what extent it can produce a working model for the novel bacterium. This
has been determined by analysis of genes essential for biomass production
in the reference model and essential genes according to other sources. More
than 93 % of the iAF1260 genes considered essential were recovered over
the set of bacteria analysed and almost 97 % of metabolic genes considered
essential by all sources considered were retained.
This analysis shows that even very closely related bacteria to the refer-
ence strain (for instance, DH10B) do not necessarily contain all the genes
required for a working model, indicating that this could provide evidence of
non-essentiality in some cases. The method of model construction was used
170on bacteria of varying phylogenetic distance to MG1655 and it was estab-
lished that although it works well within a bacterial family this method is
not effective between orders of bacteria. Its applicability between families
in the same order was not tested as there are no genome sequences outside
the family of Enterobacteriaceae within the order of Enterobacteriales.
Different subsystems of the model iAF1260 have been retained differ-
ently depending on strain according to the comparison presented. The limi-
tations of the inference to known reactions in MG1655 has been discussed,
but since it relies on direct comparison between newly sequenced genes and
the large number of experimentally characterised genes in MG1655, its in-
ferences should be very reliable. For the family Enterobacteriaceae this
quick reliable method of model inference recovers a large proportion of the
metabolic networks of these bacteria.
171Chapter 7
Stoichiometric modelling of E. coli
DH5 and CFT073 to investigate
metabolic adaptation to heterologous
metabolic genes
7.1 Preface
The gene complements inferred for all of the bacteria discussed in Chapter 6
have not been tested in simulations of growth. This is because many of these
models would not run because after initial synteny comparisons some genes
essential for biomass growth in minimal media using glucose as sole carbon
source in the model were not present. The absence of any one of these
genes renders the model inoperative. Further, there are several parameters
that are set from experimental observation in model iAF1260 (such as the
non-growth-associated energy drain on the system due to cell maintenance)
which may not have the same value either between bacterial strains or in
various experimental conditions.
172The model uropathogen E. coli CFT073 was originally chosen in this
projectasatemplateforseekingnovelgeneticcontributionstouropathogenic
metabolism and with the data on growth of CFT073 and DH5 with added
metabolic genes in deﬁned media shown in Chapter 5 it was a natural choice
for selection to test the inference of its metabolism by the DH method (see
Section 3.4.2). The genes investigated for function in Chapter 5 were con-
ﬁrmed to encode an L-sorbose uptake and utilisation operon, so experiments
have concentrated on L-sorbose metabolism, using glucose as a control.
These models are purely stoichiometric, they do not include any regu-
latory elements, as regulation of bacterial metabolism is so complex and
to a great extent unknown. If known regulation were added to the model
it would take infeasible computing power to run simulations so it is hoped
that with a few key parameters limiting reaction rates (constraints) will be
enough to produce qualitatively correct predictions.
The aims in this Chapter are: to test whether the model of CFT073
produced here can reproduce growth observed in minimal media, to test
whetherconstraintsalonecanallowsimulationstoreproduceobservedgrowth
patterns and to determine whether serial passage of DH5L has allowed this
strain to attain its theoretical growth rate limit, according to the stoichiome-
try of its metabolic network. All reaction abbreviations used in this Chapter
are those used in the iAF1260 of Feist et al [1].
173Table 7.1: Showing how the genotype of DH5 is predicted to affect its metabolic network compared to
MG1655. Each of the genes rendered inoperative by disruption or deletion that are included in iAF1260 are
shown. ‘Reactions lost’ indicates which reactions from the stoichiomeric model are removed by the gene
deletions, giving their iAF1260 designations.
Genotype Blattner Subsystem Reactions lost
number
fhuA2 b0150 Transport, Outer Membrane FE3HOXtonex, FECRMtonex,
FEOXAMtonex
(lacZYA-argF)U169
8
> > > > > > > > > > > > > > > > > > > > > > > > > > > <
> > > > > > > > > > > > > > > > > > > > > > > > > > > :
b0273 Arginine and Proline Metabolism –
b0312 Unassigned OCBT, BETALDHx, BETALDHy
b0314 Transport, Inner Membrane –
b0323 Unassigned –
b0331 Alternate Carbon Metabolism MCITL2
b0333 Alternate Carbon Metabolism MCITS
b0334 Alternate Carbon Metabolism MCITD
b0335 Alternate Carbon Metabolism ACCOAL
b0336 Transport, Inner Membrane CSNt2pp
b0337 Nucleotide Salvage Pathway CSND
b0339 Unassigned –
b0340 Nitrogen Metabolism CYNTAH
b0341 Transport, Inner Membrane CYNTt2pp
b0343 Transport, Inner Membrane LCTStpp
b0344 Alternate Carbon Metabolism LACZ
phoA b0383 Unassigned PPTHpp
relA1 b2784 Cofactor Biosynthesis GTPDPK
nupG b2964 Transport, Inner Membrane INSt2pp, DGSNt2pp, DINSt2pp,
GSNt2pp, INSt2pp
7.2 Results
7.2.1 DH5 genotype
The genotype of DH5 is as follows: F  fhuA2 (lacZYA-argF)U169 80
dlacZM15 endA1 hsdR17 deoR nupG thi-1 supE44 gyrA96 relA1 recAI
phoA  . Many of these changes from the wild-type E. coli (from which
MG1655 was derived) are metabolic in nature and the model used for the
analysis in this Chapter reﬂects these changes. Table 7.1 indicates which
aspects of the genotype have an effect on the model and which reactions
have been removed due to the genotype.
1747.2.2 CFT073 model construction
In Chapter 6 the genes conserved between E. coli MG1655 and CFT073
were inferred. This set of conserved genes has been used to construct the
part of CFT073 metabolism shared with MG1655.
Table 7.2 shows a list of genes that are missing from CFT073, but that
areessentialaccordingtoiAF1260inglucoseminimalmedium. Alsoshown
in this Table are the reactions that could be removed due to these missing
genes. All but one of the missing genes is related to lipopolysaccharide
(LPS) biosynthesis. Most are explicitly so and b0173 (dxr) which is part of
the ‘Cofactor and Prosthetic Group Biosynthesis’ subsystem is involved in
isoprenoid production, which is used in LPS and enterobacterial common
antigen biosynthesis. Of note however, dxr is also vital for menaquinone
and ubiquinone biosynthesis, which are important in electron transport at
the bacterial membrane. It is therefore not clear why this does not appear to
be present in the analysis presented here.
WithoutafullreconstructionoftheLPSbiosyntheticpathwaysofCFT073
available the assumption has been made that although the exact reactions
may be incorrect, the contribution of LPS and cell envelope material to
overall biomass formation is approximately equal between CFT073 and
MG1655. Therefore reactions considered essential for this aspect of cell
growth have been included in the CFT073 model.
The only essential gene that is not related directly to LPS biosynthe-
sis is b1262 (trpC), which encodes an enzyme that catalyses two steps in
de novo tryptophan biosynthesis. The work presented in Chapter 4 shows
that CFT073 is not auxotrophic for tryptophan, since it grows in minimal
175Table 7.2: Showing the iAF1260 genes that are not present in CFT073 and are essential for the model to run.
Reaction details can be found in supplementary material accompanying the publication of Feist et al [1].
Gene name Blattner Subsystem Reactions affected
number
dxr b0173 Cofactor and Prosthetic Group Biosynthesis DXPRIi
lpxK b0915 LPS Biosynthesis / Recycling TDSK
fabG b1093 Cell Envelope Biosynthesis 3OAR100, 3OAR120, 3OAR121,
3OAR140, 3OAR141, 3OAR160,
3OAR161, 3OAR180, 3OAR181,
3OAR40, 3OAR60, 3OAR80
trpC b1262 Tyr, Trp, and Phe Metabolism IPGS, PRAIi
rfbC b2038 Cell Envelope Biosynthesis TDPDRE
rfbD b2040 Cell Envelope Biosynthesis TDPDRR
rfaC b3621 LPS Biosynthesis / Recycling HEPT1
waaU b3623 LPS Biosynthesis / Recycling HEPT4
rfaZ b3624 LPS Biosynthesis / Recycling MOAT3C
rfaB b3628 LPS Biosynthesis / Recycling GALT1
rfaS b3629 LPS Biosynthesis / Recycling RHAT1
medium with glucose as sole carbon source. Due to the retention of genes
encoding other enzymes in the tryptophan biosynthesis pathway, and the
fact that these commit metabolites to the tryptophan biosynthesis pathway,
it seems feasible that an alternative but as yet unidentiﬁed enzyme (or en-
zymes) does catalyse these steps in CFT073. The two reactions IGPS and
PRAIi will therefore be retained in the model of CFT073.
7.2.3 Addition of L-sorbose operon to models
E. coli MG1655 (and therefore DH5) is unable to metabolise L-sorbose.
The L-sorbose operon in CFT073, the function of which has been conﬁrmed
in this work, contains genes that encode an L-sorbose uptake and utili-
sation pathway (as originally elucidated in Klebsiella penumoniae [118]):
extracellular L-sorbose ! cytosolic L-sorbose-1-phosphate ! cytosolic D-
glucitol-6-phosphate ! cytosolic D-fructose-6-phosphate. Table 7.3 shows
176Table 7.3: Showing the details of L-sorbose exchange, uptake and utilisation reactions added to models for
CFT073 and DH5M. Metabolite short names are taken from iAF1260 where the metabolite is part of that
model. The reactions are the following: SORpts is L-sorbose transport across the cell membrane by phospho-
transferase transport system with concomitant phosphorylation, SPR and SPRalt are L-sorbose-1-phosphate
reduction to D-glucitol-6-phosphate using NADH or NADPH respectively as proton donor and EX sor-L is
the exchange reaction for L-sorbose. All metabolites taking part in these reactions are in the cytosol apart
from those marked with letters ‘b’ or ‘e’, which are in the boundary and extracellular compartments respec-
tively.
Reaction name Substrate name Stoichiometry Product name Stoichiometry
SORpts pep 1 pyr 1
L-sorbose (e) 1 L-sorbose-1-phosphate 1
SPR h 1 D-glucitol-6-phosphate 1
NADH 1 NAD 1
L-sorbose-1-phosphate 1
SPRalt h 1 D-glucitol-6-phosphate 1
NADPH 1 NADP 1
L-sorbose-1-phosphate 1
EX sor-L L-sorbose (e) 1 L-sorbose (b) 1
the stoichiometries of the added reactions. The ﬁnal reaction step, glucitol-
6-phosphate to fructose-6-phosphate, is already included in the model as it
is part of the D-sorbitol utilisation pathway, catalysed by the product of gene
srlD (b2705).
7.2.4 Growth simulation calculations
The model iAF1260 is stoichiometric and linear optimisation maximising
the bacterial growth rate was used to establish how efﬁciently carbon source
uptake was converted into biomass accumulation. The models derived from
this, of both DH5 and CFT073, were the same and were considered in
the following way. Timescales over which bacterial regulation operate are
fast compared to the times over which the environment in which the bacte-
ria resided changed, therefore it was assumed that steady state assumptions
allowed the use of linear optimisation with ﬂux balance.
177Known quantities from experiments in Chapter 5 were biomass, extra-
cellular carbon source and extra-cellular acetate concentrations. Therefore
the simulations were designed to observe these quantities. Energy (and car-
bon) from the carbon source was divided by bacteria in the experiments
between biomass accumulation and acetate production, and there is also
an energy cost associated with non-growth-associated maintenance of cells
in the culture which was unobservable in these experiments, but that was
included in simulations as it is well established (it requires a ﬂux of 8.39
mmol/gDW/h through reaction ‘ATPM’ in model iAF1260).
Speciﬁc c-source uptake rate was assumed to be proportional to the c-
source concentration in the media up to a maximum value determined by
Fischer et al [162] experimentally to be around 10 mM/gDW/h, depending
on growth conditions. Therefore uptake rate was as follows:
R =
8
<
:
k1   if R < 10 mM/gDW/h
10 otherwise
(7.1)
where k1 is an afﬁnity parameter representing how well bacteria can take
up c-source when it is available and  is the millimolar concentration of
c-source in the simulated medium.
Acetate production was modelled using a simple relationship established
from Figure 5.6, but modiﬁed in light of Vemuri et al [141], relating spe-
ciﬁc c-source uptake rate (R) to speciﬁc acetate production rate (A) due to
overﬂow metabolism. This relationship is as follows:
178A =
8
> > > <
> > > :
0 if R < R0
(R   R0)y1 if R0  R < Rm
(Rm   R0)y1 if R  Rm
(7.2)
where R0 is the threshold c-source uptake rate for overﬂow to acetate pro-
duction, Rm is the uptake rate of c-source corresponding to the maximal ac-
etate production rate where acetate production saturates and y1 is the slope
of the line corresponding to acetate production due to overﬂow between
these two values. The two threshold values were calculated by minimising
glucose uptake rates at the doubling rates corresponding to the thresholds
for acetate production identiﬁed in Figure 5.6. These were R0 = 3:36 and
RM = 6:66 mM/gDW/h.
7.2.4.1 Simulation algorithm
The simulations were run as follows:
(i) at timepoint i, time from beginning of simulation was t = i  t,
(ii) R(t) was calculated from Equation 7.1 from (t   t),
(iii) A(t) was calculated from Equation 7.2 using R(t),
(iv) B(t) was calculated by maximising the biomass equation subject to the
constraints on R(t   t) and A(t   t),
and the following values were calculated:
179M(t) = M(t   t) + t  B(t); (7.3)
(t) = (t   t)   t  R(t)  M(t   t); (7.4)
(t) = (t   t) + t  A(t)  M(t   t); (7.5)
whereM(t)isbiomassingDW,(t)isc-sourceconcentrationinthemedium
and (t) is acetate concentration in the medium, both of these in mM.
7.2.5 Simulation results
Simulations compared to experimental data over the period of bacterial
growth (the growth was only simulated during this period) are shown in
Figures 7.1, 7.2 and 7.3 for CFT073, DH5L and DH5M. Simulations
were run from different times, depending on the offsets of data used for
comparison (from Chapter 5), and were ended at the point where achieving
biomass rate  0 was not possible by linear optimisation.
SimulationparametersM0 andk1 wereadjustedtogiveanaccuratebiomass
trace during the exponential phase of growth. 0 was calculated as a mean
of the ﬁrst three c-source experimental points after the beginning time of the
simulation. The parameter determining acetate production as a function of
c-source uptake rate, y1 was determined such that it ﬁt acetate production
in the early phase of growth (when the assumption of steady state was the
most reasonable). Simulation parameters for each of these simulations are
shown in Table 7.4.
Simulation results for growth rates, ﬁnal biomass concentrations and ac-
etate concentration at the end of the exponential phase of growth are shown
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Figure 7.1: Simulations compared to experimental data for growth of CFT073 in M6 minimal media with
supplemented with different c-sources. The experimental data are as follows: optical density ‘+’, c-source
concentration ‘’ and acetate concentration ‘’. Simulation results are as follows: optical density - solid line,
c-source concentration - dashed line and acetate concentration - dotted line. Top: using glucose as carbon
source. Bottom: using L-sorbose as carbon source.
in Table 7.5 along with the corresponding values from the experimental data
(from Tables 5.1, 5.3 and 5.4 in Chapter 5).
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Figure 7.2: Simulations compared to experimental data for growth of DH5L in M6 minimal media with
supplemented with different c-sources. The experimental data are as follows: optical density ‘+’, c-source
concentration ‘’ and acetate concentration ‘’. Simulation results are as follows: optical density - solid line,
c-source concentration - dashed line and acetate concentration - dotted line. Top: using glucose as carbon
source. Bottom: using L-sorbose as carbon source.
7.3 Discussion
7.3.1 Model inference
The model of DH5 metabolism shows interesting characteristics when
compared to the original model of MG1655 metabolism (iAF1260). Due to
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Figure 7.3: Simulations compared to experimental data for growth of DH5M in M6 minimal media with
supplemented with different c-sources. The experimental data are as follows: optical density ‘+’, c-source
concentration ‘’ and acetate concentration ‘’. Simulation results are as follows: optical density - solid line,
c-source concentration - dashed line and acetate concentration - dotted line. Top: using glucose as carbon
source. Bottom: using L-sorbose as carbon source.
the derivation of DH5 from the same wild-type strain as MG1655, the only
reactions it is missing are those either as-yet uncharacterised in MG1655 or
183Table 7.4: Showing the simulation parameters calculated for the simulations shown in Figures 7.1, 7.2 and
7.3. The ‘-’ for y1 when DH5L is grown on L-sorbose is because for the other model values L-sorbose
uptake rate never increases over the threshold value for carbon overﬂow. The inferred maximum speciﬁc
c-source uptake rate for each of the strains, at the initial c-source concentration, is indicated in the ﬁnal
column.
0 [mM] M0 [gDW/l 10 3] k1 y1 Max speciﬁc c-source
uptake [mM/gDW/h]
Glucose
DH5L 56 15.00 0.120 2.2 6.7
DH5M 52 3.00 0.180 2.2 9.4
CFT073 56 3.15 0.220 1.4 12.3
L-sorbose
DH5L 52 3.30 0.035 - 1.8
DH5M 52 1.20 0.100 2.0 5.2
CFT073 61 6.00 0.100 1.5 6.1
those removed by genomic disruption, as laid out in Table 7.1, 23 reactions
in total. What is surprising is that this has an impact on the maximum efﬁ-
ciency with which the DH5 could grow.
On comparison of the results of parallel linear optimisations it can be
seen that the prevention of two reactions which have a ﬂux in iAF1260
in the conditions above have potentially impacted on DH5 performance,
ACCOAL and INSt2pp, which are the acetate-CoA ligase (ADP-forming)
reaction and inosine transport in via proton symport (periplasm) reactions
respectively. The rate for INSt2pp is an artifact of the linear solution found
in this case, the alternative reverse periplasmic transport reaction, INSt2rpp,
has an equal but negative ﬂux. So the difference inefﬁciencies is due to
ACCOAL, which produces acetyl-CoA from acetate.
The model of CFT073 metabolism is not so complete. Analysis in Meta-
Cyc indicates that there are 269 reactions present in CFT073 that are not
present in MG1655, which represents about 13 % of the total number of
reactions in that strain if correct. The problem of successive inferred an-
184Table 7.5: Showing the simulation predictions of doubling rate, ﬁnal biomass concentration and extracellular
acetate concentration at the end of exponential growth, along with the experimentally derived values of these
from Chapter 5.
Doubling Rate Final Biomass Acetate conc.
[h 1] [OD] [mM]
CFT073
Glucose Data 1.12 4.1 31
Model 1.08 13.97 14.56
L-sorbose Data 0.5 5.9 18
Model 0.56 13.88 11.37
DH5M
Glucose Data 0.71 4.3 27
Model 0.85 11.2 26.6
L-sorbose Data 0.42 4.4 12
Model 0.47 11.43 7.7
DH5L
Glucose Data 0.49 4.7 24
Model 0.51 12.2 18.9
L-sorbose Data 0.24 3 0
Model 0.2 7.98 0
notation was discussed in Chapter 6, so it will only be mentioned here that
these reactions have not been experimentally conﬁrmed in CFT073, infer-
ences of these reactions are not necessarily based on comparisons with ex-
perimentally characterised genes, so it seems plausible that this number of
other reactions is an overestimate. Another important characteristic of these
reactions if they are present in CFT073 is that since iAF1260 represents a
real bacterium it contains all reactions essential for bacterial survival and
the vast majority of central pathway reactions, so inferences of a CFT073
model will not be missing these reactions unless they are genuinely absent.
The efﬁciencies in acetate production and ATP production (shown by
ATPM) in CFT073 appear to be somewhat compromised by the removal of
reactions from the original model. Two reactions missing from the CFT073
model that have positive ﬂuxes are PDH and R15BPK, the pyruvate de-
hydrogenase and ribose-1,5-bisphosphokinase reactions. There is an alter-
native pathway for production of 5-Phospho-alpha-D-ribose 1-diphosphate
185catalysed by the enzyme encoded by gene b1207 (ribose-phosphate diphos-
phokinase, reaction PRPPS), thus R15BPK ﬂux does not affect these efﬁ-
ciencies.
The loss of PDH requires that an alternative way of producing acetyl-
CoA, an essential intermediate in central metabolism. An analysis of ﬂux
distributions using iAF1260 with and without PDH shows increased ﬂux
through PFL (catalysed by pyruvate formate lyase) which also produces
acetyl-CoA, while converting pyruvate to formate. Both reactions use pyru-
vate to form acetyl-CoA, but there is an efﬁciency cost in dealing with for-
mate as a by-product, rather than NADH (as in reaction PDH).
Part of MetaCyc’s algorithm for ﬁnding reactions in new species tries to
ﬁll gaps in metabolism of such new species where there appear to be catal-
ysed reactions on either side of reactions in a metabolic pathway, but no
gene encoding an enzyme for that intermediate reaction. It is assumed that
this is why MetaCyc reports CFT073 as being able to catalyse the pyruvate
dehydrogenase reaction. However, this work shows that there is no reason
in principle why CFT073 would require this reaction. Using BLASTx it
was determined that there is deﬁnitely a truncated aceF gene in the position
corresponding to the actual aceF gene in MG1655, so this indicates that the
gene is no longer functional. While the idea of pathway closing was used
above to infer that reactions in the tryptophan pathway were present, the dif-
ference here is that there are metabolic alternatives to the reaction inferred
as missing in this case. This means that no deadend reactions are produced
by the elimination of this reaction and it seems less likely in this case that
the pyruvate dehydrogenase reaction does actually occur in CFT073.
1867.3.2 Simulations
The simulations shown in Figures 7.1, 7.2 and 7.3 show good qualitative
agreement with the data collected previously on the growth of these strains.
The simple models of carbon overﬂow into acetate production effectively
reproduce acetate excretion during growth and for DH5L and DH5M
show reasonably good agreement with total acetate produced at the end of
growth. The failure of DH5L to produce acetate in L-sorbose medium is
predicted by the model due to the low L-sorbose uptake rate in the simula-
tion. Acetate traces tend to increase, then become ﬂat towards the end of
growth and this is because growth rate drops below the threshold value for
acetate production in the model. This plateau can be seen in most of the
data in these Figures, so it would seem to support the theory that acetate is
only produced as some overﬂow when speciﬁc c-source uptake is high.
Maximum speciﬁc uptake rate of c-source, as shown in Table 7.4, shows
a clear difference between the three strains considered here. It can be seen
thatpassageimprovesDH5L’sabilitytotakeupc-sourceinbothoftheme-
dia used here to compare the strains. However the most drastic improvement
is with the uptake of L-sorbose (the conditions of the passage). Indeed the
maximum speciﬁc uptake rate approaches that of CFT073, although even
after 100 generations of adaptation it is still 15 % lower than the CFT073
value. Measured maximum speciﬁc uptake rates in E. coli MG1655 and
W3110, where they have been measured in continuous culture, are 10 and
10.5mM/gDW/h[1,163], andaccordingtothestoichiometriesandthepoint
at which the L-sorbose pathway enters central metabolism (see Figure 4.5)
there is no metabolic reason why L-sorbose could not be taken up at the
187same rate as glucose and growth occur at the same rate. Clearly this does
not happen, so there may well be constraints exerted by the L-sorbose path-
way itself in L-sorbose uptake.
There are several parameters in the iAF1260 model that have been taken
as constant for the purposes of the simulations in Chapter 7. Firstly the
non-growth dependent ATP utilisation for maintenance was taken to be 8.39
mM/gDW/h. This value has been shown to be 7.6 mM/gDW/h in W3110
[163], so how consistent this value is between other strains (MG1655 and
W3110 being so closely related) remains open to debate. It is a very im-
portant value because it represents an intrinsic drain on energy and carbon
during the growth of these bacteria. It is not a simple reaction, as rep-
resented in the model, but a wide variety of different activities for cell
maintenance, so ﬁnding an E. coli with a low maintenance rate might be
of interest to metabolic engineers looking to maximise growth or product
yields in fermentation. Maximum glucose uptake rate has been shown to be
10.5 mM/gDW/h in W3110 [163], which is consistent with the value of 10
mM/gDW/h used here.
These simulations break down in terms of biomass accumulation and
c-source uptake usually towards the point where there becomes a lack of
carbon source. Indeed in Table 7.5 it can clearly be seen that biomass ac-
cumulation is predicted to be almost three times that seen in reality. There
are several potential explanations for this, but most likely is that E. coli have
adapted to curb their growth even in the presence of some carbon source, as
proﬂigate growth would entirely deplete potential energy sources required
for maintenance and to store for potential regulatory shifts when the exter-
188nal environment changes. None of this control of metabolism is represented
in the simulations presented here.
Indeed the data presented in Chapter 5 show that DH5L fails to take
up large amounts of carbon source available to it in the media. This is
particularly true when DH5L is presented with L-sorbose, a novel carbon
source for it and it must make use of its newly acquired metabolic genes.
This could represent an inability to make full use of the L-sorbose, but it
does not then explain how the DH5L grows in the ﬁrst place. It therefore
suggests that these bacteria with metabolic genes as yet poorly integrated
into their regulatory network adopt a conservative strategy when growing in
this carbon source that is taken up at a very limited rate. This is actually
shown to an extent in Figure 7.2 bottom panel, though not to the extent that
L-sorbose is left in the experimental case.
The other unexplained aspect of these simulations is the predicted low
net acetate excretion by CFT073. The actual ﬁnal acetate concentrations in
media are higher than in the simulations and this shows that although qual-
itatively this overﬂow mechanism is correct perhaps it has slightly different
R0 and RM values to DH5, perhaps related to its loss of pyruvate dehy-
drogenase activity. The threshold for acetate production calculated from the
data presented in Chapter 5 and the models calculated here is similar to that
for acetate production in chemostat experiments conducted by Vemuri et al
[141] whose calculated lower limit was R0 = 4:4mM=gDW=h.
Although some interesting results come out of the simulations presented
here it should be borne in mind that they are greatly simpliﬁed representa-
tions of the metabolism of the underlying organisms, and acetate production
189and c-source uptake are very much more complicated in reality than in the
models presented here. For instance, uptake rate for carbon source should
be subject to some saturation effect at high c-source availability and could
be modelled by Michaelis-Menten kinetics with a single substrate (extracel-
lular c-source) with the transporter as the enzyme catalysing the reaction.
Further, there are several parameters that, if more sophisticated (and re-
alistic) models were used, could be estimated from experimental data rather
than, as here, ﬁtting to the data during simulation.
7.3.3 Model construction and validity
It can be seen from the simulations presented here that the models inferred
from the original iAF1260 model are adequate for representing qualitative
results about growth in simple circumstances. Due to the direct comparison
between the genomes of CFT073 and MG1655 conducted in Chapter 6 this
is a reliable indication of the core metabolic functions of CFT073 and much
of the peripheral metabolism shared by the two bacteria since they are so
closely related. Since CFT073 is one of the most distantly related of the
E. coli compared in Chapter 6 to MG1655 it seems plausible that the direct
inference of models from iAF1260 for any E. coli is posible and represents
a quick and easy way of beginning the reconstruction of the metabolism of
these bacteria.
Quantitative results used to constrain the model for MG1655 may not be
accurate for other bacteria, especially those not closely related to it - Feist et
al’s model uses a ﬂux through a general ATP hydrolysis equation to account
for non-growth associated energy use for cell maintenance amounting to
1908.39 mmol ATP gDW 1 H 1, but this may vary in other bacteria and might
have to be experimentally obtained on a strain-by-strain basis, though this
is beyond the scope of the work presented here.
While the problem of successive inferred annotation and the limit of
comparisons due to proteins with high homology but different functions
(e.g. [164]) this method of inference appears to be a very reliable system.
Despite the initial limitation of comparison to pathways in MG1655 models
can easily be expanded due to their simple stoichiometric nature, as shown
above with the addition of L-sorbose uptake and utilisation genes.
It should be noted that by limiting this model reconstruction of CFT073
to the iAF1260 model and the L-sorbose operon with experimentally con-
ﬁrmed function in Chapter 4 a lot of reaction pathways will be missing that
could potentially be added by careful comparison of the CFT073 genome
with the set of genes from non-E. coli organisms that also have experimen-
tally veriﬁed functions. The difﬁculty with inferring these reactions is in
collecting the speciﬁc genes from a source which connects the genes to re-
actions (such as MetaCyc) and collecting the DNA sequences of these genes
for comparison with CFT073.
7.4 Conclusions
It has been shown in this Chapter that models inferred from the genome
comparisonspresentedinChapter6, basedonstoichiometricmodeliAF1260,
representfeasible, thoughincomplete, modelsofbacterialmetabolism. Since
the organism used to compare with MG1655 is CFT073, one of the E. coli
191with the fewest mutually conserved genes with MG1655, it shows that this
method of model inference is probably valid for any E. coli strain, but va-
lidity beyond this, for instance for Shigella strains, has not yet been estab-
lished.
It has also been shown that simulations based on one of these inferred
models, using a simple model of overﬂow metabolism and c-source up-
take, qualitatively predict observed growth characteristics of the strains in
batch growth in shake ﬂask experiments. However the models fail to predict
bacterial strategies for coping with low c-source concentrations and would
require further development to predict this aspect of behaviour.
The modelling of acetate production during growth shows qualitative
agreement with experimental data and also reasonable quantitative ﬁnal ex-
tracellular acetate concentrations for the strains related to MG1655 (DH5L
and DH5M), however prediction of ﬁnal extracellular acetate for CFT073
is below that seen experimentally and implies that CFT073 may have dif-
ferent threshold values for acetate overﬂow - perhaps due to its lack of
pyruvate dehydrogenase activity, the only enzyme missing from the central
metabolism of CFT073 compared to MG1655.
192Chapter 8
Conclusions and further work
8.1 The complete process of metabolic model generation
for newly sequenced bacteria
The results presented in this Thesis represent bioinformatic and experimen-
tal approaches to reconstruction of stoichiometric metabolic models for bac-
teria with newly sequenced genomes. The initial aims of this project were to
assess the feasibility of reconstruction of such metabolic models and the use
they would be in metabolic engineering contexts. Newly sequenced bacteria
often have initial annotations, but they can be subject to mis-annotation and
the problem of successive inferred annotation (as described in Chapter 1). It
was therefore decided that basing a model on a previous well characterised
model (initially iJR904 [165], then iAF1260 [1]) and use a single inference
step directly from open reading frames of the query bacterium against the
genome of the reference bacterium (in this case MG1655). Then ways of
bridging the gaps between the sequence and the reality of the metabolism
of the strain would be investigated to try to produce a more complete model
193by bioinformatic and experimental approaches. Even in such a homologous
group of bacteria as E. coli there are vast differences in metabolic capabil-
ities of strains, so this experimental veriﬁcation of reactions would be vital
for most reconstructions. As an example strain CFT073 was selected, since
its genome had recently been sequenced and its differences in habitat (in
the urinary tract) to MG1655 were known. The principle of metabolic re-
construction could have been used on any sequenced strain of E. coli, but it
was thought that this difference in habitat would aid in the characterisation
of previously uncharacterised metabolic genes in CFT073 to enlarge and
improve the metabolic model.
In comparing the two strains, CFT073 and MG1655, metabolic genes
in CFT073 were effectively separated into three categories, characterised
genes present in both strains, genes present in CFT073 only (but with an
annotated function) and uncharacterised genes in CFT073 only. The core
metabolic model (present in both) was used as the basis of the metabolic
model used in Chapter 7 and characterisation of the uncharacterised genes
in CFT073 only was attempted to reconstruct as much of the CFT073 model
as possible, as shown in Chapter 4. In this Chapter a bioinformatic approach
was taken to try to elucidate the function of these uncharacterised genes (the
results of which can be seen in Supplementary Table 2), but only one of the
sets of genes analysed, that of L-sorbose uptake and utilisation, was sufﬁ-
ciently well characterised to merit inclusion in the model presented in Chap-
ter 7. This shows the scale of the task of reconstructing complete metabolic
networks for newly sequenced bacteria as many such uncharacterised sets of
genes are present in each newly sequenced bacterium. For CFT073 a purely
194bioinformatic approach was not enough to provide enough information to
complete the metabolic model, so the construction of such a model will of-
ten require biochemical characterisation. One large limitation of the model
presented here is that it is incomplete, but it was sufﬁciently complete to
simulate growth in limited conditions (with L-sorbose or glucose) as carbon
source, but further investigation of the model would require the addition of
the missing reactions.
In looking for these extra uncharacterised genes that could be of use to
CFT073 in the urinary tract there are problems in terms of the timescales
of adaptation and evolution in nature. Although some abilities distinct from
those of MG1655 are required for CFT073’s ability to colonise the urinary
tract, there might well be a lot of genetic material that is not subject to
selective pressure, so might be retained just because it has not been selected
against.
As discussed in Chapter 7 reliable inference of the function of the well
annotated genes in CFT073, but not in MG1655, also potentially contribut-
ing to metabolism in the urinary tract, was not done. This would be one of
the ﬁrst steps in improving the incomplete model of CFT073 that was used
in Chapter 7, but would require a lot of work linking the huge number of
gene-protein-reaction relationships (as presented in, say, MetaCyc) to gene
sequences (as presented in GenBank).
Metabolic regulation massively inﬂuences the phenotypic response of
bacteria to a particular environment, be it soil, the human gut or a shake
ﬂask culture. Therefore the genes conﬁrmed as encoding an L-sorbose up-
take and utilisation pathway were used as a model for the addition of het-
195erologous metabolic pathways to an E. coli strain. It was hoped that this
would elucidate some of the factors involved in such addition of metabolic
genes in metabolic engineering. The results of this can be seen in Chapter
5. Initial transformation of the genes resulted in a very slow growing strain,
which potentially has implications for use of such heterologous pathways
in metabolic engineering. Strain capabilities approaching the ‘native’ wild-
type capabilities of CFT073 were only achieved through passage - in this
case over about 40 generations. Even then the growth rate and biomass con-
centrations were below those of the wild-type - and beyond 40 generations
these capabilities did not improve. This shows that strains engineered by
addition of such genes might well have to take into account poor integration
of such genes into the metabolism of the host bacterium.
One potential reason for the poor growth of this initial strain DH5L
could just have been low expression of the genes on the plasmid, since the
genes were not put under the control of a constitutive or tuneable promoter.
This might well produce faster growing strains, but it would be informative
to look at growth rate as a function of expression of the genes, since the rest
of metabolism would have to adapt to changes in ﬂux through that pathway,
and an easier way to tune the metabolism might just be by selection of fast
growing mutants of DH5L (as was done here through passage), without
the need for a tuneable promoter.
Theuseofmetabolicmodelstoguidemetabolicengineeringandimprove
strain characteristics for the production of heterologous gene products has
been done. For instance, Luo et al [166] have used ﬂux balance analysis in a
model of central E. coli metabolism to improve production of recombinant
196human-like collagen in E. coli, so expansion of these models to include the
details of the entire metabolism of the host cell should improve analyses
like this further, by taking into account all the possible ﬂux distributions
potentially available to the E. coli.
One of the features of the data collected about acetate excretion in the
strains tested in Chapter 5 is that passage over 100 generations failed to
abolishtherelationshipbetweencarbonsourceuptakeandacetateexcretion.
Changing regulatory control in central metabolism by genetic engineering
has modiﬁed strain MG1655 to retain growth rate and total biomass accu-
mulation in minimal media with glucose as sole carbon source [136]. This
result indicates that just reducing the excretion of acetate will not necessar-
ily increase growth rate or biomass yield in conditions of minimal media
with glucose as sole carbon source. Some E. coli strains produce acetate in
far lower quantities in similar conditions than MG1655 and closely related
strains, for instance strain BL21 [167]. Differing acetate excretion levels
are attributed to differing gene expression to MG1655, rather than different
unique pathways in such strains [168], so it is not clear why regulation in
MG1655 and related bacteria (such as DH5) produces high acetate excre-
tion rates at high speciﬁc glucose uptake rates.
One observation from the work presented in Chapter 5 is that L-sorbose
seems to induce the same acetate production at a given growth as glucose, so
introduction of this pathway linking to central metabolism does not seem to
disrupt the regulation of the overall central metabolism of the cells. It is not
yet clear why the passage presented here has not reduced acetate production
or, given the observations of Veit et al [136], whether any length of passage
197without careful choice of selection conditions would produce a reduction of
acetate production.
Concerning the mechanism of adaptation of DH5L during passage, the
plasmid from DH5M was re-transformed into a naive DH5, grown and
repassaged (Chapter 5). The results of this indicated that changes had cer-
tainly occurred on the chromosome, and it was possible that none of the
changes on the plasmid (if there were any) had any effect on the metabolism
of the passaged strains. This result is of interest because it indicates that if
the changes are based on regulation of the L-sorbose operon then some reg-
ulatory mechanism on the chromosome has perhaps adapted to interact with
the L-sorbose operon and upregulate expression.
The model of CFT073 presented here is incomplete as it has ignored
genes with an annotated function that are not present in MG1655. Accord-
ing to MetaCyc there are 269 reactions that exist in CFT073 that are not in
MG1655, although due to the problem of successive inferred annotation and
potentially wrongly inferred reactions without a gene dependence (such as
for reaction ‘PDH’ in iAF1260 discussed in Chapter 7), this number may
be somewhat smaller. The method of gene synteny inference presented in
Chapter 6 is conservative in that only the genes (and consequent reactions)
inMG1655havebeenconsidered. Thereareofcoursemanyothermetabolic
genes with biochemically conﬁrmed functions which could be used to as-
sess whether the 269 reactions mentioned above would indeed be part of the
CFT073 metabolic network by comparison with CFT073 genes. The difﬁ-
culty in such an analysis would be extraction of the relevant biochemically
characterised genes for BLAST comparison, since although such genes are
198clearly labelled in MetaCyc such genes are not labelled in GenBank.
Overallthisworkshowsanexampleofthereconstructionofthemetabolic
modelofa newlysequencedgenomeand theassociatedwork, both bioinfor-
matic and experimental, that might be required for each new bacterial strain
sequenced to produce a complete stoichiometric model of metabolism. One
such model has been used to simulate growth of CFT073 in deﬁned media,
and models have been used to investigate the adaptation of a bacterial strain
with heterologous carbon source uptake genes. The enlargement and devel-
opment of such models will be increasingly important for analyses of such
engineered bacteria, and also in directing engineering for increasing target
product yields.
8.2 Functional Genomics and E. coli
The availability of sequence data for bacteria far outstrips the capability
of current research to analyse and understand those data. For example Es-
cherichia coli, despite 1:76106 publications (according to Google Scholar
http://scholar.google.co.uk/scholar)thatmentionitandtens
of closely related genome sequences, is not fully characterised. The most
well characterised strain E. coli MG1655 contains 475 genes encoding ei-
ther ‘conserved’, ‘hypothetical’ or ‘expressed’ proteins, none with a known
function.
Thefunctional genomicapproach togenecharacterisation takenin Chap-
ter 4 takes the approach that data relating to bacteria that survive in particu-
larenvironmentswillhavepatterns, i.e. thatgenesmorefrequentlyobserved
199in the genome sequences of bacteria from a particular environmental niche
than of bacteria residing outside that niche might have some beneﬁcial func-
tion in that niche. This is an assumption that underlies much other work on
E. coli, most comprehensively by Rasko et al [124] for metabolism but also
focusing on bacterial pathogenesis (such as [62]).
This approach has been successfully used here in the context of UPEC,
where genes of unconﬁrmed function have been identiﬁed for targeted char-
acterisation and many other candidates for characterisation have been iden-
tiﬁed.
8.3 E. coli response to the introduction of heterologous
metabolic genes
The response of bacteria to gene deletion and ampliﬁcation have been ob-
served in many instances of metabolic engineering (such as recently [169,
170] and many others) and addition of genes through cloning of plasmids
is well established as a way of changing the effective genotype of a bac-
terial strain (for instance [171]). Heterologous biosynthetic pathways have
successfully been cloned into E. coli. For instance an echinomycin biosyn-
thetic pathway has been heterologously expressed in E. coli by Watanabe et
al [172] and a mevalonate pathway has been engineered for the production
of terpenoids also in E. coli [173]. Investigation of how bacteria respond
to this sort of engineering, by way of a metabolic pathway for uptake of a
novel carbon source, was decided for this project.
The response of DH5 over approximately 100 generations of growth in
200deﬁned media to the introduction of L-sorbose uptake and utilisation genes
can be seen in Chapter 5, where it could be seen that growth rate and ﬁnal
biomass concentration were both increased for the conditions in which the
adaptation took place. However this adaptation did not bring the adapted
strain DH5M up to the yields achieved by the ‘native’ strain CFT073,
which apart from the L-sorbose uptake operon has quite a similar metabolic
network (as seen in Chapter 7). A plateau in growth rate was observed and
this indicates that there are mechanisms that might require further analysis
for a system such as this to achieve optimal performance.
It is clear that there is a difference between the growth characteristics
of the three strains tested in Chapter 5. The observation of heat sensitiv-
ity of the Klebsiella pneumoniae glucitol-6-phosphate dehydrogenase by
Sprenger and Lengeler [118] gave a clue as to a potential reason for dif-
ferences in the growth proﬁles of these strains, however Figure 5.8 clearly
demonstrates that it is not this enzyme that constitutes the difference be-
tween the strains.
8.4 Geneandreactioncomplementcomparisonsusinggenome
sequences
The inclusion of a context-based system for determining gene synteny in
bacteria, using DiagHunter, and the removal of the possibility for succes-
sive inferred annotation, were both achieved in the work presented in Chap-
ter 6. This comparison has given a reliable basis of gene inference for model
building for bacteria of the order of Enterobacteriaceae, which can be sup-
201plemented by functional genomics approaches as described in Chapter 4.
The relationship between gene retention and reaction retention for the
Enterobacteriaceae has been analysed in Chapter 6 and it has been shown
that the DH method returns approximately 83 % of the reactions inferred by
MetaCyc to be present in these bacteria. The validation of many of these
reactions could potentially be done by extraction of the DNA of the relevant
genes from GenBank and use of BLAST on just these relevant genes, to
ascertain reliable inferences of gene function conservation.
8.5 Whole genome stoichiometric models
Whole genome stoichiometric models of two strains of E. coli have been
produced and simulations of growth in deﬁned conditions have been run, as
shown in Chapter 7. qualitative predictions of growth have been good and a
simple model of acetate production as an overﬂow metabolite has predicted
the production or non-production of acetate during the course of growth.
The analysis of the retention of essential genes for stoichiometric models
is of great importance as without these genes models will not run. Chapter
7 shows that in some cases experimental evidence can be used to plausibly
argue the existence of reactions inferred absent by gene comparisons, such
as the reactions encoded by trpC, and this has been directly incorporated in
the CFT073 model.
Although these models are only subsets of the possible models for the
bacteria it is felt that they are the best basis for building further models due
to their reliability. The addition of further reactions that are experimentally
202validated (e.g. the L-sorbose uptake and utilisation operon) retains the close
link between model building and experimental veriﬁcation of gene function.
The cost of such a strategy is the amount of functional information known
about many genes that are not present in MG1655, which will not be present
in these new models, but this is mitigated by the reliability of the inferences
made by the DH method. Further, development of a tool for direct com-
parison of query genes to genes with experimentally validated metabolic
functions would greatly aid in the reconstructive effort.
8.6 Potential further work
8.6.1 Functional genomics and CFT073 metabolism
The bioinformatic data collected in Chapter 4 potentially holds much infor-
mation about the metabolism of CFT073 and functional characterisation of
the sets of metabolic genes found solely in UPEC, and in other pathotypes,
could potentially beneﬁt from an approach based on genomic comparisons
and expanded from single genes by identiﬁcation of sets of conserved genes
in such pathogens. As the number of sequenced bacteria grows and grows,
incorporation of these new bacteria would make methods of functional ge-
nomics such as this more and more powerful.
8.6.2 Further investigation of the adaptation of engineered E. coli
Further characterisation of the metabolic ﬂux changes during passage of
the strain DH5L by way of radioactive carbon labelling and measurement
could provide more insight into the adaptation of this strain to the addition
203of heterologous metabolic genes.
To benchmark the adaptation observed here (and for similar adaptive
tests with heterologous genes from closely related donor strains of bacte-
ria) passage of CFT073 over 100 generations in the same conditions to de-
termine its characteristics after the same selective pressure would provide
more information about the potential ﬂux distributions accessible to E. coli
when growing on L-sorbose. This could potentially shed light on the reason
why adaptation did not recover the rates of growth seen in CFT073 in the
passage conditions.
Since the beginning of this project fast genome sequencing, such as by
Solexa [174], have made feasible the prospect of sequencing single bacteria
in a matter of days, and with the MG1655 reference genome, DH5L and
DH5M could be sequenced to look for single nucleotide polymorphisms
(SNPs) and other changes both on the chromosome and the plasmid to try
to explain the adaptation seen here. If CFT073 were also passaged then
another set of SNPs could be identiﬁed by sequencing of passaged and un-
passaged CFT073, as a control. These SNPs could then potentially each
be studied individually in naive DH5 containing naive pQR793 L-sorbose
plasmid, to determine whether any of the changes were individually respon-
sible for changes in L-sorbose uptake and growth in this system, in order to
identify how exactly the integration of new metabolic pathways might occur
naturally in bacterial systems.
2048.6.3 Validation of the DH method of gene synteny inference
The application of the DH method to ﬁnding synteny conserved genes gives
differing inferences of gene conservation to MetaCyc. Validation of this
method would require further bioinformatic and experimental validation of
the speciﬁc genes on which there are disagreements between the two sets of
inferences. This could potentially feed back into a reﬁned version of the DH
method for gene inference. Further, combining DiagHunter with the BSR
method of gene homology measurement of Rasko et al [151] could further
reﬁne the technique presented in this work.
8.6.4 Using further bioinformatic evidence for building new metabolic
models
ThereisagreatdealofbiochemicalknowledgeaboutGene-Protein-Reaction
relationships that are not from E. coli MG1655, many of which are in the
MetaCyc database of reaction pathways. Further reliable addition of path-
ways from this database could be achieved by direct comparison of query
strain genes (and sets of genes) with the genes experimentally characterised
and deposited in MetaCyc. One way of doing this would be by developing
a tool for extracting the genes and their GPR relationships from MetaCyc,
extracting the amino acid sequences of those genes from Genbank and using
BLASTp to compare them to the query genes.
Further construction of the CFT073 model in particular will require fur-
ther experimental veriﬁcation of the putative metabolic genes presented in
this work and development of a system for reliable inference of reactions
205from genes not present in MG1655, combining sources like MetaCyc and
GenBank to produce an automatic system for direct inference of function
from experimentally characterised genes from other organisms.
8.7 Final conclusions
The application of context based gene synteny comparisons to model build-
ing and addition of experimentally veriﬁed pathways to these has been suc-
cessfully carried out. One such initial model, that of CFT073, has been
experimentally validated in some limited conditions. The DH method is
an additional tool in the reliable inference of metabolic models and could
be incorporated into any existing methods of inference based on BLAST
to potentially improve bacterial synteny comparisons. The addition of a
metabolic pathway from CFT073 to DH5 has been used to investigate the
metabolic changes that occur on addition of such heterologous pathways
and how they might integrate into the metabolism of a host bacterium. It is
hoped that the work presented here gives an indication of the type of work
that will be required in building complete models of metabolism for bacteria
and modifying them by addition of reactions from heterologous sources, a
combination of bioinformatic and experimental approaches.
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